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ABSTRACT

Functional Analysis and Post-Transcriptional Regulation of Oocyte-Specific
Transcription Factors During Early Embryogenesis in Cattle
Swamy Krishna Tripurani
Early embryonic loss is a major contributing factor to infertility in livestock species. A
growing body of evidence implicates that oocyte-expressed genes especially the transcription
factors are crucial functional mediators of oocyte and early embryonic development. Furthermore,
small non-coding RNAs called microRNAs have been demonstrated to be important in regulating
numerous biological processes. However, the identities and functions of oocyte-specific
transcription factors and microRNAs during early embryogenesis are relatively unknown.
Therefore, using bovine as a model the role of oocyte-specific transcription factors and
microRNAs were investigated during early embryonic development.
Newborn ovary homeobox (NOBOX) is an oocyte-specific transcription factor essential
for folliculogenesis and expression of many germ-cell specific genes in mice. However, the
temporal and cell specific expression of NOBOX in bovine oocytes and potential function and
regulation of NOBOX in early embryogenesis have not been described previously. Messenger
RNA for bovine NOBOX is preferentially expressed in ovaries and undetectable by RT-PCR in
somatic tissues examined. NOBOX protein is present in oocytes throughout folliculogenesis and
is stage-specifically expressed during oocyte maturation and early embryonic development.
Depletion of NOBOX in early embryos demonstrated that NOBOX is an essential maternal
derived transcription factor during bovine early embryogenesis, which functions in regulation of
embryonic genome activation, pluripotency gene expression and blastocyst cell allocation.
Furthermore, a potential microRNA recognition element (MRE) for miR-196a was identified in
the 3’ UTR of the bovine NOBOX mRNA. miR-196a is expressed both in oocytes and embryos
and tends to increase at the four-cell and eight-cell stage. Transient transfection and reporter
assays revealed that miR-196a represses the expression of NOBOX in a MRE dependent
manner. Ectopic expression of miR-196a mimic in bovine early embryos significantly reduced
the NOBOX expression at the both mRNA and protein levels. Collectively, our results establish
a novel functional role for NOBOX during early embryonic development. Results also provide
evidence that miR-196a is a bona fide negative regulator of NOBOX during bovine early
embryogenesis.
Factor In the GermLine Alpha (FIGLA), a basic helix-loop-helix transcription factor, is
essential for primordial follicle formation and expression of many oocyte specific genes that are
required for fertilization and early embryonic survival. Here we report the characterization of
bovine FIGLA gene and its regulation during early embryogenesis. Expression of bovine FIGLA
mRNA is restricted to gonads and is abundant in germinal vesicle and metaphase II stage
oocytes, as well as in embryos from pronuclear to eight-cell stage, but barely detectable in
embryos collected at morula and blastocyst stages, suggesting that FIGLA might be a maternal
effect gene. Computational predictions identified a potential microRNA recognition element
(MRE) for miR-212 in the 3’ UTR of the bovine FIGLA mRNA. Bovine miR-212 is expressed in

	
  

	
  

oocytes and tends to increase at the four-cell and eight-cell stage embryos followed by a decline
at morula and blastocyst stages. Transient transfection and reporter assays revealed that miR212 represses the expression of FIGLA in a MRE dependent manner. Furthermore, ectopic
expression of miR-212 mimic in bovine early embryos dramatically reduced the expression of
FIGLA mRNA and protein. Collectively, our results demonstrate that FIGLA is spatio-temporally
regulated during bovine early embryogenesis and miR-212 is an important negative regulator of
FIGLA during the maternal to zygotic transition in bovine embryos.
	
  
Small endogenous RNA molecules, termed microRNAs (miRNAs), are evidenced for their
involvement in the regulation of gene expression during folliculogenesis and early embryonic
development. To identify miRNAs expressed in bovine oocytes/ovaries, we constructed a
bovine fetal ovary miRNA library. Sequence analysis of random clones from the library identified
679 miRNA sequences, which represent 58 distinct bovine miRNAs. Of these distinct miRNAs,
42 are known bovine miRNAs and the remaining 16 miRNAs include 15 new bovine miRNAs
that are homologous to miRNAs identified in other species, and one novel miRNA, which does
not match any miRNAs in the database. Expression analysis of the 58 miRNAs in fetal ovaries
in comparison to somatic tissue pools identified 8 miRNAs predominantly expressed in fetal
ovaries, of these eight miRNAs, two miRNAs (bta-mir424 and bta-mir-10b) are highly abundant
in germinal vesicle (GV)-stage oocytes and are differently expressed during oocyte maturation
and early embryonic development. Expression of the novel miRNA is relatively low in oocytes
and early cleavage embryos but high in blastocysts, suggesting a role of this miRNA in
blastocyst cell differentiation. This study reports the cloning of 58 miRNAs from bovine fetal
ovaries, discovery of new bovine miRNAs including one that is completely novel, and
identification of two miRNAs that are highly abundant in oocytes and early cleavage embryos.
	
  
Sumoylation is a post-translational modification in which a SUMO (small-ubiquitin-related
modifier) moiety is conjugated to specific proteins involved in transcriptional regulation, protein
transport, chromosome segregation and signal transduction via an enzymatic cascade. SUMOconjugating enzyme Ubc9, which is highly conserved across species, is essential for several
developmental processes. As the first step towards understanding the physiological role of
bovine Ubc9, we analyzed the expression of Ubc9 mRNA in bovine tissues including fetal
ovaries of different developmental stages, and characterized the temporal expression patterns
of Ubc9 mRNA and protein during oocyte maturation and early embryogenesis. Bovine Ubc9 is
ubiquitously expressed in all tissues and is highly abundant in fetal ovaries of late gestation.
Real time PCR analysis and immunocytochemical analysis demonstrated that expression of
Ubc9 mRNA and protein is abundant in germinal vesicle (GV) and metaphase II (MII) stage
oocytes, as well as in early embryos, but decreases between eight-cell and blastocyst stage,
suggesting that Ubc9 might be a maternal effect gene. We performed yeast two-hybrid assay to
identify putative SUMO substrates from a bovine fetal ovary library using Ubc9 as bait. A total of
nine interacting clones were identified including three clones encoding activating transcription
factor 7 interacting protein 2 (ATF7IP2). Inspection of the ATF7IP2 sequence using SUMOsp
2.0 software program predicted two high probability putative SUMO attachment sites, indicating
that ATF7IP2 is a potential SUMO substrate. ATFIP2 is gonad specific and is expressed in fetal
ovaries harvested as early as 90 days of gestation and tends to increase with increased
gestational age. ATF7IP2 is stage-specifically expressed during oocyte maturation and early
embryonic development. Collectively, our results suggest that Ubc9 is developmentally
regulated in cattle and it interacts with ATF7IP2, a gonad-specific protein, which might play an
important role during folliculogenesis and early embryonic development.
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INTRODUCTION
Oocyte developmental competence is defined as the capacity of the oocyte to resume
meiosis, cleave after fertilization, help promote embryonic development and implantation, and
bring a pregnancy to term in good health (Krisher, 2004, Picton et al., 1998, Sirard et al., 2006).
Oocytes gradually and sequentially acquire developmental competence during the course of
folliculogenesis, by synthesizing and accumulating transcripts and proteins that are of
importance for successful folliculogenesis, germ cell maturation, fertilization, and early
embryogenesis, and are the functional mediators of oocyte competence (Eppig, 2001, Eppig et
al., 2002, Hussein et al., 2006). The development of transgenic mouse models and availability
of vast arrays of DNA sequence information in the forms of complete genome, expressed
sequence tags libraries and suppressive subtractive hybridization (SSH) and microarray data
has been critical in identifying and revealing how oocyte-specific transcripts are essential to
above oocyte developmental milestones and how they could be functionally associated with
poor oocyte competence (Andreu-Vieyra et al., 2006). Our lab has placed considerable
emphasis in recent years to understand the functional role of oocyte-derived gene products in
promoting early embryogenesis and determination of oocyte competence in cattle. We have
utilized a combination of functional studies of candidate genes of interest selected based on
published reports in the mouse and functional studies of genes identified using genomic tools in
the bovine model system hypothesized to be important for oocyte competence and early
embryogenesis. Given the relative lack of data in other mammalian species, this chapter
summarizes current knowledge obtained from studies in the mouse regarding the functional role
of select candidate oocyte-specific genes (transcriptional and post transcriptional regulators)
potentially relevant to oocyte competence in cattle. Available information and gaps in knowledge
in the bovine model system (Table 1), where much of the published data is descriptive, are
emphasized. In the second part of this chapter, major emphasis is placed on recent insights
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gained (using functional genomics approaches) into novel oocyte expressed genes that confer
oocyte competence and are critical for early embryogenesis in cattle.

Potential contribution of oocyte-specific transcriptional and post-transcriptional
regulators to bovine oocyte competence: Available evidence and gaps in
knowledge
The ovarian follicle is the functional unit of the ovary, and consists of the oocyte and its
associated somatic cells (granulosa, theca and cumulus cells). Folliculogenesis involves a
series of highly regulated sequential steps in which a growing follicle either develops to the
ovulatory stage or dies by apoptosis. Progression through follicular development is a
prerequisite for acquisition of oocyte competence, as > 99% of bovine follicles become arrested
in development at various stages of folliculogenesis, die via atresia and never have the
opportunity to release an oocyte to be fertilized. The major steps in folliculogenesis include the
primordial/primary transition, the primary/secondary transition, selection, and atresia. The
delicate interplay of developing oocytes and somatic cells is controlled and orchestrated through
several endocrine factors [follicle stimulating hormone (FSH) and luteinizing hormone (LH)
(Danforth, 1995, Moley and Schreiber, 1995), autocrine and paracrine regulators such as TGF-β
family members (Elvin et al., 2000), the insulin-like growth factor system (Schams et al., 1999),
inhibins/activins (Knight and Glister, 2001) and gap junctional communication (connexins)
(Kidder and Mhawi, 2002). With the advent of genomics and gene knockout studies, several
oocyte specific transcription factors, RNA binding proteins and growth factors were identified
and are proved to play essential role in mammalian folliculogenesis (Andreu-Vieyra et al., 2006,
Choi and Rajkovic, 2006b, Epifano and Dean, 2002, Pangas, 2007). The list of known oocytespecific genes required for normal development of germ cells and surrounding somatic cells
during folliculogenesis continues to expand and currently includes Figla (Factor in the germline
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alpha) (Soyal et al., 2000), Nobox (Newborn ovary homeobox) (Rajkovic et al., 2004), Sohlh1
and Sohlh2 (spermatogenesis and oogenesis specific basic helix–loop–helix 1 and 2) (Ballow et
al., 2006, Pangas et al., 2006), Obox (Oocyte-specific homeobox) (Rajkovic et al., 2002), Dazla
(deleted in azoospermia-like autosomal) (Ruggiu et al., 1997), Ybx2 (Y box protein 2) (Gu et al.,
1998), Cpeb1 (cytoplasmic polyadenylation element binding protein 1) (Racki and Richter,
2006), Gdf9 (Growth differentiation factor 9) (Dong et al., 1996) and

Bmp15 (Bone

morphogenetic protein15) (Dube et al., 1998) (Fig. 1). These genes encode for a compilation of
transcription factors, mRNA binding proteins and secreted proteins expressed in the oocyte and
surrounding somatic cells in some instances. Such genes play important regulatory roles in
control of follicle formation and germ cell development, regulation of granulosa cell proliferation
and steroidogenesis and in some instances also impact early embryonic development (Fig. 1).
To date, the functional role of above oocyte/germ cell specific transcription factors and post
transcriptional regulators (RNA binding proteins, translational regulators) during the initial stages
of early embryogenesis has largely been overlooked, often times due to defects in
folliculogenesis in gene targeting models. However, this potential functional role may be of
significance particularly to species such as cattle with a longer interval between fertilization to
transfer of developmental control to the products of the embryonic genome (maternal-toembryonic transition). The known functional role of such transcriptional and post-transcriptional
regulators in the mouse and potential significance to early embryonic development in the bovine
species is outlined below.	
  

	
  
A. Factor in the germline alpha (Figla) 	
  
Factor in the germline alpha (Figla) encodes a germ-cell specific basic-helix-loop-helix
(bHLH) transcription factor (Liang et al., 1997). Figla is a major regulator of the zona pellucida
protein genes (Zp2 and Zp3) (Liang et al., 1997). Mouse Figla transcript is expressed as early
as embryonic day (E) E13.5 in the female gonad and persists throughout folliculogenesis (Soyal
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et al., 2000). Female Figla knockout mice are infertile (Soyal et al., 2000). Germ cell migration
and proliferation and development of embryonic gonads appear normal in female Figla knockout
mice (Soyal et al., 2000). However, the formation of primordial follicles is blocked and oocytes
are rapidly lost in a matter of a few days (Soyal et al., 2000). As expected Zp1, Zp2, and Zp3
transcripts are not detectable in the ovaries of the Figla knockout mice (Soyal et al., 2000), but
important genes such as Gdf9, Bmp15, Kit, Kitl, Cx43 (connexin 43) and Fgf8 (fibroblast growth
factor 8) are present in ovaries of both knockout and wild type animals. These observations
indicate that Figla plays a key regulatory role in at least two independent oocyte- specific
pathways, those that initiate folliculogenesis and those that regulate expression of the zona
pellucida protein genes (Soyal et al., 2000) (Fig. 1). A comparison of normal and Figla knockout
mice ovaries by microarray and serial analysis of gene expression (SAGE) identified several
oocyte specific genes, including maternal effect genes, that are directly or indirectly regulated by
Figla (Joshi et al., 2007). Recently, it was shown that expression of Figla is a critical not only for
activation of oocyte-associated genes but also for repression of sperm-associated genes during
postnatal oogenesis (Hu et al., 2010).
In humans, Figla is expressed as early as 14 weeks gestational age with a dramatic
increase in the midgestation (time of primordial follicle formation) (Bayne et al., 2004).
Electrophoretic mobility shift assays with in vitro-expressed human Figla protein showed that, as
in the mouse, Figla can heterodimerize with E12 protein and bind to the E-box of the human
ZP2 promoter, suggesting a similar conserved function of the human and mouse Figla protein.
Furthermore, mutations in the Figla gene are associated with premature ovarian failure in
humans (Zhao et al., 2008). All these findings suggest that Figla is a critical transcriptional
regulator that is required to sustain transcription of its target genes that may be critical both in
folliculogenesis and early embryonic development. However, the functional role and regulation
of Figla during early embryogenesis is lacking.
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B. Newborn ovary homeobox-encoding gene (Nobox)
Nobox was identified by in silico subtraction of expressed sequence tags (ESTs) derived
from the newborn ovaries of mice (Suzumori et al., 2002). Nobox mRNA is preferentially
expressed in germ cells, is detectable in embryonic ovaries as early as E15.5 and is present in
oocytes throughout all stages of folliculogenesis (Rajkovic et al., 2004, Suzumori et al., 2002).
Female mice lacking Nobox have apparently normal embryonic ovarian development, germ cell
migration and form primordial follicles perinatally (Rajkovic et al., 2004). However, growth of
primordial follicles and development from the primordial to primary follicle stage is severely
compromised (Rajkovic et al., 2004). Nobox deletion also accelerates the loss of oocytes, such
that by 14 days post-partum only a few remain in ovaries of mutant mice (Rajkovic et al., 2004).
Gene expression analysis in newborn ovaries (before pronounced germ cell depletion) revealed
abundance of mRNA for numerous genes preferentially expressed in oocytes, such as Mos,
Oct4, Rfpl4, Fgf8, Zar1, Dnmt1o, Gdf9, Bmp15, and H1oo is reduced in ovaries of Nobox
knockout mice whereas transcripts for genes important in germ cell migration (Kitl and Kit),
apoptosis (Bcl2, Bcl2l2, Casp2, and Bax) and meiosis (Mlh1 and Msh5) display similar
expression levels in ovaries of wild type and Nobox knockout mice (Rajkovic et al., 2004).
Furthermore, Nobox has been shown to bind to putative Nobox binding elements with high
affinity and regulate transcriptional activity of mouse Gdf9 and Oct4 genes (Choi and Rajkovic,
2006a) (Fig. 1). In humans, Nobox is oocyte-specific, with expression observed from the
primordial stage ovarian follicle through to the metaphase II (MII) oocyte (Huntriss et al., 2006).
Furthermore, mutations in the Nobox gene associated with premature ovarian failure have been
described in humans (Qin et al., 2009; Zhao et al., 2005). These findings suggest that Nobox is
an important transcriptional regulator that either directly or indirectly regulates a subset of genes
preferentially expressed in postnatal oocytes, some of which have been shown to play essential
roles in oogenesis. However, the temporal and cell specific expression of NOBOX in bovine
oocytes and potential function of NOBOX in early embryogenesis is unknown.
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C. Spermatogenesis and Oogenesis specific basic helix–loop–helix 1/2 and LIM
homeodomain transcription factor 8 (Sohlh1, Sohlh2 and Lhx8)	
  
Sohlh1 and Sohlh2 encode germ cell specific basic helix-loop-helix transcription factors.
These genes were discovered using an in silico subtraction strategy to identify genes that are
preferentially expressed during early folliculogenesis in mice (Ballow et al., 2006, Pangas et al.,
2006). Sohlh1 and Sohlh2 transcripts are expressed in E15.5 and E13.5 embryonic ovaries
(Ballow et al., 2006, Pangas et al., 2006). Sohlh1 and Sohlh2 proteins are detectable in germ
cell cysts, primordial follicles, and primary follicles but undetectable by the secondary follicle
stage, suggesting that regulation of Sohlh1 and Sohlh2 may be important for early
folliculogenesis (Ballow et al., 2006, Pangas et al., 2006) (Fig. 1).
Female mice lacking Sohlh1 appears to have normal germ cell migration and embryonic
gonadogenesis, but form imperfect primordial follicles that do not progress to primary follicle
stage (Pangas et al., 2006). Ovaries of Sohlh1 knockout mice contain significantly lower
amounts of Figla transcripts and transcripts for the Figla target genes Zp1 and Zp2 (Pangas et
al., 2006). Nobox transcripts are also reduced approximately 4-fold in Sohlh1 knockout ovaries.
In addition, oocyte specific genes that were down regulated in ovaries of Nobox knockout mice
were also down regulated in Sohlh1 knockout ovaries, confirming that the Nobox pathway is
compromised in Sohlh1 mutant mice and that Nobox functions downstream of Sohlh1 (Pangas
et al., 2006) (Fig. 1).
Microarray analysis of ovaries of Sohlh1 knockout mice also revealed that the LIM
homeodomain transcription factor, Lhx8, is down regulated in the absence Sohlh1 (Pangas et
al., 2006). Lhx8 is preferentially expressed in testes and ovaries and localizes to oocytes of
germ cell cysts and primordial, primary, and antral follicles (Pangas et al., 2006). Lhx8 mRNA
expression is detectable as early as E13.5 and mimics embryonic ovary expression of Sohlh1
(Pangas et al., 2006). Ovaries of Lhx8 knockout mice fail to maintain primordial follicles, and the
transition from primordial to growing follicles does not occur (Choi et al., 2008a). Oocyte-specific
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genes, such as Nobox, Gdf9, Oct4, and Zp3 also show abnormal expression in the ovaries of
Lhx8 knockout mice (Choi et al., 2008a). Furthermore chromatin immunoprecipitation and
luciferase reporter assay revealed that Sohlh1 binds to the conserved E box element found in
the proximal promoter region of Lhx8, Nobox, Zp1 and Zp3 (Pangas et al., 2006). Collectively,
results indicate that Sohlh1 and Lhx8 are master oocyte transcription factors functionally linked
to folliculogenesis and Sohlh1 acts upstream of Lhx8, Figla, and Nobox.
Sohlh2 deficiency in female mice accelerates postnatal oocyte loss in the ovary and
causes infertility (Choi et al., 2008b). Sohlh2 knockout mice form primordial follicles and, despite
limited oocyte growth, do not differentiate surrounding granulosa cells into cuboidal and
multilayered structures (Choi et al., 2008b). In addition, Sohlh2 deficiency affects the expression
of numerous genes in oocytes (Nobox, Figla, Gdf9, Pou5f1, Zp1, Zp3, Oosp1, Nlrp14, H1foo,
Stra8) including Sohlh1 (Choi et al., 2008b). These findings show that Sohlh1 and Sohlh2 are
critical for early follicle formation and development and oocyte survival and that Sohlh1 and
Sohlh2 play distinct yet important roles (Choi et al., 2008b).
To our knowledge, there have been no published studies on Sohlh1, Sohlh2 and Lhx8
expression in bovine oocytes and early embryos. It would be interesting to know whether these
transcription factors are also linked to normal early embryonic development in cattle and help
mediate gene expression changes coincident with embryonic genome activation.

D. Oocyte-specific homeobox gene family (Obox)
Obox (oocyte-specific homeobox) genes have been referred to as the first homeobox
gene family preferentially expressed in mouse adult germ cells (Cheng et al., 2007, Rajkovic et
al., 2002). Obox1 and Obox2 were identified in adult mouse germ cells using in silico
subtraction strategies (Rajkovic et al., 2002). Obox1 and Obox2 transcripts encode
homeodomain proteins and share 97% identity with each other (Rajkovic et al., 2002).
Nucleotide sequence analysis of BACs encoding Obox1 and Obox2 and BLAST searches
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against the publicly available mouse genome database identified Obox3, Obox4, Obox5, and
Obox6, which share significant homology to Obox1 and Obox2. Northern blot and RT-PCR
analysis revealed that five of six Obox genes are preferentially expressed in gonads (ovary)
(Rajkovic et al., 2002). In situ hybridization analysis of Obox1 and Obox6 revealed their
transcripts are exclusively expressed in oocytes throughout folliculogenesis (Rajkovic et al.,
2002). Mice lacking Obox6 undergo normal embryonic development and are fertile indicating a
functional Obox6 gene is not obligatory for fertility (Cheng et al., 2007). However the roles of
other Obox gene family members are currently unknown in mice and to our knowledge, no
information is available on expression of Obox genes in bovine oocytes and early embryos.
Lack of phenotype in Obox6 knockout mice suggests potential functional redundancy amongst
Obox gene family members, but studies are needed to understand their expression and
potential contribution to early embryogenesis in cattle.

E. Deleted in Azoospermia Like gene (Dazl)
The Deleted in Azoospermia Like (Dazl) gene is a member of the Deleted in
Azoospermia (DAZ) family, expressed exclusively in germ cells. Protein products for Dazl gene
family members contain a highly conserved RNA-binding motif and a unique DAZ repeat (Yen,
2004). In humans and mouse the Dazl gene is expressed in both the testis and the ovary
(Brekhman et al., 2000, Cooke et al., 1996, Ruggiu et al., 1997), Dazl knockout mice ovaries
contain steroidogenically active cells capable of producing estradiol and inhibin, despite a total
loss of oocytes during fetal life (McNeilly et al., 2000) and absence of follicular structures. The
Dazl protein in mice functions in regulating protein translation in germ cells by interacting with
PABP-binding protein (Collier et al., 2005, Padmanabhan and Richter, 2006) and also in
maintaining pluripotency and genetic and epigenetic modifications during germ cell development
(Haston et al., 2009).
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There is limited information on Dazl expression and function in oocytes of other species
relevant to a potential functional role in the bovine species. In cattle, the Dazl gene is expressed
exclusively in testis and ovary and thought to play an important role in spermatogenesis (Liu et
al., 2007, Zhang et al., 2008). In pigs, Dazl mRNA and protein is localized to the oocyte
throughout folliculogenesis and oocyte maturation (Liu et al., 2009). Furthermore, addition of
factors such as glial cell line-derived neurotrophic factor (GDNF), epidermal growth factor
(EGF), and follicle-stimulating hormone (FSH) that are known to enhance oocyte maturation and
developmental competence, increased the expression of Dazl in oocytes derived from the small
and large antral follicles during in vitro maturation, Such results indicate that that these factors
play a potential role in promoting Dazl expression, which may subsequently affect translational
regulation of key proteins associated with oocyte maturation and subsequent embryonic
development (Liu et al., 2009). Interestingly, in human blastocysts, the presence of Dazl
transcripts was only detectable in blastocysts of good quality (Cauffman et al., 2005). Therefore,
results from other species indicate Dazl functions in germ cell differentiation, folliculogenesis
and oocyte maturation. Given the importance of translational regulatory mechanisms in the
maternal-to embryonic transition (Bettegowda and Smith, 2007), investigation of the link
between Dazl expression and bovine oocyte competence holds merit.

F. Y box protein 2 (Msy2)	
  
Y-Box proteins are multifunctional proteins that are implicated in translational regulation
via their ability to stabilize and or prevent translation of specific mRNAs. In addition, some
members are also involved in the sub cellular localization or transport of mRNAs by interacting
with cytoskeletal proteins (Matsumoto et al., 1996, Ruzanov et al., 1999, Sommerville and
Ladomery, 1996). The Y-box protein 2 (synonym, Msy2) is a germ-cell specific DNA/RNA
binding protein and a member of a cold-shock domain protein super family that is conserved
from bacteria to humans (Wolffe et al., 1992). Msy2 contains the cold shock domain that is
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highly conserved among all Y box proteins and four basic/aromatic islands that are closely
related to the other known germline Y box proteins from Xenopus (Frgy2), (Tafuri and Wolffe,
1990) and gold fish (Gfyp2) (Katsu et al., 1997). In the ovary, Msy2 is present exclusively in
diplotene-stage and mature oocytes (Gu et al., 1998). Msy2 constitutes about 2% of the total
protein in the fully-grown oocyte, but after fertilization, it is totally degraded by the late two-cell
stage in mice. Female mice lacking Msy2 are infertile due to increased oocyte loss, anovulation
and multiple follicular defects (Yang et al., 2005). Furthermore transgenic RNAi mediated
reduction of Msy2 results in abnormal intracellular Ca2+ oscillations, chromatin morphology,
meiotic spindle formation and protein synthesis during maturation (Yu et al., 2004). Collectively,
evidence in mice supports a requirement of Msy2 for oocyte survival, follicular development and
fertility, presumably by stabilization and translational regulation of mRNAs critical to oocyte
development and survival.
A similar Msy2 expression pattern as observed in mouse is characteristic of bovine
embryos (Vigneault et al., 2004b) where expression is low to undetectable after embryonic
genome activation (8-cell stage). Observed temporal expression patterns suggest Msy2 may
also play a functional role during initial stages of early embryonic development (Vigneault et al.,
2004a, Yu et al., 2001, Yu et al., 2002), particularly in cattle. However, direct evidence of such a
requirement for Msy2 during early embryogenesis is lacking.

G. Cytoplasmic polyadenylation element-binding protein1 (Cpeb1)
Cpeb is an RNA-recognition motif (RRM) and zinc-finger-containing sequence-specific
RNA-binding protein that is found in a wide range of vertebrates and invertebrates (Richter,
2007). Cpeb proteins are often referred to as Cpeb1. Cpeb1 regulates mRNA translation and,
through this activity, influences gametogenesis and early development (Mendez and Richter,
2001, Racki and Richter, 2006, Tay et al., 2003). Adult female Cpeb1 knockout mice contain
vestigial ovaries that are devoid of oocytes, but ovaries from mid-gestation embryos contain
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oocytes that are arrested at the pachytene stage due to the absence of protein components
(SCP1 and SCP2) which are targets of Cpeb1 and critical for formation of synaptonemal
complexes (Tay and Richter, 2001). Further, to assess the function of Cpeb1 later during oocyte
development, transgenic mice were generated in which short-hairpin RNA (shRNA) against
Cpeb1 was placed under the control of the zona pellucida 3 (Zp3) promoter which is transcribed
after the pachytene stage (Racki and Richter, 2006). Oocytes from the ZP3-Cpeb1 shRNA
transgenic mice do not develop normally. Such oocytes undergo parthenogenetic cell division in
the ovary, exhibit abnormal polar bodies, are detached from the cumulus granulosa cell layer
and display spindle and nuclear anomalies. Follicular development is also impacted as follicles
containing such oocytes exhibit apoptotic granulosa cells (Racki and Richter, 2006). In addition,
Cpeb1 has been shown to bind RNA transcripts for several key oocyte expressed genes (Racki
and Richter, 2006) and Cpeb1 knockdown oocytes displayed reduced expression of Gdf9,
which is important determinant of follicular development.
Some information is available on Cpeb1 expression in bovine oocytes. Cpeb1is localized
in oocyte cytoplasm and is hyperphosphorylated during the prophase/metaphase-I transition.
Most Cpeb1 is degraded in metaphase-II bovine oocytes and Cpeb1 degradation is prevented in
the presence of meiotic inhibitors such as roscovitine (Uzbekova et al., 2008). Like data for
Msy2 and Daz1 knockout animals, evidence from Cpeb1 knockout/knockdown studies illustrates
the importance of translational regulatory mechanisms and specific molecular mediators to
oocyte development and acquisition of competence. To our knowledge, Cpeb1 expression in
early bovine embryos has not been examined. However, a role for maternally derived Cpeb1 in
translational regulation during the maternal-to-embryonic transition post fertilization in cattle
seem unlikely given the massive degradation of Cpeb1 that accompanies progression of bovine
oocytes to metaphase II.

Maternal-oocyte derived factors required specifically for early embryogenesis:
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In numerous species, early embryonic development is characterized by important
developmental transitions that occur following fertilization (Schultz et al., 1999), including the
replacement of maternal with zygotic RNAs, compaction, the first lineage differentiation into
inner cell mass and trophectoderm and implantation. First chronologically and hence most
important to the focus of this review is the maternal to embryonic transition defined as the time
period during embryonic development beginning at fertilization until control of early
embryogenesis changes from regulation by oocyte-derived factors to regulation by products of
the embryonic genome (embryonic genome activation) (Bettegowda et al., 2008a). In mice,
embryonic genome activation occurs during the two-cell stage, but it begins during the four-cell
stage in humans, rats and pigs, and during the eight-cell to 16-cell stage in cattle and sheep
(Telford et al., 1990) (Fig. 2). In bovine embryos, minor genome activation is initiated as early as
the one-cell stage and referred to as minor genome activation (Memili and First, 1999), but the
significance of minor genome activation to development is not clear. Progression to the eightcell stage is not dependent on new transcription as development can occur when embryos are
cultured in the presence of inhibitors of transcription. Several studies using techniques like
microarray, gene-knockout and RNAi have proved that products of numerous maternal effect
genes transcribed and stored during oogenesis mediate the maternal-to-embryonic transition
(Cui et al., 2007, Paradis et al., 2005, Sun et al., 2008, Wianny and Zernicka-Goetz, 2000).
Maternal factors have several prominent functions during the maternal-to-embryonic transition
(Li et al., 2010, Schultz, 2002). The first function is the removal of maternal RNA and protein. A
second role is to promote dramatic reprogramming of both male and female genomes from a
repressed chromatin state to one favoring transcription and a third function of maternal factors is
robust activation of the embryonic genome. Such factors also help mediate initial cleavage
divisions post fertilization.
In the mouse, above described developmental transitions are accompanied by
orchestrated expression of transcription factors (Hsf1, Bnc1, Ctcf, Oct4 and Sox2), chromatin
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remodeling factors (Ube2a, Npm2, Trim24, Smarca4 and Brwd1), DNA methylation machinery
(Dntm1, Dppa3 and Zfp57), genes involved in degradation of maternal factors (Dicer1, Ago2
and Atg5) and genes involved in the preimplantation development (Zar1, Mater (Nlrp5), Floped,
Padi6 and Filia). However, only those that are uniquely expressed in oocytes and functionally
linked to early embryonic development (Mater, Floped, Zar1, Npm2, Dppa3 and Oct4) (Table 1)
will be discussed below.

A. Maternal antigen that embryos require (Mater)
Maternal antigen that embryos require (Mater) was identified as an antigen associated
autoimmune oophoritis in the mouse and thought to play a role in autoimmune premature
ovarian failure (Tong and Nelson, 1999). Subsequent studies demonstrated an important
functional role for Mater in early embryonic development. Mater is a single copy gene
exclusively expressed by germ cells during oogenesis and is present in early cleavage stage
embryos, but barely detectable at the blastocyst stage in several species (Ma et al., 2009,
Pennetier et al., 2006b, Pennetier et al., 2004, Tong et al., 2002, Tong et al., 2004). Mater
knockout mice have normal folliculogenesis and ovulate oocytes that can be fertilized (Tong et
al., 2000). Although resulting zygotes can progress through the first cleavage division,
subsequent development is arrested at the two-cell stage leading to a sterile phenotype in
homozygous null females (Tong et al., 2000). De novo RNA transcription is decreased in the
one- and two-cell embryos lacking Mater. Nevertheless, two-cell embryos lacking Mater were
able to synthesize the transcription-requiring complex, indicating that Mater is not critical for
initiation of embryonic genome activation (Tong et al., 2000).
Li et al. recently identified a subcortical maternal complex (SCMC) that assembles
during oocyte growth and is essential for zygotes to progress beyond the first embryonic cell
division (Li et al., 2008). The SCMC, located in the subcortex of oocytes, is excluded from
regions of cell–cell contact in the cleavage-stage embryo and segregates to the outer cells of
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the morula and blastocyst. At least four maternally encoded proteins contribute to this complex:
Floped, Mater and Tle6 interact with each other, and Filia binds independently to Mater (Li et al.,
2008). Filia was originally identified as a Mater binding partner preferentially expressed in
growing oocytes (Ohsugi et al., 2008). Both Filia and Mater co-localize to the cytocortex of
ovulated oocytes, where the stability of Filia is dependent on presence of Mater (Ohsugi et al.,
2008). Additionally, depletion of maternal stores of Filia impairs preimplantation embryo
development with a high incidence of aneuploidy that results from abnormal spindle assembly,
chromosome misalignment, and spindle assembly checkpoint (SAC) inactivation (Zheng and
Dean, 2009).
Available evidence also indicates Mater may also function as an oocyte specific
maternal effect gene in cattle. Mater mRNA and protein are present in bovine oocyte from the
primary follicle stage onwards (Pennetier et al., 2006a). Mater mRNA is decreased during
meiotic maturation and through initial cleavage divisions and is low to undetectable in morula
and blastocyst stage bovine embryos, whereas Mater protein persists through the blastocyst
stage (Pennetier et al., 2006a). To our knowledge, a potential functional role of Mater and it
binding partner Filia during bovine oocyte and early embryonic development has not been
investigated. However, no relationship between Mater transcript abundance and oocyte quality
was observed in two established models (prepubertal calf and brilliant cresyl blue staining) used
to identify oocytes of reduced developmental competence in cattle (Mota et al., 2010, Romar et
al., 2011). Investigation of potential existence of a SCMC and a functional role for Mater and
Filia in early bovine embryos merits further investigation.

B. Factor located in oocytes permitting embryonic development (Floped)
Floped was identified by screening SAGE libraries derived from ovaries of normal and
Figla null mice. Floped is exclusively expressed in the ovary, and within the ovary, expression is
restricted to growing oocytes (Li et al., 2008). During early embryonic development Floped
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transcripts are present in one-cell stage embryos, but barely detectable from 2-cell to blastocyst
stage. Female Floped null mice are infertile, but have normal ovarian histology, folliculogenesis
and oogenesis (Li et al., 2008). Oocytes from Floped mutant mice can be fertilized and normalappearing 1-cell zygotes recovered. However, progression from one-cell to two-cell stage is
delayed and blastomeres within embryos from Floped mutant mice often appear unequal in size
with attenuated contact regions (Li et al., 2008).
As stated above, Mater, Tle6 and Filia were identified as potential binding partners of
Floped and components of the SCMC (Li et al., 2008). Tle6, a mammalian homolog of the
Groucho gene from drosophila, belongs to the Groucho/Tle super family of transcriptional
corepressors known to play a critical role in a range of developmental processes (Bajoghli,
2007). Tle6 is predominantly expressed in ovaries similar to Floped and Mater (Li et al., 2008).
There is no SCMC and sub cortical localization of Mater, Tle6 and Filia is absent in the oocytes
from Floped null mutant animals and sub cortical localization of Tle6, Filia and Floped is absent
in oocytes from Mater null mutant animals indicating that existence of the SCMC depends upon
the presence of Floped and Mater (Li et al., 2008). The similar expression pattern of the four
genes, the physical interactions of the four cognate proteins, and their colocalization in
conjunction with the sterile phenotype of Floped and Mater mutant female mice has established
existence of the SCMC potentially required for progression through early cleavage stages of
preimplantation development. Comparative studies of the functional role of above genes, and
the existence and function of the SCMC in early embryogenesis in cattle both merit further
investigation to determine potential species specificity in function of maternal effect genes
during early embryogenesis.

C. Zygote arrest 1 (Zar1)
Zar1 was identified in mice by subtractive hybridization and cDNA library screening (Wu
et al., 2003a). Zar1 mRNA and protein are preferentially expressed in oocytes throughout
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folliculogenesis, persist in one-cell embryos, but are markedly diminished by the two-cell stage
and absent in embryos from four-cell through blastocyst stages (Wu et al., 2003a). Orthologs of
Zar1 have been identified and characterized for human, rat, frog, zebrafish, bovine, ovine and
chicken (Bebbere et al., 2008, Brevini et al., 2004, Michailidis et al., 2010, Wu et al., 2003b).
Zar1 knockout mice have normal ovarian development and folliculogenesis, and ovulated eggs
lacking Zar1 can be fertilized (Wu et al., 2003a). However, in contrast to the Mater null embryos,
Zar1 null embryos block predominantly at the one-cell stage (Wu et al., 2003a). Additional
analysis of the arrest in development showed that the maternal and paternal genomes remain
separate in discrete pronuclei in Zar1 null zygotes, and the two haploid genomes do not unite,
resulting in incomplete fertilization (Wu et al., 2003a). Despite containing a PHD (plant homeodomain) motif, the cytoplasmic localization of Zar1 does not support a role in gene regulation
and its absence in embryos do not affect the synthesis of the transcription requiring complex
associated with embryonic genome activation. However the precise mechanisms and potential
interacting proteins associated with Zar1 modulation of fertilization and early embryogenesis
have yet to be determined (Wu et al., 2003a).
RT-PCR studies in cattle indicate expression of ZAR1 is gonad specific and that Zar1 is
present in early embryos (Uzbekova et al., 2006). To our knowledge, evidence supporting a
functional requirement of Zar1 for normal early embryogenesis in cattle has not been reported.
However, abundance of Zar1 mRNA is lower in oocytes harvested from prepubertal animals
(model of poor oocyte quality) compared to oocytes harvested from adults (Romar et al., 2011).
The potential functional contribution of Zar1 to progression through early embryonic
development in cattle merits further investigation.

D. Nucleoplasmin 2 (Npm2)
The nucleoplasmin (NPM) family of nuclear chaperones has three members: Npm1,
Npm2 and Npm3 (Frehlick et al., 2007). These proteins have a conserved N-terminal protease-
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resistant core region domain, a classical bipartite nuclear localization signal and a C-terminal tail
domain, containing up to two additional amino acid tracts of variable length between the family
members (Frehlick et al., 2007). Npm1 and Npm3 are ubiquitously expressed in various tissues
(Frehlick et al., 2007). Npm2 is an oocyte-specific nuclear protein that binds to histones and
mediates the assembly of nucleosomes from DNA and histone proteins (Laskey et al., 1978). It
also binds sperm nuclear binding proteins (SNBPs) in order to facilitate decondensation and
remodeling of paternal chromatin following fertilization (Philpott and Leno, 1992, Philpott et al.,
1991). Within the mouse ovary, Npm2 transcripts are present exclusively in oocytes throughout
folliculogenesis, as well as early embryos, but barely detectable in embryos at morula and
blastocyst stages (Burns et al., 2003). Female Npm2 knockout mice are sub fertile or infertile
(Burns et al., 2003). Oogenesis and folliculogenesis are normal, except the DNA in the Npm2
null oocytes is amorphous and diffuse with no condensation around the nucleolus, but this
defect does not interfere with progression of oocytes to metaphase II and ovulation (Burns et al.,
2003). However, Npm2 deficient embryos display arrested development. Although sperm DNA
decondensation proceeds without Npm2, abnormalities are evident in oocyte and early
embryonic nuclei (Burns et al., 2003). These defects include an absence of coalesced nucleolar
structures and loss of heterochromatin and deacetylated histone H3 that normally circumscribe
nucleoli in oocytes and early embryos, respectively (Burns et al., 2003). The mechanisms
whereby failure of heterochromatin organization eventually leads to the mitotic failure in Npm2deficient embryos are not known.
In cattle, Npm2 expression is restricted to ovaries and is abundant in germinal vesicle
and metaphase II stage oocytes. Npm2 transcript abundance decreases in early cleavage stage
embryos, and is barely detectable in morula and blastocysts (Lingenfelter et al., unpublished).
While the functional requirement of Npm2 for early embryogenesis in the bovine to our
knowledge has not been investigated, expression of bovine Npm2 mRNA is significantly lower in
oocytes from the persistent dominant follicles (model for poor oocyte quality) compared to
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oocytes from growing dominant follicles suggesting that Npm2 transcript abundance is
associated with oocyte competence. Furthermore, a conserved microRNA (miRNA-181a)
binding site was identified in the 3’ UTR of the bovine Npm2 transcript. Transfection
experiments showed that expression of Npm2 protein is reduced dramatically in HeLa cells
expressing bovine miR-181a compared to the control cells without miR-181a, indicating that
translation of Npm2 is repressed by miR-181a. Elucidation of the role of maternal Npm2 in
bovine early embryogenesis and as a functional determinant of oocyte competence merits
further investigation

E. Developmental pluripotency associated 3 (Dppa3)
Dppa3 (also known as Stella and Pgc7) was identified while analyzing gene expression
patterns in mouse primordial germ cells and embryonic stem cells using a modified serial
analysis of gene expression protocol (Sato et al., 2002). It is specifically expressed in primordial
germ cells, oocytes, preimplantation embryos and pluripotent stem cells (Sato et al., 2002).
During early embryonic development, soon after the formation of the zygote, Dppa3
accumulates in the pronuclei, although it is also detected in the cytoplasm (Payer et al., 2003).
Both cytoplasmic and nuclear staining continues during cleavage stages until the blastocyst
stage, at which time Dppa3 is down regulated until its reappearance in primordial germ cells
(Payer et al., 2003, Sato et al., 2002). Dppa3 protein has a conserved SAP-like domain known
to be involved in chromosomal organization (Aravind and Koonin, 2000) and a splicing factor
motif like structure. Female mice lacking Dppa3 display severely reduced fertility. Embryos
without maternally derived Dppa3 are compromised in preimplantation development and rarely
reach the blastocyst stage (Payer et al., 2003). Taken together, these observations implicate
Dppa3 as an important regulator of early embryogenesis in the mouse.
In cattle, two variants of Dppa3 have been identified. Variant 1 is present in testis, ovary
and oocyte, while variant 2 is present only in oocytes (Thélie et al., 2007). Expression analysis
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during pre-implantation stages indicates that bovine Dppa3 present in early embryos is likely of
maternal origin (Thélie et al., 2007) but the functional role of Dpp3a in early embryogenesis in
cattle has not been determined.

F. Octamer binding transcription factor 4 (Oct4)
Oct4 is a member of the POU (Pit, Oct, Unc) domain transcription factor family and can
activate or repress the expression of target genes through binding to cis-acting elements which
contain an octameric DNA sequence motif (Ovitt and Scholer, 1998). Oct4 is well studied for its
role in maintenance of embryonic stem cell self-renewal and pluripotency (Boyer et al., 2006,
Lengner et al., 2008, Pei, 2009). The POU domain transcription factor Oct4 shows a dynamic
expression pattern in mouse oocytes and embryos. It is expressed during oogenesis and
folliculogenesis (Ovitt and Scholer, 1998). Maternal Oct4 RNA and protein are present in
fertilized oocytes until the two-cell stage, and zygotic Oct4 gene expression starts at the four- to
eight-cell stage (Ovitt and Scholer, 1998). Oct4-deficient mouse embryos develop to the
blastocyst stage, but the inner cell mass cells in such embryos are not pluripotent leading to
peri-implantation lethality (Nichols et al., 1998). Furthermore, in the absence of a true inner cell
mass, trophoblast proliferation is not maintained in Oct4-deficient embryos (Nichols et al.,
1998). Oct4-directed expression of Fgf4 provides a paracrine signal that couples expansion of
the extra embryonic trophoblast lineage with development of the embryonic primordium.
Collectively, above results indicate embryonic Oct4 expression plays a pivotal role in
promoting formation of pluripotent inner cell mass layer in the mammalian embryo and
expansion of the trophectoderm layer (Nichols et al., 1998). However, microinjection of Oct4
antisense morpholino oligonucleotides into one-cell mouse embryos revealed a key role for
maternal Oct4 in early events during embryogenesis. Results of such studies suggest that
maternal Oct4 is required for early embryonic development and plays a critical role in embryonic
genome activation (by regulating genes that encode transcriptional and post-transcriptional
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regulators as early as the two-cell stage (Foygel et al., 2008). Therefore, the transcription factor
Oct4 is a master regulator of multiple aspects of early embryonic development in the mouse.
Temporal expression of bovine Oct4 during oocyte and early embryonic development is
similar to its human and murine orthologues. Bovine Oct4 transcript is present at low levels in
the bovine oocyte, increases soon after zygotic genome activation, followed by a sharp increase
subsequent to compaction (Kurosaka et al., 2004, van Eijk et al., 1999). Furthermore selective
degradation of Oct4 in bovine embryos by injection of double stranded RNA (RNAi) resulted in a
significant reduction in numbers of inner cell mass cells in bovine blastocysts (Nganvongpanit et
al., 2006). Collectively, results support an important functional role for Oct4 in bovine early
embryogenesis, but specific Oct4 target genes critical to early embryogenesis and the functional
role of Oct4 of maternal versus embryonic origin remain to be elucidated.

Functional genomics studies of bovine oocyte competence: Identification of
novel mediators
Evidence described above documents the clear contribution of gene targeting studies in
mice to enhanced understanding of the functional contribution of oocyte-derived transcriptional
and post transcriptional regulators to early embryogenesis and many areas where
complementary comparative studies in the bovine model system are warranted. However,
inherent species-specific differences in the duration and number of cell cycles required for
embryonic genome activation and completion of the maternal-to-embryonic transition in mice
versus cattle may suggest potential for species specificity in the regulatory mechanisms and
genes mediating this transition (Bettegowda et al., 2008a). Thus, comparative genomics
approaches coupled to functional studies in the bovine model system are needed to address
dissimilarities in transcriptome composition between model organisms and provide information
on existence of genes or gene families that may play important regulatory roles in early
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embryogenesis and contribute to oocyte competence. In recent years, our lab have utilized
expressed sequence tag sequencing and microarray approaches as tools to identify potential
novel mediators of oocyte competence and the maternal-to-embryonic transition in cattle,
coupled with pharmacological and gene knockdown strategies to determine the functional
contribution of such genes to early embryogenesis (Fig. 3). The discovery of such novel
mediators is described below.

A. JY-1
To gain a better understanding of the bovine oocyte transcriptome, a cDNA library was
generated from a pool of 200 immature, germinal vesicle and metaphase II stage oocytes. While
only a limited number of ESTs were sequenced (Yao et al., 2004) from this library, important
novel information on oocyte gene expression was obtained. The initial 230 ESTs represented
102 unique sequences. Forty-six of such sequences displayed significant similarity to
sequences for known genes present in the Genbank database. Several ESTs represented
housekeeping genes (e.g. RPL15).

Some represented genes with previously documented

expression both in oocytes and other tissues (e.g. CKS1B). However, most of the ESTs
encoded either for genes whose expression in mammalian oocytes was previously unknown or
for genes of unknown function (Yao et al., 2004). Among the oocyte ESTs (Yao et al., 2004)
encoding for genes of unknown function, one sequence (represented by 14 fully sequenced
clones of 2 different sizes) was selected for further investigation because it was completely novel
and showed no significant homology to sequences of any known genes or ESTs in Genbank. The
name JY-1 was assigned to the putative novel gene encoding for this transcript. This novelty of
this sequence was considered significant because at the time there were approximately 4.9 million
human, 3.7 million murine and approximately 228,000 bovine EST sequences available in
Genbank.
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Published studies (Bettegowda et al., 2007) established that the JY-1 gene encodes for a
species specific secreted protein belonging to a novel protein family and support an important
functional role for oocyte derived JY-1 in promoting early embryogenesis. JY-1 mRNA and protein
are expressed in an ovary-specific fashion, present throughout follicular development in primordial
through antral follicles and expression within ovarian tissues is restricted exclusively to the oocyte.
Within early embryos, abundance of JY-1 transcripts is maximal at the GV stage and declines
thereafter to nearly undetectable levels in 16-cell embryos. Results of embryo culture
experiments in the presence of the transcription inhibitor α-amanitin indicate the JY-1 gene is
not transcribed during the 1st and 2nd embryonic cell cycles and thus JY-1 mRNA detected in
early bovine embryos is oocyte-derived (Bettegowda et al., 2007).
To test the functional requirement of JY-1 for bovine early embryogenesis, siRNA
mediated gene silencing was performed. Microinjection of siRNA targeting JY-1 into zygote
stage embryos results in reduced JY-1 mRNA and protein in resulting embryos and a dramatic
reduction in proportion of embryos developing to the eight-cell to 16-cell and blastocyst stages
relative to uninjected, sham injected and negative control siRNA injected embryos (Bettegowda
et al., 2007). Furthermore, addition of recombinant JY-1 protein during initial 72 h of embryo
culture rescues development of JY-1 siRNA injected embryos to the blastocyst stage (Lee et al.,
unpublished). Results indicate that the novel oocyte-specific protein JY-1 is obligatory for bovine
early embryonic development.
Given the fact that JY-1 sequences identified in the bovine oocyte cDNA library were
totally novel, the presence of JY-1 orthologues in other species was previously investigated
(Bettegowda et al., 2007) using available genome sequence resources. JY-1-like sequences are
present at chromosomal locations in other vertebrate species e.g. mice, rats, humans) that are
syntenic to the JY-1 locus on bovine chromosome 29. However, putative JY-1 loci in other
species lack exons 1 and 2 and do not encode for a functional protein (Bettegowda et al., 2007).
Thus, results to date indicate pronounced species specificity in evolution and functional
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requirement of the novel oocyte-specific JY-1 gene for early embryonic development in cattle
versus other species noted above.

B. Importin alpha 8 (Kpna7)
Further analysis of initial EST sequences obtained from above bovine oocyte cDNA
library resulted in identification of a novel transcript with similarity to genes of the importin α
family. Kpna7 (importin alpha 8) is a new member of the importin alpha family (Tejomurtula et
al., 2009). Members of this family are well studied for their role in nuclear transport in several
species (Goldfarb et al., 2004). Kpna7 mRNA is specifically expressed in bovine ovaries and it
is abundant in germinal vesicle and metaphase II oocytes as well as in early cleavage stage
bovine embryos collected before embryonic genome activation, but is barely detectable in
morula and blastocyst stage embryos (Tejomurtula et al., 2009). RNAi mediated knockdown of
Kpna7 in early embryos resulted in a decreased proportion of embryos reaching the blastocyst
stage, indicating a functional requirement of Kpna7 for early embryonic development
(Tejomurtula et al., 2009). Furthermore, GST pull-down assays revealed that Kpna7 has a
stronger binding affinity for the nuclear protein nucleoplasmin 2 relative to that of other importin
alpha protein family members, suggesting that Kpna7 may have an important role in the
transport of key oocyte-specific nuclear proteins (e.g., chromatin remodeling and transcription
factors) during early development (Tejomurtula et al., 2009). Elucidation of Kpna7 binding
partners critical to early embryogenesis and their specific functional role merits further
investigation.

C. Follistatin
Functional genomics approaches were utilized to identify differences in RNA transcript
profiles of both the oocyte and adjacent cumulus cells associated with poor oocyte competence
(Bettegowda et al., 2008b, Patel et al., 2007) using the prepubertal calf model of poor oocyte
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quality (Damiani et al., 1996, Revel et al., 1995). A total of 193 genes encoding for transcripts
displaying higher mRNA abundance in oocytes collected from adult animals and 223 genes
encoding for transcripts displaying greater mRNA abundance in compromised oocytes from
prepubertal calves were detected. Such results formed the foundation for a series of
subsequent studies designed to elucidate the diagnostic and functional significance of putative
markers identified. Of particular interest from the differentially expressed genes revealed from
oocyte microarray studies were genes in the regulation of hormone secretion ontology category
which were overrepresented in the good quality oocytes harvested from adult (control) versus
prepubertal animals. Messenger RNA for one such gene from this ontology category (follistatin;
FST) was also greater in two-cell bovine embryos that cleaved early and developed to the
blastocyst stage at a rate four-fold greater than their late cleaving counterparts, which displayed
reduced follistatin mRNA. Given embryos were collected prior to completion of the maternal-toembryonic transition and initiation of robust transcription from the embryonic genome
(Bettegowda et al., 2008a), such differences likely reflect inherent differences in maternal
(oocyte-derived) follistatin mRNA content post fertilization and suggest a potential functional role
for oocyte-derived follistatin in early embryogenesis.
Based on above results, it was hypothesized that maternal (oocyte-derived) follistatin
abundance is a key determinant of early embryonic development in vitro and conducted studies
to test this hypothesis (Lee et al., 2009). Exogenous follistatin addition to bovine embryo culture
(during the first 72 h; until time of embryonic genome activation) enhanced proportion of
embryos that cleaved early (within 30 h post insemination; indicator of embryo developmental
capacity) and proportion of embryos developing to the blastocyst stage in a dose dependent
fashion. Furthermore, follistatin supplementation increased blastocyst total cell numbers
specifically through an increase in trophectoderm cells, as no effect on numbers of ICM cells
was observed. An increase in mRNA for the trophectoderm specific transcription factor Cdx-2
was also observed in response to follistatin treatment. Collectively, results indicate that
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exogenous follistatin treatment of early bovine embryos can enhance multiple indices of embryo
developmental capacity (Lee et al., 2009). Follistatin is best known for its ability to bind the
growth factor activin at a high affinity and inhibit its activity (Nakamura et al., 1990). However,
multiple lines of evidence indicate stimulatory effects of follistatin on embryo developmental
capacity are non classical and not mediated by inhibition of activity of endogenous activin (Lee
et al., 2009).
Loss of function experiments were also done (Lee et al., 2009) to determine the
requirement of endogenous follistatin for bovine early embryonic development. Microinjection of
follistatin siRNA into bovine zygotes reduced follistatin mRNA abundance in at four-cell stage by
> 80% relative to uninjected, sham injected and negative control siRNA injected embryos and
resulted in lower follistatin protein in eight-cell embryos. Furthermore, follistatin siRNA
microinjection caused a > 50% reduction in blastocyst development which can be rescued with
exogenous follistatin treatment. Follistatin treatment of siRNA injected embryos also restored
blastocyst Cdx-2 mRNA abundance to control levels. Collectively, results (Lee et al., 2009)
strongly support a functional role for follistatin in control of time to first cleavage, blastocyst
development and blastocyst cell allocation in bovine embryos and suggest that follistatin may be
an important functional determinant of bovine oocyte competence. However, the molecular
mechanisms whereby follistatin can enhance early embryonic development remain to be
elucidated.

D. Cumulus cell cathepsins and oocyte competence
A similar microarray approach was utilized to identify cumulus markers associated with poor
quality oocytes in the same prepubertal model system (Bettegowda et al., 2008b). Microarray
experiments revealed 110 genes encoding for transcripts displaying greater mRNA abundance
in cumulus cells surrounding germinal vesicle stage oocytes collected from adult animals and 45
genes encoding for transcripts displaying greater mRNA abundance in cumulus cells
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surrounding compromised prepubertal oocytes. Genes in the cysteine type endopeptidase
activity category (cathepsins B, K, S and Z) were overrepresented in cumulus cell samples
harvested from oocytes of prepubertal animals and thus tentatively associated with poor oocyte
competence based on microarray studies. Real-time PCR analysis confirmed that greater
amounts of mRNA for cathepsins B, K, S and Z are present in cumulus cells surrounding poor
quality oocytes harvested from ovaries of prepubertal animals (Bettegowda et al., 2008b). It was
hypothesized that cumulus cell cathepsin B, K, S and Z expression may also be relevant to
oocyte quality in adult animals. To test this hypothesis, parthenogenesis was used as an
experimental tool to measure the quality of an oocyte as assessed by its potential to develop
into a blastocyst following activation and the relationship between oocyte quality and cathepsin
mRNA abundance determined retrospectively. Parthenogenesis was used since presence of
cumulus cells during IVF is required for subsequent bovine embryonic development (Luciano et
al., 2005, Zhang et al., 1995). As hypothesized, the relative abundance of mRNAs for
cathepsins B, S and Z is ~1.5-6 fold higher in cumulus cells collected from oocytes with low
developmental competence versus those collected from oocytes of high developmental
competence (Bettegowda et al., 2008b) providing further evidence that cumulus cell cathepsin
expression is potentially predictive of an oocyte’s embryo development potential.
Functional studies were also conducted to test the influence of cumulus cell cathepsin
activity on oocyte competence. Given the observed association of cathepsin B, S and Z
transcript abundance with oocyte competence, we investigated the effects of treatment with an
irreversible, cell permeable and highly selective cysteine proteinase inhibitor (E-64: inhibits
cathepsin B) on oocyte meiotic maturation and early embryonic development. E-64 treatment
during in vitro maturation does not affect progression to metaphase II, but results in a 40 to 50%
increase in development to the blastocyst stage (d 7) after parthenogenetic activation or in vitro
fertilization (Bettegowda et al., 2008b).
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Given the negative association of cumulus cell cathepsin expression with oocyte
competence, stimulatory effects of cathepsin inhibitor (E-64) treatment during meiotic
maturation on oocyte competence and reported proapoptotic role of cathepsins (Broker et al.,
2005, Stoka et al., 2005), we hypothesized that stimulatory effects of E-64 on oocyte
competence may be mediated via promoting cumulus cell survival. Meiotic maturation of bovine
oocytes in the presence of a cathepsin inhibitor (E-64) results in a pronounced reduction in
numbers of apoptotic cumulus cells (Bettegowda et al., 2008b). Results suggest that cumulus
cell cathepsin expression is functionally linked to poor oocyte competence by a negative effect
on cumulus cell survival and that a threshold number of viable cumulus cells may be necessary
during in vitro maturation to maximize acquisition of oocyte developmental competence and
success of subsequent early embryogenesis. The mechanisms whereby cumulus cells directly
impact developmental competence during meiotic maturation in cattle are directly relevant to a
greater understanding of oocyte gene expression and developmental capacity following
fertilization.
From a practical standpoint, oocyte competence is a key limiting factor in the efficiency
of in vitro embryo production in cattle (Lonergan, 2007). Thus, a greater understanding of the
oocyte-expressed genes critical to various milestones in acquisition of developmental
competence in general and specifically to progression through early embryogenesis is
warranted. Discoveries made possible through functional genomics, and gene-targeting
technologies in mice have greatly increased understanding of genes/gene products obligatory to
maternal control of early embryogenesis and completion of the maternal-to-embryonic transition
in the mouse. However, comparative data establishing a functional role of such genes,
particularly the transcriptional and post-transcriptional regulators described in previous section,
is lacking in most instances for the bovine model system (Fig. 3).
It is conceivable that disruptions in the maternal-to-embryonic transition attributed to
deficiencies in abundance or activity of key regulatory molecules contribute at least in part to the
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less than desirable efficiency of in vitro embryo production, even for those embryos that proceed
in development beyond the eight-cell stage and embryonic genome activation. Such
perturbations may also be relevant to the high rates of embryonic loss in vivo experienced in
bovine species, particularly dairy cattle (Inskeep and Dailey, 2005, Sreenan and Diskin, 1983).
Information obtained from mouse models described is a relevant foundation for comparative
studies. However, because of inherent species-specific differences in the duration and number
of cell cycles required for embryonic genome activation and completion of the maternal-toembryonic transition in cattle, it is also possible that the regulatory mechanisms and maternal
effect genes involved may not be identical to those described for the mouse. For example,
available evidence indicates the functional role of the JY-1 gene in early embryogenesis is
species specific as a functional JY-1 gene is not present in the murine genome. Furthermore,
oocyte-derived follistatin does not make a functional contribution to control of early
embryogenesis in mice as the follistatin gene is not expressed in oocytes and follistatin mutant
embryos display normal progression through early embryonic development (Matzuk et al.,
1995). Thus, a systematic search for additional regulatory molecules mediating this key window
in early embryonic development in cattle is warranted along with studies to test their functional
contribution to early embryogenesis. Such scientific advancements will greatly increase
knowledge of maternal control of early embryonic development in cattle with potential practical
application to in vitro embryo production and potentially reproductive efficiency in vivo in cattle.

MicroRNAs: small non-coding RNA regulators of development
During oogeneis, mammalian oocyte is transcriptionally active and accumulates a large
pool of mRNA molecules and protein required for the early development until the embryonic
genome activation (EGA) (Gosden, 2002). Depending on the species embryonic genome
activation starts at a specific time after fertilization for example it begins during the two-cell
stage in mice; the four-cell stage in humans, rats and pigs, and during the eight-cell to 16-cell
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stage in cattle and sheep (Telford et al., 1990) (Fig. 2). Activation of embryonic genome is also
accompanied by a gradual degradation of maternal mRNAs and proteins. Degradation of
untranslated maternal mRNAs is shown to be critical in several species (Bachvarova et al.,
1985; Paynton et al., 1988; Sagata et al., 1989; Memili and First, 1999). In mouse embryos, 90
percent of maternal mRNA is degraded by the two-cell stage, coincident with the complete
genome activation (Bachvarova et al., 1985; Paynton et al., 1988). Furthermore, injection of
oocyte-specific c-mos mRNA into Xenopus two-cell embryos inhibits clevage (Sagata et al.,
1989). Thus degradation of maternal mRNAs is critical to embryogenesis and represents a
conserved mechanism of vertebrate development.
Multiple negative regulatory mechanisms are reported to be critical for posttranscriptional regulation of maternal transcripts, such as transcript deadenylation and
interaction with RNA-binding proteins in a nonspecific or sequence-specific fashion (Bettegowda
and Smith, 2007). Recent studies in zebrafish have established a role for microRNAs (miRNA)
as key regulatory molecules targeting maternal mRNA for degradation during the maternal to
zygotic transition (Giraldez et al., 2006). MicroRNAs are approximately 21-nucleotide (nt)
endogenous small noncoding RNAs that bind primarily to the 3’ UTR of target mRNAs to
repress their translation and accelerate their decay (Bartel, 2004). The majority of miRNAs are
evolutionarily conserved across species boundaries and play essential roles in regulating many
distinct processes such as animal development and growth, cell differentiation, signal
transduction, cancer, disease, virus immune defense, programmed cell death, insulin secretion
and metabolism (Ambros, 2004; He and Hannon, 2004; Wienholds and Plasterk, 2005).

A. MicroRNA biogenesis
MicroRNA genes reside in regions of the genome as distinct transcriptional units as well
as in clusters of polycistronic units carrying the information of several microRNAs (Bartel, 2004).
The mammalian miRNA biogenesis pathway can be divided into multiple steps. Initially, in
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nucleus miRNA genes are transcribed by RNA polymerase II, yielding long primary microRNAs
(pri-miRNAs) of hundred to thousands of bases in length (Bartel, 2004). Pri-miRNAs are
processed in the nucleus into ~70-80 nucleotide precursor miRNAs (pre-miRNAs) by the
ribonuclease III enzyme Drosha together with the double-stranded RNA (dsRNA)-binding
domain containing the protein DGCR8 (Kim, 2005; Tomari and Zamore, 2005). The excised
~70-nt fold-back dsRNA precursor (pre-miRNA) is then exported to the cytoplasm by Exportin-5
in the presence of Ran-GTP as cofactor (Bartel, 2004). In the cytoplasm, the pre-miRNAs are
processed by the RNase III enzyme Dicer to form ~ 22-nucleotide duplex miRNA (Bartel, 2004).
Next the miRNA:miRNA* duplex are separated by helicases and based on the strength of the 5’
end pairing, one single stand is chosen as the mature miRNA, the opposing strand referred to
as the miRNA* is degraded rapidly following the separation (Bartel, 2004). Mature miRNAs are
incorporated into silencing complexes that contain Argonaute protein and bind their mRNA
targets, which are often in the 3’ untranslated region (UTR), resulting in translation inhibition or
possible target mRNA degradation in animals (Bartel, 2004).

B. Approaches to microRNA discovery
MicroRNAs (miRNAs) were first identified in Caenorhabditis elegans through genetic
screens for aberrant development (Lee et al., 1993; Wightman et al., 1993) and later found in a
number of multicellular eukaryotes. miRNA identification relies largely on two approaches:
experimental approach (cloning and sequencing of small RNA libraries) and computational
approach (Berezikov et al., 2006). The experimental approach is the most preferred method for
the identification of miRNAs. In this method the expression of small RNAs is first established,
and bioinformatics is then used to identify the microRNAs that meet structural requirements
(Berezikov et al., 2006). The limitation of the experimental approach is that it is difficult to find
the miRNAs that are expressed at a low level and at very specific stages or in rare cell type.
However, the experimental approach remains the best choice for identification of miRNAs in
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organisms whose genomes have not been sequenced. In computational-driven approaches,
candidate miRNAs are predicted in whole genome on the basis of structural features and
phylogenetic conservation, which are essential characteristics of miRNA. Several computational
programs such as MIRscan (Lee, 2003) and MiRAlign (Wang et al., 2005) have been developed
for identification of known miRNA homologs from organisms whose genome sequences are
available. However, computationally predicted candidate miRNAs need further experimental
validation.

C. Predicting miRNA targets in animals
MicroRNAs are important regulatory molecules that control gene expression at the
posttranscriptional levels. It is predicted that 1 to 5% of genes encode for miRNA and they
regulate the expression of as many as 30% of mRNA (Lewis et al., 2003). Since, experimental
identification of the miRNA targets is difficult there has been an explosion of algorithms that
predict miRNA targets. However, computational prediction of miRNA targets is more challenging
in animals than plants due to the imperfect complementarity of miRNAs to their target mRNA
(Yoon and De Micheli, 2006). Almost all algorithms use relatively similar detection principles,
and are based on the previous knowledge on the pairing of mRNAs and miRNA such as lin-4
(Lee et al., 1993) and let-7 in C. elegans (Reinhart et al., 2000), as well as bantam in Drosophila
(Brennecke et al., 2003). The minimal requirements for a functional miRNA-target pairing used
by most target prediction algorithms (Target Scan, PicTar and Microinspector) are 1. The
miRNA sequence should be complementary to the 3’ UTR sequence of potential target mRNAs,
especially the strong binding in the seed region (the first seven to eight base pairs in the 5’ end
of miRNA) is very important for targeting (Brennecke et al., 2005). 2. The conservation of target
3’ UTR sites in related genomes is critical; especially the conservation around the seed region
should be considered (Lewis et al., 2005). 3. A strong secondary structure at the miRNA-binding
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site on the target is an important feature for effective silencing of the target (Brennecke et al.,
2005).

D. MicroRNAs mediated regulation of early embryonic development
The role of miRNAs during early embryogenesis has been assessed by analyzing
animals that are deficient in DICER. DICER, a ribonuclease III type endonuclease, is highly
expressed in oocytes, and its expression is spatio-temporally regulated during oocyte
maturation and fertilization, with greatest decrease at the two-cell stage when maternal
transcripts are globally degraded (Cui et al., 2007). Dicer- knockout and knokdown mutants
exhibit a lack of miRNA production and arrest during embryogenesis in zebrafish and mice
(Bernstein et al., 2003; Wienholds et al., 2003; Giraldez et al., 2005; Murchison et al., 2007;
Tang et al., 2007). The first major developmental transition that occurs following fertilization is
the maternal-to-embryonic transition (MET) in which the maternally inherited proteins that drive
the developmental programme initially were replaced with zygotically produced transcripts.
A role for miRNAs in the regulation of the MZT was uncovered with discovery of miR-430
in zebrafish (Giraldez et al., 2006). miR-430 is encoded by a large gene family and it is the most
abundant miRNA family expressed during early zebrafish development (Giraldez et al., 2005).
Expression of the miR-430 initiates at the moment of maternal-to-embryonic transition, and
targets to over 300 maternal transcripts in zebrafish by binding to the complementary sites in
their 3’ UTR and promoting their deadenylation and cleareance of maternal transcripts during
early embryogenesis (Giraldez et al., 2006). In the absence of miR-430 activity, these maternal
mRNAs accumulate and are thought to interfere with embryonic morphogenesis (Giraldez et al.,
2006). Similarly to findings in the zebrafish, mouse mature oocytes depleted of maternal
miRNAs failed to progress through the first cell division due to disorganized spindle formation,
indicating that the maternal miRNAs are essential for the mouse early embryonic development
and miRNA regulation of the MET is a conserved regulatory mechanism (Tang et al., 2007).
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In summary, multiple mechanisms regulate RNA synthesis and degradation during early
embryogenesis. miRNAs represent a subset of small RNAs and play critical role in the
repression of maternal mRNA translation. To date much of the work in the non-traditional animal
models has focused on miRNA profiling in different tissues and stages of development, but the
expression, regulation and function of several miRNAs still needs to be determined. Our
understanding of miRNAs functions in the oocyte and early embryonic development is in its
infancy and much remains to be uncovered, which will provide insight into we can enhance
reproductive efficiency and design of better reprogramming strategies.

SUMOylation: a novel post-translational modification in regulating mammalian
development
Post-translational modifications of proteins play a critical role in most cellular processes
through their unique ability to alter rapidly and reversibly the functions of preexisting proteins,
multiprotein complexes, and intracellular structures. In addition to phosphorylation, acetylation
and ubiquitylation, recently several small ubiquitin-like proteins (Ubls) have been discovered to
be reversible post-translational protein modifiers. Among Ubls, SUMO (small ubiquitin modifier)
is the best characterized (Hay, 2005). However, unlike ubiquitin that targets proteins for
degradation,

SUMO-modification

affects

the

target

proteins

intercellular

localization,

interactions, stability and activity (Hay, 2005) thereby affecting a wide range of cellular
processes, including gene transcription, cell cycle, protein stability, nuclear localization, signal
transduction, protein-protein interactions and chromatin dynamics (Geiss-Friedlander and
Melchior, 2007).
SUMO constitutes a highly conserved protein family ubiquitously expressed throughout
the eukaryotic kingdom. SUMO proteins are ~10kD in size and share only ~18% sequence
identity with ubiquitin, but the three-dimensional structure of SUMO is virtually super imposable
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on that of ubiquitin (Johnson, 2004). Organisms, such as S. cerevisiae, C. elegans and D.
melanogaster, have a single SUMO gene whereas vertebrates contain at least four SUMO
genes, namely SUMO-1, 2, 3 and the mostly recently identified SUMO-4 (Table 2) (GeissFriedlander and Melchior, 2007). However, plants contain even more SUMO genes, with eight in
A. thaliana (Table 2) (Johnson, 2004). SUMO proteins can be divided into two sub-families:
SUMO-1 proteins and SUMO-2/SUMO-3 proteins (Melchior, 2000). Within a given species,
SUMO2/3 proteins are present at much higher levels than SUMO-1 (Johnson, 2004). Although
members of each sub-family are nearly identical, SUMO1 and SUMO2/3 proteins share only
about 50% amino-acid sequence identity. SUMO-1, 2, 3 are ubiquitously expressed in all tissue
and at all developmental stages and use the same conjugation machinery, but their functions
are different, such as they conjugate to different target proteins, respond differently to stress,
are differentially affected by isopeptidase enzymes, and can be distinguished by their ability
(SUMO2/3) or inability (SUMO1) to form SUMO chains (Melchior, 2000).

A. The SUMO conjugation pathway (SUMOylation)
SUMOylation, the conjugation of SUMO peptide to the target protein, results in the
formation of an isopeptide bond between the C-terminal Glycine residue of the modifier protein
and the ε-amino group of a Lysine residue in the acceptor protein by a series of enzymatic
reactions similar to those involved in the ubiquitination (Johnson, 2004). SUMOylation is a
highly conserved pathway from yeast to humans and mostly targets specific proteins that
contains a consensus motif ψKXE, where ψ represents a large hydrophobic amino acid, K is the
SUMO attachment site, X is any residue and E is a glutamic acid (Johnson, 2004). Modification
of target proteins by SUMO is an ATP-dependent enzymatic cascade involving three key
enzymes - E1 activating enzyme (the heterodimer Aos1-Uba2), E-2 conjugating enzyme (Ubc9)
and several E3 ligating enzymes (PIAS, RanBP2/Nup358 and Pc2) (Fig. 4). Newly synthesized
SUMO is immature, as it cannot conjugate to its targets until a SUMO-specific protease
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generates a mature SUMO by removing some carboxy-terminus residues and exposing the two
glycine residue (Hay, 2005). Mature SUMO, is then activated by the SUMO-specific E1
activating enzyme heterodimer AOS1-UBA2. This reaction uses ATP for the formation of a
SUMO-adenylate conjugate. Next, activated SUMO is transferred from UBA2 to the active site
cysteine (Cys) of the SUMO-specific E2 conjugating enzyme (Ubc9), forming a thioester linkage
between the catalytic Cys residue of Ubc9 and the C-terminal carboxy group of SUMO. In the
last step, Ubc9 transfers SUMO to the target protein (substrate), forming an isopeptide bond
between the C-terminal Glycine residue of SUMO and a Lysine side chain of the target. This
step is usually facilitated by SUMO E3 ligases, but some targets are efficiently SUMOylated by
E2 conjugating enzyme (Ubc9). SUMOylation is a reversible modification, and cleavage of the
isopeptide bond between SUMO and its target is carried out efficiently by SUMO-specific
proteases of the SENP/Ulp family. Both the released SUMO and target are then recycled for
subsequent rounds of SUMOylation (Fig. 4) (Melchior, 2000; Johnson, 2004; Hay, 2005; GeissFriedlander and Melchior, 2007).

B. Emerging role of SUMOylation during development
SUMOylation is a key regulator of numerous biological and cellular events, including
gene transcription, cell cycle, protein stability, nuclear localization, signal transduction, proteinprotein interactions and chromatin dynamics. Recently, SUMO and SUMO pathway genes were
shown to be important in diverse reproductive functions such as steroid receptor activity,
ovulation, gametogenesis and embryogenesis (Broday et al., 2004; Jones, 2006; Abdel-Hafiz et
al., 2009; Wang et al., 2010). In C. elegans, the reproductive system is a major SUMO target
during postembryonic development, and is required for gonandal and uterine-vulval
morphogenesis (Broday et al., 2004). Lack of SUMO-conjugating enzyme (Ubc9) in C.elegans
leads to embryonic lethality due to pleiotrphic defects during larval development (Jones et al.,
2002). In D.melanogaster, mutations in the semushi (semi) gene, Ubc9 (SUMO-conjugating
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enzyme) ortholog, blocks nuclear import of the transcription factor Bicoid (Bcd) and results in
impaired embryogenesis (Epps and Tanda, 1998). Another mutation in the D.melanogaster
Ubc9 homologue, termed lesswright, dominantly suppresses the nondisjunction and cytological
defects of female meiotic mutations that affect spindle formation (Apionishev et al., 2001).
Knockdown of Ubc9 in zebrafish embryos leads to early embryonic apoptosis and inactivation of
zygotic Ubc9 function causes more specific developmental defects in brain, eyes and
pharyngeal arches due to defects in G2/M transition and mitosis during organogenesis (Nowak
and Hammerschmidt, 2006). Conditional deletion of Ubc9 in chicken DT40 cells causes
polynucleated and cell cycle-independent apoptosis (Hayashi et al., 2002). Loss of Ubc9 in
mouse embryos causes severe defects in the chromosome segregation and nuclear
organization and embryos die at early postimplantation stage (Nacerddine et al., 2005).
Together, these studies indicate that SUMO and its pathway genes can influence
developmental programs of both vertebrate and invertebrate metazoans.
Work over the last decade has shown that SUMOylation is an important regulator of
protein modification and is essential in a number of different biological pathways. However,
investigations in regard to how SUMO affects biological processes are still limited and poorly
understood. Many basic questions regarding SUMO components, mechanism of action and
SUMO target proteins remain unanswered and needs further investigation.
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Table 1. Oocyte specific genes addressed in this chapter potentially required for early embryonic
development in cattle.
Gene name/ symbol

Year
discovered

Protein

Domain/motif

Species
first
identified

Key Function

Published Work
in Bovine

Factor in the germline
alpha (Figla)

1997

Transcription
factor

Helix-loop-helix

Mouse

Folliculogenesis

None

Newborn ovary
homeobox gene
(Nobox)

2002

Transcription
factor

Homeobox
domain

Mouse

Folliculogenesis and
early embryogenesis

None

Spermatogenesis and
Oogenesis specific
basic helix–loop–helix 1
and 2 (Sohlh1and
Sohlh2)

2006

Transcription
factor

Helix-loop-helix

Mouse

Early
Folliculogenesis

None

Oocyte-specific
homeobox gene family
(Obox)

2002

Transcription
factor

Homeobox
domain

Mouse

Unknown

None

Deleted in Azoospermia
Like gene (Dazl)

1996

RNA binding
protein

RNA binding
domain

Mouse

Folliculogenesis and
oocyte maturation

Liu et al (2007);
Zhang et al
(2008)

Y box protein 2
(Ybx2)

1990

RNA binding
protein

S1-like cold-shock
domain

Xenopus

Folliculogenesis and
early embryogenesis

Vigneault et al
(2004)

Cytoplasmic
polyadenylation
element-binding
protein1
(Cpeb1)

1994

RNA binding
protein

RNA binding
domain

Xenopus

Folliculogenesis,
oocyte maturation
and early
embryogenesis

Uzbekova et al
(2008)

Maternal antigen that
embryo require
(MATER)

2000

Antigen

NACHT NTPase;
Leu-rich repeat

Mouse

Early embryonic
development

Pennetier et al
(2004, 2006);

Factor located in
oocytes permitting
embryonic development
(FLOPED)

2008

RNA-binding
protein

A typical KH

Mouse

Early embryonic
development

None

Zygote arrest 1 (Zar1)

2003

Transcriptional
regulator

A typical PHD
domain

Mouse

Early embryonic
development

Brevini et al
(2004);
Uzbekova et al
(2006)
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Nucleoplamin2 (Npm2)

1980

Nuclear
chaperone

Nucleoplasmin

Xenopus

Early embryonic
development

Lingenfelter et al
(2008)

Developmental
pluripotency associated
3 (Dppa3)

2002

Basic protein

SAP-like domain

Mouse

Early embryonic
development

Thélie et al
(2007)

Octamer binding
transcription factor 4
(Oct4)

1990

Transcription
factor

POU specific and
Homeobox

Mouse

Early embryonic
development and
pluripotency

Gandolfi et al
(1997); van Eijk
(1999);
Kurosaka (2005)

JY1

2007

Secreted
Protein

No significant
matches

Bovine

Early embryonic
development

Bettegowda et al
(2007)

Importin alpha 8
(Kpna7)

2009

Nuclear
transport
receptor

Importin-β binding
domain and
armadillo (ARM)
motifs

Bovine

Early embryonic
development

Tejomurthula et
al (2009)
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Table 2. Components of SUMOylation
Organism

SUMO

E1

E2

E3

SUMO
protease

Yeast

SUMO-1

Aos1, Uba2

Ubc9

Siz1,2

Ulp1, 2

Arabidopsis

Several SUMO
genes

SAE1a, b and
SAE2

SCE1a, b, c

Siz1,2

Ulp1 a-d
Ulp2 a-h

Mouse

SUMO-1, 2, 3

SAE1, SAE2

Ubc9

PIAS3

SENP2

Human

SUMO-1, 2, 3, 4

Aos1, Uba2

Ubc9

PIAS1

SENP1

Bovine

SUMO-1, 2, 3

Aos1, Uba2

Ubc9

PIAS1

SENP1
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Late Folliculogenesis

Early Folliculogenesis

Antral follicle

Early antral follicle
Germ cells

Primordial follicle

Primary follicle

Secondary follicle

( )
( ) ( )

( )
( )
( )

TRANSCRIPTION FACTORS
ZP1
ZP3

ZP2

Oocyte quality regulators
SOHLH1
SOHLH2

OCT4

GROWTH FACTORS

E12

FIGLA

NOBOX

LHX8

GDF9

BMP15

SMAD 2/3

SMAD 1/5/8

• Promotes Follicle Growth
• Promotes cumulus cells expansion
• Increases granulosa cell mitosis
• Suppresses progesterone production
• Stimulates ovulation

	
  
	
  
	
  
Figure 1. During the early folliculogenesis, clusters of germ cells break down to form primordial

	
  

follicles, which upon activation become primary follicles. A number of oocyte-specific
transcription factors (FIGLA, NOBOX, SOHLH1, SOHLH2 and LHX8) are known to regulate
each other and a number of other genes essential for folliculogenesis, fertilization and early
embryonic development. Mice lacking these transcription factors show loss of follicles at the
primordial follicle-to-primary follicle transition or before primordial follicle formation. During late
folliculogensis (secondary follicle to antral follicle) oocyte-derived bone morphogenetic protein
15 (BMP15) and growth differentiation factor 9 (GDF9) act via SMAD 1/5/8 and 2/3 signaling
pathway, to elicit cellular responses that are essential for folliculogenesis and ovulation. Dotted
lines indicate indirect transcriptional regulation where as solid lines indicate direct transcriptional
regulation.
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Figure 2. Embryonic genome activation (EGA) in different species.
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Figure 3. Oocyte-derived regulators and regulatory events during the bovine maternal-toembryonic transition and subsequent stages of early embryogenesis.
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Figure 4. The SUMO conjugation pathway (SUMOylation)
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STATEMENT OF PROBLEM

Reproductive efficiency is a major determinant of economic success of domestic livestock
operations. In domestic ruminants, embryonic and fetal death account for approximately 75% of
all reproductive loss and 57% of failure of pregnancy in cattle is due to early embryonic loss. In
cattle, only 30-40% of oocytes after fertilization and culture in vitro, are able to reach the
blastocyst stage and 60-70% of in vitro-derived embryos are capable of initiating successful
pregnancies after embryo transfer. In addition, in vitro-derived offspring are susceptible to large
offspring syndrome resulting from certain culture conditions. The exact contribution of
compromised competence of in vitro-derived embryos to embryonic loss in farm animals is
unclear, and hampered by an incomplete understanding of important genes required for
embryonic development. Therefore, the present studies were conducted to understand the
function and regulation of oocyte-specific transcription factors in mediating key developmental
events critical to success of early embryonic development and provide foundation for future
investigation on the identification of molecular biomarkers predictive of oocyte quality, which
would be useful in developing assays to test oocyte developmental competence and strategies
to enhance in vitro development rate, including improved media formulation.
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OBJECTIVES

In efforts to understand the function and regulation of oocyte-specific transcription factors during
early embryonic development in cattle, the objectives of this study are to:

1.

2.

Clone and characterize the expression of bovine FIGLA and NOBOX.

Functionally analyze the effect of siRNA-induced knockdown of NOBOX on bovine early

embryonic development and blastocyst cell allocation.

3.

Determine if a specific microRNA is responsible for the degradation of the FIGLA and

NOBOX mRNA and inhibition of its translation following embryonic genome activation in bovine
early embryos.

4.

Cloning and expression analysis of bovine fetal ovary microRNAs

5.

Elucidate the role of SUMOylation in regulating bovine oocyte-specific proteins.
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ABSTRACT
Newborn ovary homeobox (NOBOX) is an oocyte-specific transcription factor essential
for folliculogenesis and expression of many germ-cell specific genes in mice. Here we report the
characterization of the bovine NOBOX gene and its role in early embryogenesis. The cloned
cDNA for bovine NOBOX contains an open reading frame encoding a protein of 500 amino
acids with a conserved homeodomain. mRNA for NOBOX is preferentially expressed in ovaries
and undetectable by RT-PCR in somatic tissues examined. NOBOX protein is present in
oocytes throughout folliculogenesis. NOBOX is expressed in a stage-specific manner during
oocyte maturation and early embryonic development and of maternal origin. Knockdown of
NOBOX in early embryos using small interfering RNA demonstrated that NOBOX is required for
embryonic development to the blastocyst stage. Depletion of NOBOX in early embryos caused
significant down-regulation of genes associated with transcriptional regulation, signal
transduction and cell cycle regulation during embryonic genome activation. In addition, NOBOX
depletion in early embryos reduced expression of pluripotency genes (POU5F1/OCT4 and
NANOG) and number of inner cell mass cells in embryos that reached the blastocyst stage. This
study demonstrates that NOBOX is an essential maternal-derived transcription factor during
bovine early embryogenesis, which functions in regulation of embryonic genome activation,
pluripotency gene expression and blastocyst cell allocation.
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INTRODUCTION
During oogenesis, there is an accumulation and storage of maternal RNAs and proteins
that are obligatory not only for successful folliculogenesis and germ cell maturation, but also for
activation of the embryonic genome and subsequent early embryonic development (De Sousa
et al., 1998; Amleh and Dean, 2002). A growing body of evidence supports a role for oocyte
derived growth factors, such as growth differentiation factor-9 and bone morphogenetic protein15 in regulation of ovarian follicular development and several oocyte specific transcription
factors have been identified that are required for follicle formation or progression during
development. For example, FIGLA (Factor in the germline α), an oocyte-specific basic helixloop-helix (bHLH) transcription factor required for primordial follicle formation (Soyal et al.,
2000), is implicated in the coordinate expression of the three zona pellucida genes (Zp1, Zp2,
Zp3) essential for fertilization (Liang et al., 1997). However less is known about maternal
regulation of early embryonic development.
The time period during development spanning from fertilization until when control of
early embryogenesis changes from regulation by oocyte-derived factors to regulation by
products of the embryonic genome is referred to as the “maternal-to-embryonic transition”. The
products of numerous maternal-effect genes transcribed and stored during oogenesis mediate
this transition. Maternal antigen that embryos required (Mater or Nlrp5) is the first oocytespecific maternal factor identified in mouse and is known to be essential for the development of
embryos beyond the two-cell stage (Tong et al., 2000). The roles of additional oocyte-specific
genes Zar1 (Zygotic arrest 1) and Npm2 (Nucleoplasmin 2) in early embryonic development
have been revealed from gene targeting studies in mice. Zar1-knockout embryos are arrested at
the one cell stage and show marked reduction in the synthesis of the transcription-requiring
complex during the maternal-to-embryonic transition (Wu et al., 2003). Npm2-knockout females
have fertility defects due to reduced cleavage, absence of coalesced nucleoar structures and
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heterochromatin loss, suggesting that Npm2 is a critical chromatin remodeling during early
embryonic development (Burns et al., 2003). Recently, another maternal-effect gene, FILIA was
discovered in mice. FILIA binds to MATER and is essential for maintaining euploidy during
cleavage-stage embryogenesis (Zheng and Dean, 2009).
Understanding of maternal-effect genes required for early embryogenesis has clearly
been enhanced through results of gene targeting studies in mice. However, due to inherent
species-specific differences in the duration and number of cell cycles required for embryonic
genome activation and completion of the maternal-to-embryonic transition in mice vs. humans
and cattle or other livestock species (Bettegowda et al., 2008a), the regulatory mechanisms and
maternal effect genes mediating this transition may vary. Furthermore, understanding of the
regulatory role of many known oocyte derived transcription factors in early embryonic
development through gene targeting models is limited due to defective follicular development
and female sterility. One such transcription factor is newborn ovary homeobox (NOBOX)encoding gene). NOBOX mRNA and protein are preferentially expressed in the germ cells
throughout folliculogenesis (Suzumori et al., 2002). Female mice lacking NOBOX are infertile
due to postnatal oocyte loss and a disrupted transition in follicular development from primordial
to primary follicle (Rajkovic et al., 2004). Furthermore, expression of numerous genes in oocytes
linked to female fertility (e.g. Pou5f1/Oct4, Gdf9, Bmp15, Zar1, and Mos) and certain
microRNAs were drastically reduced in newborn ovaries that lack NOBOX (Rajkovic et al.,
2004; Choi et al., 2007). Recently, mutations in the NOBOX gene that are associated with
premature ovarian failure in humans have been identified (Qin et al., 2007; Qin et al., 2009).
However, despite its established role in control of oocyte gene expression, the requirement of
NOBOX for early embryonic development has not been investigated.
We hypothesize that maternal (oocyte-derived) NOBOX also is required for early
embryonic development and expression of NOBOX-responsive genes at embryonic genome
activation critical for normal blastocyst development. The objectives of the present studies were
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1) to clone and determine intraovarian localization of the bovine NOBOX gene, and 2) to
elucidate the functional role of bovine NOBOX in early embryonic development.

MATERIALS AND METHODS

Tissue collection
Bovine tissue samples including adult ovary, adult testis, liver, thymus, kidney, muscle,
heart, cortex (brain), spleen, pituitary, adrenal, lung, fetal ovary and fetal testis were obtained at
a local slaughterhouse. Age of fetuses from which fetal ovaries were collected was estimated by
measuring the crown-rump length (Richardson et al., 1990). Granulosa cells (Murdoch et al.,
1981) and cumulus cells (Bettegowda et al., 2008b) were isolated as described. All samples
were frozen in liquid nitrogen and stored at -800C until use.

RNA isolation, cDNA synthesis and RT-PCR analysis
Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA) according to
the manufacturer’s instructions. After treatment with TURBOTM DNase I (Ambion, Inc., Austin,
TX), reverse transcription was performed on approximately 1µg of isolated RNA in 20 µl of
reaction solution using Superscript III reverse transcriptase (Invitrogen). The RT-PCR was
performed by denaturation at 95 C for 3 minutes followed by 35 cycles of 95 C for 30 sec, 58 C
for 45 sec and 72 C for 90 sec and final extension at 72 C for 10 min. The amplified products
were separated through a 1% agarose gel containing ethidium bromide. Amplification of cDNA
for bovine ribosomal protein L19 (RPL19) was used as a positive control for RNA quality and
RT. See Table 1 for the list of primer sequences.

Cloning of Bovine NOBOX cDNA
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Based on the predicted cDNA sequence for the bovine NOBOX gene in the National
Center for Biotechnology Information Database, primers were designed (Table 1) to amplify
1500 bp fragment from bovine fetal ovary (enriched source of oocytes). The amplified cDNA
fragment (1500 bp) was cloned using a TOPO cloning kit (Invitrogen) and completely
sequenced. Gene-specific rapid amplification of cDNA ends (RACE) primers (Table 1) were
designed based on the obtained sequence, and 5’ and 3’ RACE was performed to extend the 5`
and 3’ end of the cDNA sequence using the second-generation 5’/3’ RACE kit (Roche
Diagnostics, Indianapolis, IN) according to the manufacturer’s protocol.

Northern Blot Analysis
For determining the size of the bovine NOBOX transcript, Northern blot analysis was
performed as described previously (Tejomurtula et al., 2009).

Immunohistochemistry
Immunohistochemistry was performed using Ultrasensitive avidin-biotin-peroxidase
complex staining kit (Pierce Chemical Co., Rockford, IL) according to the manufacturer's
instructions. Briefly, approximately 10-µm serial sections of bovine fetal ovary (d 230 of
gestation) were prepared and mounted onto polylysine-coated slides. The sections were
deparaffinized in xylene and then rehydrated in graded alcohol. After treatment with 0.3%
hydrogen peroxide in methanol to eliminate endogenous peroxidase activity, the sections were
blocked for 30 min with blocking buffer. After blocking, rabbit polyclonal anti-NOBOX antibody
(ab41612; Abcam, Cambridge, MA) diluted 1:100 in blocking buffer was applied to each section
and incubated for 1 h. The sections were then washed for 15 min in PBS, and incubated with
biotinylated anti-rabbit IgG for 1 h, followed by incubation with avidin-biotin-peroxidase complex
reagent for 1 h at room temperature. The sections were developed using a metal-enhanced
DAB Substrate kit (Pierce) for 2-10 min and were then counterstained with VECTOR
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Hematoxylin QS (Vector Laboratories, Burlingame, CA) and mounted with Permount (Fisher
Scientific, Fair Lawn, NJ). For negative controls, sections were incubated in the absence of antiNOBOX antibody.

Quantitative real-time RT-PCR
The oocytes and embryo samples used in the experiment included germinal vesicle
(GV)- and metaphase II (MII)-stage oocytes and pronuclear, two-cell, four-cell, eight-cell, 16-cell
and morula- and blastocyst- stage embryos (n = 5 pools of 10 embryos) generated by in vitro
fertilization of abattoir-derived oocytes as described elsewhere (Bettegowda et al., 2006).
Procedures used for RNA isolation, cDNA synthesis and quantitative real-time PCR analysis of
mRNA abundance during oocyte maturation and early embryonic development were conducted
as described previously (Bettegowda et al., 2006; Tejomurtula et al., 2009). See Table 1 for the
list of primer sequences.

RNAi experiments
Knockdown of endogenous NOBOX in bovine embryos was performed via microinjection
of NOBOX small interfering RNA (siRNA). RNAi experiments were conducted according to our
published procedures (Bettegowda et al., 2007; Lee et al., 2009; Tejomurtula et al., 2009) with
modifications noted herein. The publicly available siRNA design algorithm (siRNA target finder,
Ambion) was used to design four distinct siRNA species targeting the open reading frame of
bovine NOBOX mRNA (designated as siRNA species 1, 2, 3 and 4 respectively). The candidate
siRNA species were interrogated by using the basic local alignment tool program
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) to rule out homology to any other known genes in the
bovine expressed sequence tag and genomic database. The NOBOX siRNA species were
synthesized using the Silencer siRNA construction kit (Ambion) according to the manufacture’s
instructions. The sense and antisense oligonucleotide template sequences for both siRNA
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species are given in Table 1. Procedures for in vitro maturation of oocytes (obtained from
abattoir-derived ovaries) and in vitro fertilization to generate zygotes for microinjection, and for
subsequent embryo culture were conducted basically as described elsewhere (Bettegowda et
al., 2006). Presumptive zygotes collected at 16-18 h post insemination (hpi) were used in all
microinjection experiments. Each individual siRNA species was validated for efficacy of NOBOX
mRNA knockdown in early embryos. Presumptive zygotes were microinjected with
approximately 20 pl of individual NOBOX siRNA species (25 µm concentration each) and fourcell embryos were collected at 42-44 hpi for real-time PCR analysis of NOBOX mRNA.
Uninjected embryos and embryos injected with a negative siRNA (universal control No. 1;
Ambion) were used as control groups (n = 4 pools of 10 embryos per treatment). Efficacy of
NOBOX siRNA in reducing NOBOX protein in early embryos was determined by NOBOX
immunostaining of eight-cell embryos collected 72 hpi (n = 10-15 embryos per group). The
development of the uninjected or injected embryos (with NOBOX siRNA or negative control
siRNA) was evaluated by recording the proportion of embryos that cleaved (48 h after
insemination) and reached eight- to 16-cell stage (72 h after insemination) and blastocyst stage
(7 days after insemination). Each group contained 25-30 embryos per treatment (n = 4
replicates).

Immunofluorescent Staining
Immunoflorescent staining was performed according to previously published procedures
(Silva et al., 2003) with modifications noted herein. Oocytes and embryos were fixed in 4%
paraformaldehyde in PBS for 30 min at room temperature. Fixed oocytes and embryos were
washed in PBS three times and quenched for 5 min with 0.05% (wt/vol) solution of sodium
borohydrate in PBS to reduce fluorescence background. They were washed again in PBS three
times and permeabilized with 0.1% Triton X-100 in PBS for 15 min. After washing with PBS
samples were incubated in blocking solution (2% BSA and 10% normal goat serum in PBS) for
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at least 1 h. Immunoflorescent staining was performed by incubating samples in rabbit
polyclonal anti-NOBOX antibody diluted 1:50 in PBS containing 0.5% (wt/vol) BSA and 0.1%
(wt/vol) NaN3 overnight at 40C. Oocytes and embryos were then washed for 45 min in PBS
containing 0.1% (wt/vol) Tween-20 at room temperature, transferred to the fluorescein
isothiocyanate-conjugated secondary antibody (F9887; Sigma-Aldrich) diluted in PBS containing
0.5% (wt/vol) BSA and 3% normal goat serum and incubated for 60 min. Finally they were
washed with PBS containing 0.1% (wt/vol) Tween-20 for 30 min and mounted on slides using an
anti-fading medium containing 4', 6-diamidino-2-phenylindole (ProLong® Gold antifade reagent
with DAPI, Invitrogen). At least 10 oocytes/embryos were processed for each stage/treatment,
and experiments were replicated at least three times. For negative control, the oocytes and
embryos were incubated in the absence of anti-NOBOX antibody.

Identification of zygotic transcripts in eight-cell embryos by microarray analysis
In vitro maturation of oocytes and in vitro fertilization were conducted as described
(Bettegowda et al., 2006). Presumptive zygotes were cultured in potassium simplex optimization
medium containing 0.3% BSA in the presence or absence of 50 mg/ml of the transcription
inhibitor alpha-amanitin and eight-cell embryos collected 52 h later. Groups of eight-cell
embryos were pooled within treatment (n = 10 embryos per pool; n = 3 replicates for alphaamanitin and n = 4 replicates for untreated controls) and frozen in 20 µl PicoPure lysis buffer
and RNA purification was performed using PicoPure RNA isolation kit. Purified RNA was
subjected to two rounds of reverse transcription and in vitro transcription with biotinylated
nucleotides according to Affymetrix (Santa Clara, CA) two-cycle eukaryotic target labeling
protocol. Biotin-labeled cRNA samples were fragmented and hybridized to Affymetrix Bovine
Genome Arrays at the University of Pennsylvania Microarray Core Facility. Raw probe level
data were imported into Affymetrix Expression Console 1.1, and a quantile normalization and
summarization were performed using the Robust Multichip Analysis function. For Significant
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Analysis of Microarray, analysis probe sets were first filtered by detection calls using Affymetrix
MAS 5.0. Only those probe sets called ‘Present’ in at least three out of four replicates were
considered for Significant Analysis of Microarray. Probe sets identified as differentially
expressed at the False Discovery Rate less than 5% were analyzed further by Student t-test.
Probe sets that were higher in untreated embryos at P < 0.05 and hence down-regulated by αamanitin treatment were considered as alpha-amanitin sensitive probe sets representing
transcripts of embryonic origin in eight-cell embryos.

Effect of NOBOX knockdown on expression of predicted NOBOX responsive genes at
embryonic genome activation
To determine the effects NOBOX knockdown on expression of predicted NOBOXresponsive genes at EGA, presumptive zygotes were subjected to NOBOX siRNA
microinjection. Uninjected embryos and embryos injected with a negative control scrambled
siRNA (universal control No. 1; Ambion) were used as control groups. After microinjection,
groups of embryos were cultured in 75- to 90-µl drops of potassium simplex optimization
medium (Specialty Media, Phillipsburg, NJ) supplemented with 0.3% BSA and eight-cell
embryos were collected at 52 hpi for real time PCR analysis of predicted NOBOX responsive
genes (n = 10 embryos per treatment; n = 4 replicates). See Table 1 for the list of primer
sequences. oPOSSUM analysis software (http://www.cisreg.ca/cgibin/oPOSSUM/opossum) (Ho
Sui et al., 2007) was used to identify the NOBOX binding elements (NBE) in the promoter
regions of zygotic transcripts at EGA. A combination of a Z score more than 10, Fisher P value
< 0.01 and transcription factor binding score more than 10 was used, which is known to provide
minimal likelihood of false positive results (Ho Sui et al., 2007).

Effects of NOBOX knockdown on cell allocation to trophectoderm and inner cell mass in
bovine blastocyts
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To determine the effect of NOBOX depletion on total cell numbers and allocation to TE
vs. ICM cells, NOBOX siRNA injected embryos that reached the blastocyst stage were
subjected to differential staining using previously published procedure (Machaty et al., 1998).
The uninjected embryos and negative control siRNA injected embryos that reached the
blastocyst stage were used as controls. At least 10 blastocyts were processed for each
treatment, and experiments were replicated four times. A subset of blastocysts from each
treatment group were pooled (n = 4 pools of three blastocysts) and subjected to real-time RTPCR analysis of mRNA abundance for POU5F1/OCT4, ICM marker NANOG and TE marker
CDX2. See Table 1 for the list of primer sequences.

Statistical Analysis
For real-time PCR experiments, differences in NOBOX mRNA abundance were
analyzed by one-way ANOVA using the general linear models procedure of SAS. For
microinjection experiments, rates of embryo development (eight- to 16-cell and blastocyst
stages) and blastocyst cell numbers (TE, ICM and total cell numbers) percent data were
subjected to arc-sin transformation before analysis as described above. Differences in treatment
means were compared using Fisher’s protected least significant difference test. Different letters
indicate significant differences (P < 0.05).

RESULTS

Complementary DNA (cDNA) cloning and genome organization of bovine NOBOX
Using the primers designed based on the predicted bovine NOBOX cDNA sequence; we
successfully amplified a cDNA fragment (1500 bp) representing the coding region of bovine
NOBOX from bovine fetal ovary cDNA. Northern blot analysis revealed a single transcript of
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approximately 2.2 kb in bovine adult ovary sample (Fig. 1A). Thus additional 5’ - (463 bp) and 3’
- (312 bp) sequences were obtained using RACE procedures. The assembled full-length
NOBOX cDNA (HQ589330) is 2275 bp containing an open reading frame encoding a protein of
500 amino acids with a conserved homeodomain and typical nuclear localization signal (Fig. 2).
The predicted NOBOX protein shares 61% and 49% amino acid sequence identity with its
human and mouse counterparts, respectively (Fig. 3). A basic local alignment tool search of the
bovine genome database at National Centre for Biotechnology Information revealed that the
bovine NOBOX gene is located on chromosome 4, and spans approximately 5.5 kb. Exon and
intron

boundaries

of

the

genes

were

determined

using

the

Spidey

program

(http://www.ncbi.nlm.nih.gov/IEB/Research/Ostell/Spidey/). The bovine NOBOX gene has seven
exons and six introns as determined by the program (Table 2), and all splice sites are in
agreement with the consensus sequence (GT-AG rule).

Tissue distribution of bovine NOBOX mRNA
RT-PCR analysis of RNA samples from a panel of 14 different bovine tissues revealed
that expression of NOBOX mRNA is restricted to adult and fetal ovaries with very minor
expression in adult testicular samples (Fig. 1B). Analysis of NOBOX mRNA expression in
bovine fetal ovaries of different developmental stages showed that the NOBOX mRNA could be
detected in fetal ovaries harvested as early as 100 days of gestation period (when primary
follicles start to form in cows), and is highly abundant in the fetal ovaries of late gestation (Fig.
1C). RT-PCR analysis using RNA isolated from oocytes, granulosa cells and cumulus cells
indicates that bovine NOBOX is expressed in oocytes but not in other follicular somatic cells
examined (Fig. 1D).

Intraovarian and intra-oocyte localization of NOBOX protein
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Immunohistochemical localization of NOBOX protein within fetal ovary sections revealed
that NOBOX protein is present in oocytes of growing follicles at the primordial (Fig. 4A panel A;
single layer of flattened granulosa cells), primary (Fig. 4A panel B; single layer of cuboidal
granulosa cells), secondary (Fig. 4A panel b; multiple layers of cuboidal granulosa cells) through
antral follicle stages (Fig. 4A panel C). Immunoreactivity was not detected in granulosa cells,
theca cells, cumulus cells and control tissue sections incubated in absence of NOBOX antibody
(Fig. 4A panel D). Immunocytochemical analysis of NOBOX protein in GV oocytes using
confocal spinning disk microscopy demonstrated that NOBOX protein is localized in both the
nucleus and cytoplasm (Fig. 4B).

Spatiotemporal expression of bovine NOBOX mRNA and protein during oocyte
maturation and early embryonic development
To determine the function of NOBOX during bovine early embryonic development, the
temporal expression characteristics of NOBOX in oocytes and early bovine embryos were first
investigated. NOBOX mRNA was abundant in germinal vesicle and metaphase II stage oocytes,
as well as pronuclear to eight-cell stage embryos, but barely detectable in embryos collected at
morula and blastocyst stages (Fig. 5A) suggesting that NOBOX mRNA was maternal in origin.
Furthermore, NOBOX mRNA abundance in eight-cell embryos was not diminished by culture in
the

presence

of

the

transcriptional

inhibitor

alpha-amanitin

(data

not

shown).

Immunocytochemical analysis demonstrated that NOBOX protein was abundant in GV- and MIIstage oocytes as well as in pronuclear, two-cell and four-cell stage embryos, but
immunostaining for the NOBOX protein abundance declined by the eight-cell stage and was
barely detectable at morula and blastocyst stages (Fig. 5B). Based on the observed
spatiotemporal expression pattern, we hypothesized that NOBOX may have a functional role in
bovine early embryonic development.

	
  

78	
  

NOBOX is required for bovine early embryonic development
To investigate the function of NOBOX in early embryonic development, we performed
RNAi experiments to reduce NOBOX expression in bovine embryos. Four NOBOX siRNA
species targeting different regions of the NOBOX transcript were produced in vitro, and initial
experiments were performed to test the efficacy and specificity in silencing the NOBOX gene.
siRNA 2 and siRNA3 each resulted in a more than 80% reduction (P < 0.05) in NOBOX mRNA
in four-cell embryos relative to uninjected control (Fig. 6). Microinjection of a cocktail of NOBOX
siRNA2 and 3 significantly reduced NOBOX mRNA levels in four-cell embryos by more than
95% relative to uninjected and negative control siRNA-injected embryos (Fig. 7A). Microinjection
of the siRNA mixture (siRNA2 and siRNA3) also dramatically reduced NOBOX immunostaining
in eight-cell embryos (Fig. 7B). Further analysis by Western blot also showed reduced NOBOX
protein in siRNA-injected embryos (Fig. 8).
To determine whether knockdown of NOBOX in bovine embryos has any effect on
embryonic development, cleavage rate and proportion of embryos developing to eight- to 16-cell
and blastocyst stage for NOBOX siRNA injected vs. uninjected and negative control siRNA
injected embryos were determined. NOBOX siRNA (siRNA2 and siRNA3) injection into bovine
zygotes did not affect the cleavage rates (Fig. 9A) but reduced the proportion of embryos
developing to eight- to 16-cell stage (Fig. 9B) and blastocyst stage (Fig. 9C) relative to the
uninjected and negative control siRNA-injected embryos. These results clearly indicate that
knockdown of NOBOX in bovine zygotes impaired development to the blastocyst stage.

NOBOX is essential for induction of specific zygotic transcripts during embryonic
genome activation
Given the effect on preimplantation development, we tested whether NOBOX regulates
expression of zygotic transcripts synthesized during embryogenesis. Microarray analysis of
control and α-amanitin treated embryos collected at the eight-cell stage was used to identify
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transcripts of embryonic origin induced coincident with EGA. A total of 198 gene transcripts,
which were decreased by 10-fold and greater range in α-amanitin treated eight-cell stage
embryos was selected to identify NOBOX binding elements (NBE) in their promoter regions
using the oPOSSUM analysis software (http://www.cisreg.ca/cgibin/oPOSSUM/opossum) (Ho
Sui et al., 2007). A total of 21 genes with NBEs that are significantly overrepresented in their
promoter regions was identified (Table 3). Six such genes (JAG1, WEE1, PITX2, CCNE1, KLF5
and FZD8) were chosen for further examination based on their function and importance during
embryogenesis. Interestingly, all six mRNAs were significantly diminished in abundance in
NOBOX siRNA injected embryos collected at the eight-cell stage (Fig. 10 A-F). The expression
of these transcripts was also suppressed in the α-amanitin treated embryos collected at eightcell stage, confirming they originated from the embryonic genome. Our results suggest that
NOBOX either directly or indirectly up-regulates expression of genes from the embryonic
genome linked to early development.

NOBOX regulation of blastocyst cell allocation
NOBOX directly regulates the transcription of Pou5f1/Oct4 in mouse oocytes during
folliculogenesis (Choi and Rajkovic, 2006). Therefore, we sought to address whether the
expression of POU5F1/OCT4 and other genes linked to blastocyst cell allocation (NANOG and
CDX2) was affected in the NOBOX siRNA-injected embryos that reached the blastocyst stage.
By performing quantitative real-time PCR analysis, we found that the POU5F1/OCT4 and
NANOG mRNA expression levels were significantly reduced in the NOBOX siRNA-injected
embryos that reached the blastocyst stage compared to the uninjected embryos and negative
control siRNA-injected embryos that reached the blastocyst stage (Fig. 11 A-B). No effect of
NOBOX siRNA on CDX2 (marker of TE) mRNA abundance in the resulting blastocysts was
observed (Fig. 11 C). NOBOX knockdown dramatically reduced the numbers of ICM cells and
total cell numbers but did not influence numbers of TE cell in resulting blastocysts (Fig. 11 D-F).
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Collectively, these results support a functional role for NOBOX in regulating pluripotency genes
and cell allocation in bovine blastocysts.

DISCUSSION
Our results established a functional role for the oocyte derived transcription factor
NOBOX in regulation of early embryonic development. NOBOX is expressed in a stage-specific
manner during early embryonic development and its depletion in bovine zygotes by siRNA
microinjection impaired embryo development to the blastocyst stage. Moreover, knockdown of
NOBOX affected the expression of genes from the embryonic genome critical to early
development and expression of pluripotency genes and blastocyst cell allocation were altered in
the NOBOX siRNA-injected embryos that reached the blastocyst stage. Previous studies have
established an important functional requirement for NOBOX for normal follicular development in
mice (Rajkovic et al., 2004; Choi et al., 2007) and women (Qin et al., 2007; Qin et al., 2009) and
ovarian expression of specific genes linked to fertility. To our knowledge, a functional role for
NOBOX in regulation of early embryonic development has not been reported.
The data for mouse and bovine together thus indicate an important functional
requirement of the oocyte transcription factor NOBOX in the regulation of both follicular
development and early embryogenesis. However, a requirement of NOBOX for early embryonic
development could not be directly ascertained from previous gene targeting studies in mice.
Whereas the contribution of gene targeting technology to enhanced understanding of oocyte
regulation of follicular development and early embryonic development is unquestionable,
important functional roles of oocyte derived gene products in early embryogenesis could, in fact,
be undetected in gene-targeting models with an ovarian phenotype due to disruptions in
follicular development that preclude development/release of oocytes from null mutant mothers
and presence of oocyte derived RNA and protein for targeted gene in null mutant embryos
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derived from mothers heterozygous for the mutation. These limitations to the study of the
functional role of oocyte-derived factors in early embryogenesis can be overcome by
cytoplasmic microinjection of double stranded RNA (dsRNA) into wild type embryos post
fertilization, which can result in specific and effective translational block through later stages of
preimplantation embryo development (Wianny and Zernicka-Goetz, 2000; Paradis et al., 2005;
Schellander et al., 2007). The absence of targeted gene product during these developmental
stages would reveal important information on gene function and unmask a functional role in
early embryogenesis that may not be detectable using conventional gene-targeting strategies.
Results of the present studies clearly support a functional role for NOBOX in regulation of
multiple aspects of early embryonic development in cattle. For reasons stated above, it is
unclear whether observed role of NOBOX in early embryogenesis is conserved across multiple
species, including the mouse, or in fact the role of NOBOX in early embryogenesis is species
specific. It is known that EGA occurs later in monoovulatory species such as cattle and primates
including human, compared with the polyovulatory mouse. Thus the maternal-effect genes
required to promote initial cleavage divisions and ensure successful early embryonic
development in such monotocous species may be distinct from those required in the polytocous
mouse model. A species-specific role for the oocyte specific JY-1 gene in regulation of early
embryonic development in cattle has been reported previously (Bettegowda et al., 2007).
The inability of an embryo to reprogram chromatin and activate transcription of important
genes during EGA critical to subsequent development is believed to be the one of the major
cause of embryo developmental block in vitro (Betts, 2001; Sirard et al., 2006) and presumably
early embryonic loss in general. Among the early genes that are transcribed at EGA include
genes involved in cell cycle progression, transcription regulation, signal transduction, epigenetic
modification, transporters and metabolism (Misirlioglu et al., 2006). However, the specific
maternal transcription factors that mediate up-regulation of these early expressed transcripts
and proteins during embryonic development are poorly defined. Our results indicate that siRNA
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mediated ablation of NOBOX in early embryos blocks induction of key zygotic transcripts at
EGA linked to transcriptional (KLF5, PITX2) (Parisi et al., 2008; Rodríguez-León et al., 2008),
cell cycle (WEE1, CCNE2) (Tominaga et al., 2006; Gotoh et al., 2007) and signaling functions
(JAG1, FZD8) (Deardorff et al., 1998; Xue et al., 1999) during embryogenesis. Hence, the
reduced development of NOBOX-depleted embryos to the blastocyst stage may be attributed to
defects in EGA and absence of expression of specific zygotic transcripts critical to development.
The first cell lineage allocation event in mammalian embryogenesis occurs at
compaction in mouse embryos and results in the formation of the ICM and TE lineages in the
blastocyst (Rossant and Tam, 2009). Multiple lines of evidence indicate the transcription factor
Oct4 is essential for the control of early lineage development (Pei, 2009) and the level of Oct4 is
crucial for determining the development of distinct cell fates of embryonic stem (ES) cells.
Artificial repression of Pou5f1/Oct4 in ES cells induces differentiation of the TE lineage; but
when Pou5f1/Oct4 is overexpressed ES cells differentiate mainly into primitive endoderm-like
cells (Niwa et al., 2000). In addition, only 1.5 fold-elevated expression of Pou5f1/Oct4 in germ
cells leads to development of gonadal tumors (Gidekel et al., 2003) and loss of Pou5f1/Oct4 in
germ cells results in apoptosis (Kehler et al., 2004). Furthermore, morpholino-mediated
depletion of Pou5f1/Oct4 in one- to two-cell stage mouse embryos affected embryonic
development prior to the blastocyst stage (Foygel et al., 2008). Interestingly, such studies also
reported that Pou5f1/Oct4 plays a critical role in reprogramming the early embryo during the
maternal-to-embryonic transition by regulating genes that encode for transcriptional and posttranscriptional regulators (Foygel et al., 2008). Therefore, Pou5f1/Oct4 expression must be
strictly controlled in a developmental stage- and cell type-specific manner. However, the precise
mechanism and the number of transcription factors involved in the regulation POU5F1/OCT4
levels in vivo during development are not well understood. Recently, several factors have been
identified, such as NANOG (Pan et al., 2006), SOX2 (Chew et al., 2005), FOXD3 (Pan et al.,
2006) and SALL4 (Zhang et al., 2006), that are critical in modulating embryonic stem cell
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pluripotency and early embryonic development via transcriptional regulation of POU5F1/OCT4.
Results of the present studies demonstrated that ablation of NOBOX in early embryos
significantly reduced the zygotic transcription of POU5F1/OCT4 in embryos that reached the
blastocyst stage, indicating that NOBOX is also a key regulator of POU5F1/OCT4 expression
during early embryonic development. NOBOX binding and transactivation of the mouse
Pou5f1/Oct4 promoter have been previously reported (Choi and Rajkovic, 2006).
Ablation of NOBOX in early embryos also impacted cell lineage determination in
embryos that reached the blastocyst stage resulting in reduced total cell numbers and numbers
of ICM cells. Effects of NOBOX depletion on cell allocation in embryos reaching the blastocyst
stage may be directly linked to reduced expression of POU5F1/OCT4. Previous studies
demonstrated that POU5F1/OCT4 knockdown in bovine zygotes resulted in reduced numbers of
ICM cells in resulting blastocysts (Nganvongpanit et al., 2006). Reduced expression of NANOG
mRNA in blastocysts derived from NOBOX siRNA injected embryos was also observed in the
present studies. Previous studies reported that POU5F1/OCT4 is required for the transcriptional
regulation of Nanog, because knockdown of Pou5f1/Oct4 through RNAi in mouse ES cells
significantly reduced Nanog promoter activity (Rodda et al., 2005). Hence, the decreased
expression of NANOG mRNA and reduced number of ICM cells might also be directly attributed
to down-regulation of POU5F1/OCT4 expression in NOBOX-depleted embryos.
No effect of NOBOX ablation on numbers of TE cells or expression of the TE specific
transcription factor CDX2 mRNA was observed in the present studies, supporting specific
effects of NOBOX ablation on the ICM lineage. In contrast, Pou5f1/Oct4 regulation of Cdx2 and
the TE lineage has been reported previously in the mouse model. Suppression of Pou5f1/Oct4
mRNA in mouse ES cells caused induction of characteristics of trophectodermal differentiation
and an increase in expression of the trophoblast-specific factor CDX2 (Velkey and O'Shea,
2003; Hay et al., 2004). More recent studies have described the function of maternally and
zygotically provided CDX2 in maintaining appropriate polarization of blastomeres at the eight-
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and 16-cell stage and TE lineage-specific differentiation during early development of the mouse
embryo (Jedrusik et al., 2010). More detailed analysis will be required to determine the specific
mechanisms responsible for reduced numbers of ICM, but not TE cells in blastocysts derived
from NOBOX-depleted embryos and the specific role of oocyte-derived NOBOX in regulatory
networks in embryo-derived pluripotent stem cells.
In summary, results of the present studies establish a novel functional role for NOBOX
during early embryonic development in the bovine model. Results support an important
requirement of NOBOX for embryonic development to the blastocyst stage and blastocyst cell
allocation and suggest that NOBOX mediates up-regulation of specific zygotic transcripts at
EGA critical to subsequent development. Results also provide critical new information regarding
the spatiotemporal expression of NOBOX during oocyte and early embryonic development. In
the unique developmental context of the maternal-embryonic transition, accompanied by
deadenylation and degradation of maternal transcripts, it will be interesting to determine the
post transcriptional regulatory mechanisms that mediate observed temporal changes in NOBOX
mRNA and protein in early embryos and the functional significance of this expression pattern
characteristic of other maternal effect genes critical to early embryogenesis.
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Table 1. List of primers used in this study
Gene Name

Primer Name

Primer sequence (5’ to 3’)

Application

NOBOX

NOBOX-ATG-F
NOBOX- TAG-R
NOBOX-RACE-3SP1
NOBOX-RACE-3SP2
NOBOX-RACE-3SP3
NOBOX-RACE-5SP1
NOBOX-RACE-5SP2
NOBOX-RACE-5SP3
NOBOX-RTPCR-F
NOBOX-RTPCR-R
NOBOX-Real time-F
NOBOX-Real time-R
NOBOX-siRNA-AS1
NOBOX-siRNA-S1
NOBOX-siRNA-AS2
NOBOX-siRNA-S2
NOBOX-siRNA-AS3
NOBOX-siRNA-S3
NOBOX-siRNA-AS4
NOBOX-siRNA-S4

ATGAAGGCCTGCCAGCGCCC
CTAGGGGCCATGGCCACTCT
GGAGCGGCCCCCGGCCCCCGAG
CCGAGGAAGAAGACAAGAGTG
AAGAGTGGCCATGGCCCCTAG
GGGGCGCTGGCAGGCCTTCAT
CCTTCATAGGCCCAGTCCCTTCC
CCTTCCCCAGGGGCCTCTGACGG
TGGAGGAGCTAGAAAGGCTCT
GTGTTGGAAGAACTGGGTCTG
AGACCCAGTTCTTCCAACACC
CACAGGACAAGGCAAAGAGAG
AAGCAGAAGAAGCCTAGGGATCCTGTCTC
AAATCCCTAGGCTTCTTCTGCCCTGTCTC
AAGTGGCGAAAAATGAATGGGCCTGTCTC
AACCCATTCATTTTTCGCCACCCTGTCTC
AAGACCCTCTCTTTGCCTTGTCCTGTCTC
AAACAAGGCAAAGAGAGGGTCCCTGTCTC
AAGTTGAAGGAAAGACTGGACCCTGTCTC
AAGTCCAGTCTTTCCTTCAACCCTGTCTC

RPS18

RPS18-RealTime-F

GTGGTGTTGAGGAAAGCAGACA

RPL19

RPS18-RealTime-R
RPL19-RTPCR-F
RPL19-RTPCR-R

TGATCACACGTTCCACCTCATC
GAAATCGCCAATGCCAACTC
GAGCCTTGTCTGCCTTCA

GFP

GFP-Realtime-F

CAACAGCCACAACGTCTATATCATG

GFP-Realtime-R
JAG1-Real time-F
JAG1-Real time-R
WEE1-Real time-F
WEE1-Real time-R
PITX2- Real time-F
PITX2- Real time-R
CCNE2-Realtime-F
CCNE2-Realtime-R
FZD8-Realtime-F
FZD8-Realtime-R
KLF5-Realtime-F
NANOG-Realtime-F
NANOG-Realtime-R
CDX2-Realtime-F
CDX2-Realtime-R

ATGTTGTGGCGGATCTTGAAG
CTGCATTTAGGGAGTATTCT
GATTTCCTCACTTAAGGCAG
GCCTTGTGAATTTGCTGCTAT
CCAATGCACTAGCTTCAAAGT
AGCTGTGCAAGAATGGCTTT
GCTCATGGACGAGATGGAAT
CAGGTTTGGAATGGGACAAC
CCTGGTGGTTTTTCAGTGCT
TGCCATTTGCTGAGCTTGAA
AGCAGAGTCGAGGGAGAAAACTT
CTCAGACAGGTAGCCCCATCTC
GCTTTGGGAAGAACACTGCAA
AAAGTTACGTGTCCTTGCAAACG
GAGGAGGGAAGAGGAGAGACAGT
CGTCTGGAGCTGGAGAAGGA
CGGCCAGTTCGGCTTTC

cDNA cloning
cDNA cloning
3`RACE
3`RACE
3`RACE
5`RACE
5`RACE
5`RACE
RT-PCR analysis
RT-PCR analysis
Real Time PCR
Real Time PCR
siRNA synthesis
siRNA synthesis
siRNA synthesis
siRNA synthesis
siRNA synthesis
siRNA synthesis
siRNA synthesis
siRNA synthesis
Real Time PCR (endogenous
control)
Real Time PCR (endogenous
control)
RT-PCR control
RT-PCR control
Real Time PCR (exogenous
control)
Real Time PCR (exogenous
control)
Real Time PCR
Real Time PCR
Real Time PCR
Real Time PCR
Real Time PCR
Real Time PCR
Real Time PCR
Real Time PCR
Real Time PCR
Real Time PCR
Real Time PCR
Real Time PCR
Real Time PCR
Real Time PCR
Real Time PCR
Real Time PCR

OCT4- Realtime-F
OCT4- Realtime-R

AGGTGTTCAGCCAAACGACTA
TCTCCTGCAGATTCTCGTTGT

Real Time PCR
Real Time PCR

JAG1
WEE1
PITX2
CCNE2
FZD8
KLF5
NANOG
CDX2
Pou5f1
(OCT4)
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Table 2. Genomic organization of bovine NOBOX gene
Exon no.

Size (bp)

Sequence

Intron no.

Size (bp)

Sequence

1

841

TGTACCGCTCGGgtaagtcc

1

385

tcttctagACCAGCTGGAGG

2

106

CAGCGCATCATGgtaaaggg

2

319

ccctacagGTGTGGTTCCAG

3

109

CAACCAATGCAGgtaagact

3

774

gccaccagCTCTGTGGCCGA

4

73

ATTCCCTTCCAGgtgagccg

4

223

gttcccagAGCCGTCCATGC

5

231

GTGGGGAACAAGgtacttgt

5

470

ccccacagCATCACTCCACC

6

301

CCGGGAATGTGGgtgagtcg

6

920

ccccacagGTACGGTGCCCT

7

591

Exon and intron sizes are given in base pairs. Intronic and exonic sequences are shown in lower-case and
upper case characters, respectively. The first and last two bases of the introns (gt and ag for donors and
acceptor splice sites, respectively) are shown in bold and underlined.
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Table 3. List of zygotic transcripts (α-amanitin sensitive) with NOBOX binding elements (NBE)
significantly over-represented in their promoter regions, as identified using oPOSSUM analysis software
Accession no

Gene Name

Symbol

Fold
change

TFBS

Function

NM_001046199.1

Collagen, type XI, alpha 2
Diablo homolog
(Drosophila), nuclear gene
encoding mitochondrial
protein
Pre-mRNA-processing factor
39 (PRP39 homolog)
Pituitary homeobox 2
(Paired-like homeodomain
transcription factor 2)

COL11A2

36.475

10.325

Extracellular matrix structural constituent

DIABLO

35.736

11.363

Apoptosis

PRPF39

19.351

11.012

RNA processing

PITX2

28.877

10.503

Cell differentiation and WNT signalling
pathway , TGF beta pathway

Deleted liver cell 1
Ankyrin repeat domaincontaining protein 1
Achaete-scute homolog 1
(HASH1)
WD repeat-containing
protein 89
Lysine-specific demethylase
3A (similar to JMJD1A)
RING finger protein 43
Precursor
Unconventional prefoldin
RPB5 interactor

DCL1

12.797

10.854

ANKRD1

19.659

10.503

Cell adhesion and migration
Protein binding, transcription corepressor
activity

ASCL1

11.641

11.363

Transcriptional regulation

WDR89

19.486

10.834

KDM3A

10.556

10.325

Unknown
DNA methylation, histone modification, X
chromosome activation

RNF43

57.738

11.363

Ubiquitin pathway

C19orf2

15.247

10.325

Transcriptional corepressor activity

JAG1

19.536

11.157

Notch signalling pathway

ZCCHC6

17.795

10.854

DNA binding

NM_001045882
NM_001109789
NM_001097991
NM_001110191
NM_001034378
XM_594382
NM_001034658
XM_616193
XM_001252464
NM_134447
XM_001251494

DNAJB9

111.660

10.503

NM_001101054

Protein jagged-1 Precursor
Zinc finger CCHC domaincontaining protein 6
DnaJ homolog subfamily B
member 9
Cyclin-dependent kinase 4
inhibitor C

CDKN2C

12.659

10.325

NM_001015665

G1/S-specific cyclin-E2

CCNE2

13.031

10.834

Chaperone activity
Cyclin-dependent protein kinase inhibitor
activity
p53 signalling / cell cycle / cyclin-dependent
protein kinase inhibitor activity

NM_001101205

Wee1

12.907

10.567

DNA binding / Protein binding/ Cell cycle

XM_869051

WEE1 homolog
Frizzled homolog 8
(Drosophila)

FZD8

13.981

11.012

WNT signalling pathway

NM_001083727

Kruppel-like factor 5

KLF5

18.090

10.065

NM_001046074

myc proto-oncogene protein

MYC

19.806

10.834

RNA polymerase II transcription factor activity
Transcription factor activity/ DNA binding/
Protein binding

XM_590860
XM_866142
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Figure 1. Expression of NOBOX mRNA. A) Northern blot analysis of bovine NOBOX transcript.
B) Bovine NOBOX mRNA expression in ovary, testis and 11 somatic tissues determined by RTPCR analysis. C) RT-PCR analysis of bovine NOBOX mRNA expression in bovine fetal ovaries
of different developmental stages. D) Expression of bovine NOBOX mRNA in GV stage oocytes,
granulosa cells and cumulus cells. Bovine RLP19 was used as an internal control.
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TTCCAAGCTACGTATGTACGTATGTGTTAGCTCAGTCGTGTCCGACTCTTTGTTACCCCGTGGACTGTAGCCTGCCAGGCTTCTCTGT

89
179
269

CCATGGAATTCTCCAGGCAAGAAGGATTCCCTCCTGTGATCCTCACGGTAGCCGAGTTAGGAAGGTACGCCTGGAACTGTTACCGCGTTT
GTTAAGTAGACAAGTGAAAGCTTAAGGTCAAACAGGACACCAGTTGCAGACCAGGAAGCAGCGCATCCTCCTGGGCCAGGCTCTTCCTTC
TCCTGTGCTGAGTCGGGGTGCTGGCTCTCCACAGGCCAGGGGGGTGTCCCTGCTGCCAGGCTGGAGGAGGAGGAGGAAGCCCTGCAGAGG

359
449

TCAGCCCCCCACACTCAGGATGCCCCAGGCAAGGACGTGCCTATTTCCTGCACCATCTACGGGGAGAAGCGGCCGTCAGAGGCCCCTGGG
GAAGGGACTGGGCCT ATG AAGGCCTGCCAGCGCCCCAGCCCAGGAGCTCTCCACGAAGACAGGAGCCTGGCCTCGCCTAGACCCCAGCCT
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CAAGGGCAAGGGCCTCCCTTCCCGGGGACAGAGGGCAGGCTGGGGAAGAGGCCCTCTTCTCCAGCCACCGGCAAGCAGAAGAAGCCTAGG

26
629

Q G Q G P P F P G T E G R L G K R P S S P A T G K Q K K P R
GATGTGGGTCCGGCCTCGACGGCATCTCCCAGCAGCGTTAACCCGGCTCGGGCCACGTACAACCCAGGGCCTTGTGGGTTAGGCCGGGGG

56
719
86
809

D V G P A S T A S P S S V N P A R A T Y N P G P C G L G R G
TCCTGCCATGTGGCCAACCTCCTCAACACACTGGCCCAGAAGAACCAAAACCTGGACCAGGAGAAGAGGTCCCCGGAAGTGACCTGCCAG
S C H V A N L L N T L A Q K N Q N L D Q E K R S P E V T C Q
GTCCGGAAGAAGACTCGCACCCTGTACCGCTCGGACCAGCTGGAGGAGCTAGAAAGGCTCTTCCAAGATGACCACTATCCAGACAGCGAT

116
999

V R K K T R T L Y R S D Q L E E L E R L F Q D D H Y P D S D
AAGCGCCGTGAGATTGCCCAGACAGTGGGGGTCACCCCCCAGCGCATCATGGTGTGGTTCCAGAATCGCCGGGCCAAGTGGCGAAAAATG

146
989

K R R E I A Q T V G V T P Q R I M V W F Q N R R A K W R K M
AATGGGAAGGAGAGTAAGGACGCACCTGCCGGTCCCGCCCTTACCCCAGCCCCCGCCAGCAACCAATGCAGCTCTGTGACCGAGCTGCCA

176
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206
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N G K E S K D A P A G P A L T P A P A S N Q C S S V T E L P
CCTACCGAGTCCACGATGCTGGAGCCTGGGACCCTCCCTCAGGATTCCCTTCCAGAGCCGTCCATGCTGCTGACATCTGACCAGACTCTG
P T E S T M L E P G T L P Q D S L P E P S M L L T S D Q T L
GGCCCAAACCTGCAGAATGAGGGCCCCCAGAGAAGGCCTGTGACCCCCCCACTCTTCAGCCCCCCACCTGTCCGAAGAGCCAACCTTCCC

236

G

P

N

L

Q

N

E

G
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R

R

P

V

T

P

P

L

F

S

P
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R

R
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P
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GGGTTGTGGGGAACAAGCATCACTCCACCCCCTGCCTGCTCATACTTAGAGGATCTGGAACTCCAGGAGTACCAACCCAGCAGCAGCCAG

296
1439
326

G L W G T S I T P P P A C S Y L E D L E L Q E Y Q P S S S Q
CCAGGATCGTTCCCCTTCTCCCAGGGGCCACAGACCCAGTTCTTCCAACACCCACAGCCCCAGTTTCCATACCTGCACCCCTTCCCTTTG
P G S F P F S Q G P Q T Q F F Q H P Q P Q F P Y L H P F P L

1529
356

TCCAGCTCGCTGACTCCACCACTGCCCGAAGACCCTCTCTTTGCCTTGTCCTGTGGCCCCGGCGGGGGCTCATCCCAGGGCTATTTCCCA
S S S L T P P L P E D P L F A L S C G P G G G S S Q G Y F P

1619
386
1709

GGCCCTCCGTCGGGGCCCGTCCTGCTGCAGCCGCCGGCCGGGAATGTGGGTACGGTGCCCTGGGCCGACCCCTGCCTGCCAGACTTGCCA
G P P S G P V L L Q P P A G N V G T V P W A D P C L P D L P
TTCCCCAGTGCCTTCTGCCCGCAGTCTCTGGGGGGCCCCCCGGGAGGGGACGGCTGCTTCCTGGACCTGTTTGCTGCCCCCTACGCACAG

416
1799
446

F P S A F C P Q S L G G P P G G D G C F L D L F A A P Y A Q
GCTTCAGGTAGGCTGCCTTCCCCGGGCCTCACCCAGATGCCCGAGAGCACCCCACCTGCAGCAGGAAAAGCCCCGCTCAGCCAGGCCCAG
A S G R L P S P G L T Q M P E S T P P A A G K A P L S Q A Q

1889

GAGGAACCACCGGCTGCCCCCGGGGAGCGGCCCCCGGCCCCCGAGGAAGAAGACAAGAGTGGCCATGGCCCC TAG TCATGGAGCCGAAGA
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E
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2069

ACCAAGAGGCCGTCCTGCTGGAGATGGCTGGAGCACCCAGAGGAGACAGGGCTCGAAGTTGAAGGAAAGACTGGACTCCAGGGCTCATTT
TGCCAAATGCTGACTTGAGGAGGAGGAGGCCTGGACCACCCGTCCTTCCCCCACAGCTCCGAATGGTGGTCCTGGAGAAATGGAGTGGGG

2159
2249

CCGTGTCGCCTCTGACGGTTGCTTCCGTTTATGTTATTTGCTCTCCTTGCTCCACAGCCGCTCCAGTGGCCACCATAAGCAGTAAACTGC
CTCCTCTTGGGAAACAAAAAAAAAAAA

Figure 2. The full-length NOBOX cDNA sequence and predicted amino acid sequence of the
NOBOX protein. The initiator ATG and stop codon TAA are boxed and the polyadenylation
signal is bold and underlined. The homeodomain region is bold and double underlined. The
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nuclear localization signal (NRRAKWRK) within the homoedomain region is shaded. A putative
proline-rich site for binding to an Src Homology 3 (SH3) domain is bold and italicized.
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-------------------------------------------------MALLLTLTSPDLEGTWDTRDKDGFKAQEGPPLAVPEFPVCGLYRIYGVCG
-------------------------------------------------------------------------------------------------MK
SFSSFFIIRCSLCALETLKSPQHDPLEIPEQSLKLIPLVSGKRELTRGQK
-------------------------MEPTEKLCKKM----------QGQE
ACQR---------------------------------------------AGEKPLAAGPGEEELLRGSAPHAQDTQSEELPPSCTISGEKKPPAVSGEA
AGDK--------------------------------------------------------PSPGALHEDRSLAS-PRPQPQGQGPPFPGTEGRLGKRPS
TGADAGRLCPPPRSRAPHKDRTLAR-SRPQTQGEDCSLPVGEVKIGKRSY
-----------PRTAALETEGPLQDSALPIQDDQDKQSSLPRASLGKRPL
SPATGKQKKP-----RDVGPASTASPSSVNPARATYNPGPCGLGRGSCHV
SPAPGKQKKP-----NAMGLAPTSSPGAPNSARATHNPVPCGSGRGPCHL
SKTSEELMDAGTCRVHKAPTAAACGPQSEEEGCSPPERKAESLKPSISAV
ANLLNTLAQKNQNLDQEKRSPEVTCQVRKKTRTLYRSDQLEELERLFQDD
ANLLSTLAQSNQNRDHKQGPPEVTCQIRKKTRTLYRSDQLEELEKIFQED
PGQATAGSLNSHEGDLKKESLEVTCQFRKKTRTLYRSDQLEELERIFQED
HYPDSDKRREIAQTVGVTPQRIMV-------------------------HYPDSDKRREIAQTVGVTPQRIMVKGAGSLVAGWSGGGPTIETLELQSER
HYPDSDKRHEISQMVGVTPQRIMV-------------------------------WFQNRRAKWRKMNGKESKDAPAGPALTPAPASNQCSSVTELPPT
SAVAWVWFQNRRAKWRKMEKLNGKESKDNPAAPGPASS-QCSSAAEILPA
------WFQNRRAKWRKVEKLNEKETKNGPAAPSADSS-QHRSAPELLDP
ESTMLEPGTLPQ----DSLPEPSMLLTSDQTLGPNLQNEGPQRRPVTPPL
VPMEPKPDPFPQESPLDTFPEPPMLLTSDQTLAPTQPSEGAQR-VVTPPL
MPTDLEPGPVPPENILDVFPEPPMLLTSEQTLTPFQNNEGAERVAVTPPL
FSPPPVRRANLPFPLGPVHAPQLMPLLLDTLGSDSSHKDGPCGLWGTSIT
FSPPPVRRADLPFPLGPVHTPQLMPLLMDVAGSDSSHKDGPCGSWGTR-LSPPPIRRANLPLPLGPVQTPQVLPPMRDVPGSDSIYKDKAYVSWGTSIA
PPPACSYLEDLELQEYQPSSSQPGSFPFSQGPQTQFFQHPQPQFPYLHPF
-------------------------------------------------SPPTYSNLEDLGSQDYQASS-QLGSFQLSQAPHLPLFPSLQSQFPYLPPF
P--LSSSLTPPLPEDPLFALSCGPGGGSSQGYFPGPPSGPVLLQPPAGNV
-------------------------------------------------PYPIPSSMPFLPPEDSLFSFPFGFSGDSSQDYCPGPPPGQILLQPPAENM
GTVPWADPCLPDLPFPSAFCPQSLGGPPGGDGCFLDLFAAPYAQASGRLP
-------------------------------------------------GTGPWSGHCLPEPPFPRPHYPQALGQPLGAEGYFPNLLPTPYALTMSKQS
SPGLTQMPESTPPAAGKAPLSQAQEEPPAAPGERPPAPEEEDKS----GH
-------------------------------------------------SLGLNGLLEGTRVETGSS-LSKMSDEQTSSSLEQPALEEVRDKNKNSHAA
GPR
---GAKE

	
  
	
  
	
  
Figure 3. Multiple alignment of the deduced amino acid sequence of NOBOX bovine, human
and mouse using ClustalW analysis.
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Figure 4. Intraovarian and intra-oocyte localization of NOBOX protein. A) Immunohistochemical
localization of NOBOX protein in bovine adult ovary. Oocyte-specific localization of NOBOX
protein in primordial follicles (panel A), primary follicle (panel B, 10 F), secondary follicle (panel
B, 20 F) and antral follicle (panel C) was observed. No staining signal was observed in the
oocytes incubated in the absence of NOBOX antibody (panel D). B) Localization of NOBOX
protein in GV oocytes by immunocytochemical analysis using confocal spinning disk
microscopy. For negative control, oocytes were incubated with NOBOX antibody preabsorbed
with excess antigen (ab41611; Abcam, Cambridge, MA).
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Figure 5. Expression characteristics of bovine NOBOX mRNA and protein during oocyte
maturation and early embryonic development. A) Relative abundance of NOBOX mRNA in
bovine oocytes and in vitro produced bovine early embryos: GV and MII stage oocytes,
pronuclear (PN), two-cell (2C), four-cell (4C), eight-cell (8C), 16-cell (16C), morula (MO) and
blastocyst (BL) – stage embryos. Nobox transcript levels were normalized relative to abundance
of exogenous control (GFP) RNA and are shown as mean ± SEM (n = 4 pools of 10 embryos
per treatment). Different letters indicate statistical difference (P < 0.05). B) Immunofluorescent
localization of NOBOX protein during oocyte maturation and pre-implantation bovine embryos.
Nuclear DNA was stained with 4`, 6-diamidino-2-phenylindole (DAPI). Neg, Negative.
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Figure 6. Validation of NOBOX siRNA species for efficacy of NOBOX mRNA knockdown in 4cell stage embryos. Quantitative real-time PCR analysis of NOBOX mRNA expression after
microinjection of individual siRNA species targeting different exons in NOBOX transcript at
presumptive zygote stage. Data were normalized relative to abundance of endogenous control
ribosomal protein S18 (RSP18) and are shown as mean ± SEM (n = 4 pools of 5 embryos per
treatment). Different letters indicate statistical difference (P < 0.05).
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Figure 7. Effect of NOBOX siRNA injection in bovine zygotes on expression of NOBOX mRNA
and protein in resulting embryos. A) Effect of NOBOX siRNA microinjection on abundance of
NOBOX mRNA in four-cell embryos as determined by real-time PCR. Data were normalized
relative to abundance of endogenous control ribosomal protein S18 (RSP18) and are shown as
mean ± SEM (n = 4 pools of 10 embryos per treatment). Different letters indicate statistical
difference (P < 0.05). B) Effect of NOBOX siRNA microinjection on abundance of NOBOX
protein in eight-cell stage embryos as determined by immunofluorescent staining (n = 4 pools of
5-10 embryos per treatment). Uninjected embryos and embryos injected with a nonspecific
siRNA (Neg siRNA) were used as control. Nuclear DNA was stained with 4`, 6-diamidino-2phenylindole (DAPI).
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Figure 8. Effect of NOBOX siRNA microinjection on NOBOX protein abundance in embryos. A)
Western blot analysis of NOBOX protein abundance in eight- to 16-cell embryos injected with
the NOBOX siRNA mixture (25 embryos per lane). The analysis was performed as described
(18). B) Densitometric analysis of protein bands on the Western blot represented in A using the
FluorChem imaging system and Alpha EaseFC software (Alpha Innotech Corporation, San
Leandro, CA).
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Figure 9. Effect of RNAi mediated depletion of NOBOX on early embryonic development A)
Proportion of embryos that cleaved within 48 h after fertilization B) Proportion of embryos
developing to eight- to 16-cell stage (determined 72 hpi) C) Proportion of embryos developing to
blastocyst stage (determined on d 7). Uninjected embryos and embryos injected with a
nonspecific siRNA (Neg siRNA) were used as controls. Data are expressed as mean + SEM
from four replicates (n = 25-30 zygotes per treatment per replicate). Values with different letters
across treatments indicate significant differences (P 0.05). Neg, Negative.
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Figure 10. Knockdown of NOBOX down-regulates the expression of zygotic transcripts (αamanitin sensitive) in eight-cell stage embryos. Quantitative real-time PCR was used to analyze
the expression level of zygotic genes containing NBEs in their promoter regions: JAG1 (A),
WEE1 (B), PITX2 (C), CCNE2 (D), KLF5 (E), and FZD8 (F). Data were normalized relative to
abundance of endogenous control ribosomal protein S18 (RSP18) and are shown as mean ±
SEM (n = 4 pools of 10 embryos per treatment). Uninjected embryos and embryos injected with
a nonspecific siRNA (Neg siRNA) were used as controls. α-amanitin treated embryos were used
to confirm the zygotic origin of the transcripts. Different letters indicate statistical difference (P <
0.05). Neg, Negative.
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Figure 11. Knockdown of NOBOX alters the expression of pluripotency genes and bovine
blastocyst cell allocation. Expression of POU5F1/OCT4 (A), NANOG (B) and CDX2 (C) in
bovine blastocysts collected on day 7 after insemination. Data were normalized relative to
abundance of endogenous control ribosomal protein S18 (RSP18) and are shown as mean ±
SEM (n = 4 pools of three blastocyst per treatment). Uninjected embryos and embryos injected
with a nonspecific siRNA (Neg siRNA) were used as control. Different letters indicate statistical
difference (P < 0.05). NOBOX regulation of bovine blastocyst cell allocation (D) number of TE
cells (E) number of ICM cells (F) and total cell numbers. Data are expressed as mean ± SEM
from four replicates (n = 25-30 blastocysts per replicate). Uninjected embryos and embryos
injected with a nonspecific siRNA (Neg siRNA) were used as control. Different letters indicate
statistical difference (P < 0.05).
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ABSTRACT
Oocyte-derived maternal RNAs drive early embryogenesis when the newly formed
embryo is transcriptionally inactive. Recent studies in zebrafish have identified the role of
microRNAs during the maternal-to-embryonic transition (MET). MicroRNAs are short RNAs that
bind to the 3’ UTR of target mRNAs to repress their translation and accelerate their decay.
Newborn ovary homeobox gene (NOBOX) is a transcription factor that is preferentially
expressed in oocytes and essential for folliculogenesis in mice. NOBOX knockout mice are
infertile and lack of NOBOX disrupts expression of many germ-cell specific genes and
microRNAs. We recently reported the cloning and expression of bovine NOBOX during early
embryonic development and our gene knockdown studies indicate that NOBOX is a maternal
effect gene essential for early embryonic development. As NOBOX is a maternal transcript
critical for development and NOBOX is depleted during early embryogenesis, we hypothesized
that NOBOX is targeted by microRNAs for silencing and/or degradation. Using an algorithm
“MicroInspector”, a potential microRNA recognition element (MRE) for miR-196a was identified
in the 3’ UTR of the bovine NOBOX mRNA. Expression analysis of miR-196a in bovine oocytes
and during early embryonic development indicated that it is expressed both in oocytes and
embryos and tends to increase at the four-cell and eight-cell stages. Ectopic expression of
NOBOX and miR-196a in HeLa cells inhibited the expression of NOBOX protein compared to
the control cells without miR-196a. Similarly, the activity of a luciferase construct containing the
entire 3’ UTR of bovine NOBOX was suppressed, and the regulation was abolished by
mutations in the miR-196a binding site indicating that the predicted MRE is critical for the direct
and specific binding of miR-196a to the NOBOX mRNA. Furthermore, ectopic expression of
miR-196a mimic in bovine early embryos significantly reduced the NOBOX expression at the
both mRNA and protein levels. Collectively, our results demonstrate that miR-196a is a bona
fide negative regulator of NOBOX during bovine early embryogenesis.
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INTRODUCTION
The earliest stages of embryonic development in vertebrates primarily rely on the
maternal RNA and proteins synthesized during oogenesis (Schultz, 2002; Li et al., 2010). The
period of maternal control of embryonic development varies among species according to the
onset of embryonic genome activation and the degradation of maternal gene products
(DeRenzo and Seydoux, 2004). The major onset of embryonic genome activation begins during
the two-cell stage in mice; the four-cell stage in humans, rats and pigs, and during the eight-cell
to 16-cell stage in cattle and sheep (Telford et al., 1990). Upon fertilization, in mouse embryos,
90 percent of the maternal mRNA is degraded by the two-cell stage, coincident with the
complete activation of the embryonic genome (Bachvarova et al., 1985; Paynton et al., 1988).
There is direct evidence that maternal mRNA clearance is critical for early embryonic
development. For example oocyte-specific c-mos mRNA, essential for regulating meiotic arrest
at metaphase, is degraded soon after fertilization and injection of c-mos protein into Xenopus
two-cell embryos induces cleavage arrest (Sagata et al., 1989). In mouse, maternal mRNA
degradation is dependent on the 3’ untranslated region (3’ UTR) of the mRNA transcript. For
example, chimeric mRNAs composed of the c-mos coding region fused to the hypoxanthine
phosphoribosyltransferase (Hprt) 3’ UTR have reduced rates of degradation following
microinjection into mouse fertilized oocytes (Alizadeh et al., 2005). Thus degradation of
maternal mRNAs is critical to embryogenesis and represents a conserved mechanism of
vertebrate development.
Multiple negative regulatory mechanisms are critical for post-transcriptional regulation of
maternal transcripts, such as transcript deadenylation and interaction with RNA-binding proteins
in a nonspecific or sequence-specific fashion (Bettegowda and Smith, 2007). Recent studies in
zebrafish have established a role for microRNAs (miRNA) as key regulatory molecules targeting
maternal mRNA for degradation during the maternal-to-embryonic transition (MET) (Giraldez et
al., 2006). MicroRNAs are endogenous small noncoding RNAs that bind primarily to the 3’ UTR
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of target mRNAs to repress their translation and accelerate their decay (Bartel, 2004). The
majority of miRNAs are evolutionarily conserved across species boundaries and play essential
roles in regulating many distinct processes such as animal development and growth, cell
differentiation, signal transduction, cancer, disease, virus immune defense, programmed cell
death, insulin secretion and metabolism (Ambros, 2004; He and Hannon, 2004; Wienholds and
Plasterk, 2005).
In recent years, several studies have revealed the significance of miRNAs in
reproduction and embryonic development. For example, targeted disruption of Dicer, a key
enzyme involved in miRNA processing and the synthesis of small interfering RNAs from long
double-stranded RNA (Carmell and Hannon, 2004; Jaskiewicz and Filipowicz, 2008) in mice
and zebrafish resulted in embryonic lethality due to abnormalities in morphogenesis, cell
division and chromosome organization (Bernstein et al., 2003; Giraldez et al., 2005;
Kanellopoulou et al., 2005; Tang et al., 2007; Nagaraja et al., 2008). In zebrafish, miR-430 has
been linked to maternal mRNA decay accompanying the maternal-to-embryonic transition
(Giraldez et al., 2006). At the onset of embryonic genome activation, the level of miR-430
substantially increases and the miRNA targets several hundred maternally provided mRNAs by
binding to the complementary sites in their 3’ UTR and promotes their deadenylation (Giraldez
et al., 2006). Furthermore, miR-196a regulates mammalian development via targeting
homoeobox clusters (Yekta et al., 2004) and misexpression of miR-196a leads to specific eye
anomalies in a dose-dependent manner in Xenopus laevis (Qiu et al., 2009).
Newborn ovary homeobox gene (NOBOX) is a transcription factor, identified by in silico
subtraction of expressed sequence tags (ESTs) derived from newborn ovaries in mice
(Suzumori et al., 2002). NOBOX mRNA and protein are preferentially expressed in oocytes
throughout folliculogenesis (Rajkovic et al., 2004). Nobox knockout mice are infertile due to
disrupted folliculogenesis and expression of many germ-cell specific genes and miRNAs is
perturbed in such animals (Rajkovic et al., 2004; Choi et al., 2007). Furthermore, mutations in
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the NOBOX gene associated with premature ovarian failure have been described in humans
(Qin et al., 2007; Qin et al., 2009). We recently established a key role for NOBOX in bovine
early embryonic development (Tripurani et al., 2011). Bovine NOBOX is stage-specifically
expressed during oocyte maturation and early embryonic development and of maternal origin.
Depletion of NOBOX in bovine zygotes by siRNA microinjection impaired embryo development
to the blastocyst stage. Furthermore, knockdown of NOBOX affected the expression of genes
from the embryonic genome critical to early development and expression of pluripotency genes
was altered in the inner cell mass of NOBOX siRNA injected embryos that reached the
blastocyst stage. However, despite its established role in folliculogenesis and early embryonic
development, the post-transcriptional regulation of NOBOX has not been investigated. Given
the importance of NOBOX, as a maternal transcript critical for development, and observed
depletion of NOBOX during MET, we hypothesized that NOBOX is targeted by miRNAs for
silencing and/or degradation in early embryos. In this study we identified a miRNA (miR-196a)
targeting bovine NOBOX, examined the temporal expression of miR-196a during bovine early
embryonic development and determined the effect and specificity of miR-196a in regulating
bovine NOBOX expression both exogenously (HeLa cells) and endogenously in early embryos.

MATERIALS AND METHODS

Bioinformatics Analysis
To examine the possibility of NOBOX regulation by miRNAs, we searched for potential
microRNA recognition elements (MRE) in the NOBOX 3’ UTR using Microinspector
(http://bioinfo.uni-plovdiv.bg/microinspector/), an algorithm for detection of possible interactions
between miRNAs and target mRNA sequences (Rusinov et al., 2005).
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Tissue collection, RNA isolation and microRNA expression analysis
Bovine tissue sample collection, total RNA isolation and miRNA expression analysis in
multiple tissues, oocytes and early embryos were performed as described previously (Tripurani
et al., 2010).

Plasmid construction
The full-length bovine NOBOX mRNA sequence was amplified from bovine adult ovary
cDNA samples by PCR using gene-specific primers containing restriction sites BamHI/XhoI
(Supplemental data table 1 for the list of primer sequences). The PCR product was digested
with BamHI and XhoI enzymes and subsequently cloned into pcDNA3.1 (Invitrogen, Carlsbad,
CA) vector digested with the same enzymes. pcDNA3.1: miRNA196a was constructed by PCR
amplifying a ~220nt region of genomic sequence surrounding pre-miR-196a from bovine
genomic DNA sample using primers containing restriction sites BamHI/XhoI (Supplemental data
table 1 for the list of primer sequences). The PCR product was digested and subsequently
cloned into pcDNA3.1 vector digested with BamHI and XhoI. For construction of a vector
containing NOBOX-3’ UTR fused to the 3’ end of a luciferase reporter, we used the dual
luciferase pmirGLO vector (Promega, Madison, WI). The NOBOX 3’ UTR was amplified from
pcDNA3.1: NOBOX construct using primers containing restriction sites SacI/XbaI (Supplemental
data table 1 for the list of primer sequences). The PCR product was digested with SacI and XbaI
and subsequently cloned into dual luciferase pmirGLO vector digested with the same enzymes.
Mutation of the mir-196a miRNA recognition element (MRE) in the NOBOX 3’ UTR was
performed using the QuickChange site-directed mutagenesis kit (Stratagene, Santaclara, CA)
according to the manufacturer’s instructions. (Supplemental data table 1 for the list of primer
sequences).

Cell culture and Reporter assay
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HeLa cells were cultured in DMEM (Invitrogen, Carlsbad, CA) containing 10% FBS and
1% penicillin/streptomycin (Invitrogen, Carlsbad, CA). For transient transfection, FuGENE6
(Roche Applied Science, Indianapolis, IN) was used according to manufacturer’s instructions.
Following transfection, cells were incubated for 48 h before harvest for western blotting and
luciferase assay. Luciferase assay was performed using the Dual-Glo luciferase assay system
(Promega, Madison, WI) as described by the manufacturer. Firefly luciferase activity was
normalized to renilla luciferase activity to adjust for variations in transfection efficiency among
experiments. All transfection experiments were performed in quadruplicate (n = 4) with data
averaged from four independent experiments.

Western blot analysis
Western blot was performed as previously described (Tejomurtula et al., 2009) with
minor modifications. After 48 h of transfection, HeLa cell lysates were harvested and washed
once with phosphate-buffered saline (PBS), suspended in 50 µl of PBS, and mixed with an
equal volume of Laemmli sample buffer (Bio-Rad, Hercules, CA). Protein samples (15 µg/each)
were separated on a 4-20% gradient polyacrylamide gel (Bio-Rad, Hercules, CA) and
electroblotted onto a polyvinylindene difluoride (PVDF) membrane (Bio-Rad, Hercules, CA).
Following transfer and blocking in 5% nonfat dry milk in Tris-buffered saline containing 0.1%
Tween-20 (TBST) for one hour, the membrane was then incubated in NOBOX antibody
(ab41612; Abcam, Cambridge, MA) diluted 1:100 in blocking buffer overnight at 4°C. After
washing three times with TBST, the membrane was incubated for 1 h with horseradish
peroxidase-conjugated goat anti-rabbit IgG (Pierce, Rockford, IL) diluted 1:10 000 in blocking
solution. The membrane was washed again with TBST, followed by detection with SuperSignal
West Pico Chemiluminescent Substrate (Pierce, Rockford, IL). The membrane was stripped in
Restore Plus Western Blot Stripping Buffer (Pierce, Rockford, IL), followed by detection of β-
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actin (ACTB) protein (positive control) using anti-β-actin antibody (Ambion, Austin, TX) and
horseradish peroxidase-conjugated goat anti-mouse IgG (Pierce, Rockford, IL).

Microinjection experiments
Procedures for in vitro maturation of oocytes (obtained from abattoir-derived ovaries) and in
vitro fertilization to generate zygotes for microinjection and for subsequent embryo culture were
conducted basically as described (Bettegowda et al., 2006; Bettegowda et al., 2007).
Presumptive zygotes collected at 16-18 hours post-fertilization (hpf) were used in all
microinjection experiments. Mature miRNA-196a mimic (MIMAT0000226) and negative control
cel-miR-67 (CN-001000-01-05) were obtained from Dharmacon Technologies (Dharmacon Inc,
Lafayette, CO), and diluted with RNase free water to a final concentration of 10 µM and 20 µM
before microinjection (The final concentration used for microinjection was 20 µM based on initial
experiments showing this concentration is more effective in repressing Nobox expression).
Approximately 20 pl of miRNA mimic (20 µM) was injected into the cytoplasm of zygotes using
an inverted Nikon microscope equipped with micromanipulators (Narishige International USA,
Inc., East Meadow, NY). Uninjected embryos and embryos injected with above negative control
miRNA were used as control groups. Each group contained 25-30 embryos per replicate (n = 4).
After microinjection, groups of embryos were cultured in 75- to 90-µl drops of potassium simplex
optimization medium (KSOM) (Specialty Media, Phillipsburg, NJ) supplemented with 0.3%
bovine serum albumin (BSA) until 72 h after insemination at which time point embryos were
collected. The efficiency of NOBOX mRNA/protein knockdown in miRNA-196a mimic injected
and

control

embryos

was

determined

by

quantitative

real-time

PCR

analysis

and

immunocytochemistry in eight-cell stage embryos as described previously [30]. Imaging was
performed using confocal spinning-disk microscopy. Optical sections every 1 µm were acquired
for each embryo and MetaMorph software (Universal Imaging, Downingtown, PA, USA) was
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used for image acquisition and analysis.

Statistical Analysis
One-way ANOVA using the general linear models (GLM) procedure of SAS were used to
determine the significance of differences in mRNA abundance and between the treated samples
and the controls where values resulted from the luciferase reporter assay, quantitative real-time
PCR and western blots. Different letters indicate significant differences (P < 0.05).

RESULTS AND DISCUSSION

miR-196a binds to the 3’ UTR of bovine NOBOX
MicroRNAs regulate mRNA translation rate by perfect or imperfect base pairing with the
3’ UTR regions of their targets (Rajewsky, 2006). It has been predicted that one miRNA can
potentially regulate translation of up to a hundred mRNAs, which creates a challenge for
experimentally validating miRNA-specific targets (Bartel, 2009). To identify miRNAs that
potentially regulate NOBOX expression, we analyzed the 3’ UTR sequence of bovine NOBOX
using the “Microinspector” algorithm to predict potential miRNA target sites (Rusinov et al.,
2005). miR-196a was chosen for further studies, because the predicted MRE in the bovine
NOBOX 3’ UTR had a low predicted free energy of hybridization with the cognate miRNA (-19.8
kcal/mol), suggesting a stable miRNA: mRNA duplex within the 9 nucleotide (nt) seed region at
the 5’ end of the miRNA (Fig. 1). This seed sequence is an important determinant of miRNAinduced repression of gene expression (Brennecke et al., 2005). RNA secondary structure
prediction analysis using Mfold (Zuker, 2003) revealed that the apparent miR-196a binding site
was positioned on a hairpin-loop structure, in an exposed position, which might facilitate miRNA
accessibility. In addition, when the NOBOX sequence was analyzed with other miRNA target
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prediction algorithms, miR-196a always was listed as a top candidate miRNA, further indicating
that miRNA-196a might be a potential post-transcriptional regulator of NOBOX in early embryos.
The lack of conservation of miR-196a recognition sequence in bovine NOBOX might be due to
the rapid drifting of 3’ UTR during evolution (Bartel, 2009; Shen-Orr et al., 2010). Furthermore, it
has been reported that a large fraction of bona fide targets of microRNA would be missed
(Bentwich, 2005; Giraldez et al., 2006; Bartel, 2009) if evolutionary conservation were used as
the sole criterion for predicting targets. Moreover, recent studies support a functional role for this
specific miRNA as miR-196a targets specific homeobox genes (HoxB8, HoxC8, HoxD8 and
HoxA7) in mouse embryos and mammalian cells and plays a major role in animal development
(Yekta et al., 2004). Thus, the functional role of miR-196a in regulation of NOBOX was further
investigated.

miR-196a is spatio-temporally regulated during development
To determine the tissue specific expression pattern of miR-196a, quantitative real-time
PCR was performed. As shown in Fig. 2A, miR-196a is expressed predominantly in kidney; it is
also detected significantly in fetal and adult ovary, brain and hypothalamus. A similar expression
pattern was observed in mice where miR-196a is enriched in the kidney and adult reproductive
tissues (Landgraf et al., 2007). In order to examine if miR-196a expression is inversely
correlated to bovine NOBOX expression during early embryonic development, we analyzed
miR-196 expression during oocyte maturation and early embryogenesis. Expression analysis
indicates that bovine miR-196a is increased in four-cell and eight-cell stage embryos relative to
germinal vesicle stage oocytes and declines at morula and blastocyst stages (Fig. 2B). The
increased expression level of miR-196a near the eight-cell stage of embryogenesis potentially
indicates miR-196a involvement in maternal transcript degradation during the maternal-tozygotic transition, as was observed for miR-430 in zebrafish (Giraldez et al., 2006) miR-427 in
Xenopus (Lund et al., 2009) and miR-290 in mouse (Tang et al., 2007). Moreover, when the
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spatio-temporal expression pattern of miR-196a is compared with the expression pattern of
bovine NOBOX during early embryogenesis, miR-196a expression increases steadily from twocell to eight-cell stage of embryogenesis, while NOBOX expression decreases gradually during
the same period (Tripurani et al., 2011). Thus, the inverse relationship between miR-196a and
NOBOX expression/activity supports the proposed role of miR-196a as a physiological regulator
of NOBOX during early embryogenesis.

miR-196a specifically suppresses the expression of bovine NOBOX
To confirm the binding of miR-196a to bovine NOBOX in vitro, HeLa cell transfection
studies were conducted. A significant inhibition of NOBOX expression was observed in HeLa
cells ectopically expressing both NOBOX and miR-196a (Fig. 3A) relative to cells transfected
with NOBOX alone. Semi-quantitative analysis of western blot data showed a significant
inhibition of NOBOX expression in the miR-196a-transfected cells (Fig. 3B). These results
unequivocally show that bovine NOBOX is regulated at the post-transcriptional level by miR196a and further supports the hypothesis that miR-196a is responsible for the negative
regulation of NOBOX.
Furthermore, luciferase reporter assays were performed to validate specificity of the
miR-196a regulation of NOBOX through the predicted miR-196a recognition sequence in the 3’
UTR of NOBOX. NOBOX 3’ UTR sequence was inserted downstream of the firefly luciferase
coding region. Mutations in the predicted MRE in the 3’ UTR of the NOBOX for miR-196a were
created such that interaction between miR-196a and NOBOX is compromised (Fig. 4A). Ectopic
expression of miR-196a by transfection of miR-196a duplex into the HeLa cells suppressed
activity of a chimeric luciferase construct containing the miR-196a MRE of NOBOX at its 3’ end
(Fig.4B). Luciferase activity was restored when a four-base mismatch mutation was introduced
into the seed region of the miRNA-196a recognition sequence in the NOBOX 3’ UTR (Fig. 4B).
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These data indicate the predicted MRE is critical for the direct and specific binding of miR-196a
to NOBOX transcript.
miR-196a represses endogenous NOBOX in bovine early embryos
Since we determined in heterologous systems that miR-196a is capable of regulating
NOBOX expression through direct binding to the 3’ UTR of its mRNA, the ability of miR-196a to
regulate endogenous NOBOX expression in early embryos was determined. Microinjection of
miRNA mimics into zygotes has been utilized previously as a tool to determine effects of
overexpression of specific miRNAs in mouse and zebrafish embryos (Krützfeldt et al., 2006;
Begemann, 2008; Spruce et al., 2010). Ectopic expression of miR-196a mimic in bovine
embryos effectively reduced NOBOX protein expression in eight-cell embryos compared to
uninjected and the negative control miRNA-injected embryos (Fig. 5A). Furthermore, recent
studies have suggested that miRNAs not only inhibit productive translation but also accelerates
target mRNA decay (Bagga et al., 2005; Lim et al., 2005). Microinjection of miR-196a mimic in
bovine embryos significantly reduced NOBOX mRNA levels in eight-cell embryos by more than
80% relative to uninjected and negative control miRNA-injected embryos (Fig. 5B).
The degradation of the untranslated maternal RNA pool is very critical to early
embryonic development (Schultz, 2002). The translation potential of a maternal mRNA
transcript is affected by the length of the poly (A) tail as it confers mRNA stability and stimulates
translation via interaction of poly (A) binding protein (PABP) with the 5’ m7G cap (Curtis et al.,
1995; Amano, 2005). Moreover, maternal mRNAs are dependent on post-transcriptional and
post-translational mechanisms to regulate their activity, as they cannot be repressed at the
transcriptional level (Vasudevan et al., 2006; Bettegowda and Smith, 2007). Recent studies in
zebrafish and Xenopus found that miRNAs promote deadenylation of target mRNAs and induce
maternal mRNA degradation/clearance during early embryogenesis (Giraldez et al., 2006; Lund
et al., 2009), indicating that miRNA-induced clearance of maternal mRNAs might be a universal
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mechanism during MET. Thus, a similar mechanism is likely to be involved in the miR-196a
negative regulation of NOBOX expression in bovine embryos during MET.
miR-196a is an evolutionary conserved miRNA that has been identified in a wide range
of vertebrate species. It is expressed from intergenic regions of HOX gene clusters, and targets
several HOX genes in these clusters, which are known to play crucial roles during development
(Yekta et al., 2004; Sehm et al., 2009; Braig et al., 2010). Recent studies showed that 75% of
tumors express high levels of miR-196a and miR-196a is involved in regulating key pathways
such as AKT signaling, p53 and WNT signaling pathways (Andl et al., 2006; Schimanski et al.,
2009). It has also been reported that miR-196a is differently regulated during polycystic kidney
disease suggesting that miR-196 is important for normal functioning of kidney (Pandey et al.,
2008). The involvement of miR-196a in regulating the expression of NOBOX supports a new
role of this miRNA in early embryonic development during MET.

CONCLUSION
Collectively, our results demonstrate the ability of miR-196a to negatively regulate
NOBOX expression in a sequence specific fashion and the ability of miR-196a to suppress
NOBOX mRNA and protein in early embryos. Future studies of interest will investigate whether
loss of miR-196a has any effect on the early embryonic development and identify putative miR196a targets by next generation sequencing analysis of miR-196a depleted and wild type
embryos.
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Table 1.	
  List of primers used in this study
Gene
Name

Primer Name

NOBOX

Primer Sequence (5’ to 3’)

NOBOX-BamHI-F

TATGGATCCTTCCAAGCTACGTATGTACG

NOBOX-XhoI-R

ATACTCGAGAGGCAGTTTACTGCTTATGGTGG

NOBOX-3`UTR-SacI-F

TATGAGCTCTCATGGAGCCGAAGAACCAAGA

NOBOX-3`UTR-XbaI-R

ATATCTAGAGTTTCCCAAGAGGAGGCAGTT

NOBOX-3UTRmut-F

CGCTCCAGTGGCCACCATAAGCAGTTTTGAGCCTCCTCTTGGG

NOBOX-3UTRmut-R
NOBOX-Real time-F
NOBOX-Real time-R

CCCAAGAGGAGGCTCAAAACTGCTTATGGTGGCCACTGGAGCG
AGACCCAGTTCTTCCAACACC
CACAGGACAAGGCAAAGAGAG

RPS18

RPS18-RealTime-F

GTGGTGTTGAGGAAAGCAGACA

miR-196a

RPS18-RealTime-R
miR-196a - RT

TGATCACACGTTCCACCTCATC
UAGGUAGUUUCAUGUUGUUGGG

miR-196a-BamHI-F

TATGGATCCGACGGGGCTGAATTTCTTCC

miR-196a-XhoI-R

ATACTCGAGCACTGGGGAGGGTAGGAGCGGGATA

miR-125b-RT

TCCCTGAGACCCTAACTTGTGA

miR-125b
	
  

Application
Cloning of NOBOX
mRNA into pcDNA3.1
Cloning of NOBOX
mRNA into pcDNA3.1
Cloning of NOBOX
3`UTR into pmirGLO
vector
Cloning of NOBOX
3`UTR into pmirGLO
vector
Generating mutant
NOBOX 3`UTR for
luciferase reporter assay
Generating mutant
NOBOX 3`UTR for
luciferase reporter assay
Real Time PCR
Real Time PCR
Real Time PCR
(endogenous control)
Real Time PCR
(endogenous control)
Real Time PCR
Cloning of miR-196a into
pcDNA3.1
Cloning of miR-196a into
pcDNA3.1
Real Time PCR
(endogenous control)
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Figure 1. miR-196a binds to the 3’ UTR of bovine NOBOX. Predicted binding site of miR-196a
within the 3’ UTR of the bovine NOBOX mRNA (underlined region).
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Figure 2. Spatial and temporal expression profile of miR-196a. (A) Tissue distribution of miR196a analyzed by quantitative real-time PCR. Quantity of miRNA-196a was normalized to
abundance of RPS18 mRNA and abundance expressed as relative fold change using the
sample with the lowest value as the calibrator (n = 4 per tissue; mean ± SEM depicted). (B)
Relative abundance of miR-196a in bovine oocytes and in vitro produced bovine early embryos
(n = 4 pools of five oocytes/embryos each). Quantity of miRNA was normalized relative to
abundance of miR-125b. The relative amount of miR-196a was expressed as relative fold
change using the sample with the lowest value as the calibrator (n = 4, mean ± SEM). Different
letters indicate statistical difference (P < 0.05).
	
  

	
  

125	
  

	
  
	
  
	
  
Figure 3.	
   Regulation of bovine NOBOX expression by miR-196a in vitro in HeLa cells. (A)
Representative Western blot showing specific suppression of bovine NOBOX by miR-196a in
HeLa cells. β-Actin was used as loading control. The experiment was repeated four times with
similar results, and a representative experiment is shown. (B) Semi-quantitative analysis of
miRNA-196a regulation of NOBOX expression in transfected HeLa cells. Abundance of NOBOX
protein in each sample was determined by densitometry and normalized relative to abundance
of β-Actin protein (control). Data are expressed as mean relative pixel density (n = 4 mean +
SEM). Different letters indicate statistical difference (P < 0.05).
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Figure 4. miR-196a specifically binds to the 3’ UTR of bovine NOBOX and regulates its
expression. (A) Schematic of the luciferase reporter constructs used to demonstrate sequence
specificity in recognition sequence in bovine NOBOX 3’ UTR mediating miR-196a mediated
repression. Nucleotides changed to generate the target site mutant 3’ UTR are underlined (B)
Repression of luciferase activity due to specific interaction between miR-196a and the predicted
MRE in the luciferase-NOBOX-3’ UTR constructs. Repression of luciferase reporter gene
activity by miR-196a was abolished when the MRE was mutated. Data is presented as relative
firefly luciferase units (RLUs). Relative firefly luciferase values were determined by a ratio of
firefly to renilla luciferase with the negative control (cells transfected with native NOBOX-3’ UTR
construct alone) set at 1. Each group represents the mean ± SEM of four wells for an
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experiment repeated four times with similar results. Different letters indicate statistical difference
(P < 0.05).
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Figure 5. Microinjection of miR-196a mimic represses endogenous NOBOX expression in
bovine early embryos. (A) Effect of miR-196a mimic microinjection on abundance of NOBOX
protein in 8-cell stage embryos as determined by immunocytochemical analysis using confocal
spinning-disk microscopy (n = 4 pools of 5-10 embryos per treatment). Uninjected embryos and
embryos injected with a nonspecific miRNA (Neg miRNA) were used as controls. Nuclear DNA
was stained with DAPI. (B) Effect of miR-196a mimic microinjection on abundance of NOBOX
mRNA in eight-cell embryos as determined by real-time PCR. Data were normalized relative to
abundance of endogenous control ribosomal protein S18 (RSP18) and are shown as mean ±
SEM (n = 4 pools of 10 embryos per treatment). Different letters indicate statistical difference (P
< 0.05).
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ABSTRACT
Ovarian folliculogenesis and early embryogenesis are complex processes, which
require tightly regulated expression and interaction of a multitude of genes. Small endogenous
RNA molecules, termed microRNAs (miRNAs), are involved in the regulation of gene
expression during folliculogenesis and early embryonic development. To identify miRNAs
expressed in bovine oocytes/ovaries, a bovine fetal ovary miRNA library was constructed.
Sequence analysis of random clones from the library identified 679 miRNA sequences, which
represent 58 distinct bovine miRNAs. Of these distinct miRNAs, 42 are known bovine miRNAs
present in the miRBase database and the remaining 16 miRNAs include 15 new bovine miRNAs
that are homologous to miRNAs identified in other species, and one novel miRNA, which does
not match any miRNAs in the database. The precursor sequences for 14 of the new 15 miRNAs
as well as the novel miRNA were identified from the bovine genome database and their hairpin
structures were predicted. Expression analysis of the 58 miRNAs in fetal ovaries in comparison
to somatic tissue pools identified eight miRNAs predominantly expressed in fetal ovaries.
Further analysis of the expression of these eight miRNAs in germinal vesicle (GV) stage
oocytes identified two miRNAs (bta-mir424 and bta-mir-10b) that are highly abundant in GV
oocytes. Both miRNAs show similar expression patterns during oocyte maturation and
preimplantation development of bovine embryos, being abundant in GV and MII stage oocytes,
as well as in early stage embryos (until 16-cell stage). The amount of the novel miRNA is
relatively small in oocytes and early cleavage embryos but greater in blastocysts, suggesting a
role of this miRNA in blastocyst cell differentiation.
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INTRODUCTION
MicroRNAs (miRNAs) are single-stranded endogenous non-coding small RNAs ranging
in size from 19 to 24 nucleotides (nt). It is estimated that 1 to 5 % of the genes in the genome
encode for miRNAs (Lim et al., 2003), which may regulate up to 30% of the genes (Lewis et al.,
2003). Many miRNA genes are transcribed by RNA polymerase II, yielding primary miRNAs
(Bartel, 2004; He and Hannon, 2004), which are processed by Drosha into miRNA precursors
(pre-miRNAs) of approximately 70 nt (Lee et al., 2003). The pre-miRNAs are then transported to
the cytoplasm and processed by DICER to form an miRNA:miRNA* duplex (Bartel, 2004; He
and Hannon, 2004). Mature miRNAs associate with an Argonaute protein and act either at the 3’
untranslated region (UTR) (Bentwich, 2005; Rajewsky, 2006) or the amino acid coding region of
the transcript (Tay et al., 2008) resulting in the suppression of the target gene expression
(Ambros, 2004). The majority of miRNAs are evolutionarily conserved across species
boundaries and are important regulators of molecular and cellular processes such as brain
morphogenesis (Giraldez et al., 2005), cardiomyocyte proliferation/differentiation (Zhao et al.,
2005), viral defense (Lecellier et al., 2005) and insulin secretion (Poy et al., 2004).
Ovarian folliculogenesis and early embryogenesis are complex and coordinated
biological processes, which require tightly regulated expression and interaction of large groups
of genes. Maternal transcripts and proteins synthesized and stored in oocytes during oogenesis
are indispensable for proper recommencement of meiosis and early embryogenesis prior to
embryonic genome activation (De Sousa et al., 1998). Genes specifically expressed in oocytes
are known to play important roles in folliculogenesis and early development (Zheng and Dean,
2007). Recent studies indicate that miRNAs may play a critical role in controlling the expression
of genes essential for folliculogenesis and early embryogenesis (Zhao and Rajkovic, 2008;
Carletti and Christenson, 2009). Loss of maternal miRNAs by specific deletion of Dicer results in
an arrest of zygotic development in mice (Tang et al., 2007) and a specific miRNA, miR-430,
has been shown to be responsible of the degradation of many maternally expressed mRNAs in
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zebrafish (Giraldez et al., 2006). Efforts to identify miRNAs expressed in mouse ovaries have
been made using either microarray approach (Choi et al., 2007) or cloning approach (Ro et al.,
2007). However, the role of individual miRNAs in oocyte and embryonic development in
mammalian species is currently unknown.
In recent years, cattle has been recognized as an important model animal for
biochemistry, reproduction and nutrition research as cattle and human genomes contain many
identical genes, and even the whole chromosomes of two species are configured in the similar
way when compared to mouse (Gibs et al., 2006). Computational and experimental methods
have been used to identify miRNAs in cattle (Coutinho et al., 2007; Gu et al., 2007). To date,
615 bovine miRNAs have been identified (miRBase release 14.0). In an attempt to identify
miRNAs specifically or predominantly expressed in oocytes, a miRNA library was constructed
from bovine fetal ovaries (a rich source of oocytes). This study reports the cloning of 58 miRNAs
expressed in bovine fetal ovaries, discovery of new bovine miRNAs including one that is
completely novel, and identification of two miRNAs that are highly abundant in oocytes and
early cleavage embryos.

MATERIALS AND METHODS

Tissue collection and RNA isolation
Bovine tissue samples including liver, kidney, muscle, heart, brain, hypothalamus,
spleen, lung, small intestine and fetal ovary were collected at a local abattoir. Fetal age was
estimated based on crown-rump length (Richardson et al., 1990). All samples were frozen in
liquid nitrogen and stored at -80°C until use. Total RNA was isolated using the TRIzol reagent
(Invitrogen, Carlsbad, CA) according to the manufacturer’s instruction. Concentrations of
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isolated RNA were determined by measuring absorbance at 260 nm using a Nanodrop
spectrophotometer (Thermo scientific, Wilmington, DE).

MicroRNA library construction and sequencing
The miRNA library was constructed using the small RNA cloning kit mirCat (IDT DNA,
Coralville,

IA)

according

to

the

manufacturer’s

instruction

with

minor

modifications

(Ramachandra et al., 2008). Briefly, a pool of total RNA (500 µg) isolated from two fetal ovaries
(230 and 250 days of gestation, respectively) was size fractionated using a doubleconcentration (3% and 15%) denaturing polyacrylamide gel. Small RNAs were purified from the
excised gels and 3’ linker (5’ phosphorylated) was ligated to the small RNAs in the absence of
ATP. The 3’ linker-ligated small RNAs were size fractionated and purified again, and then
ligated to 5’ linker in the presence of ATP. The ligation products were reverse transcribed using
the primer on the 3’ linker and PCR amplified using primers on both linkers followed by TA
cloning using pGEM-T easy vector system (Promega, Madison, WI). A total of 1536 clones were
randomly picked from the library and sequenced (Agencourt Biosciences Corporation, Beverly,
MA).

Bioinformatic analysis
Low quality sequences and sequences with no inserts were removed first. Vector and
adapter sequences were then removed from the remaining good quality sequences. A total of
685 sequences of typical miRNA size (19-24 nt) were obtained after removing smaller
sequences (< 18 nt) and used for further analysis. To identify miRNAs, all small RNA
sequences

were

initially

analyzed

using

the

miRbase

search

tool

(http://microrna.sanger.ac.uk/sequences/search.shtml). If a small RNA matches to a registered
bovine miRNA, it was classified as a known bovine miRNA. If a small RNA matches to a
registered miRNA identified in other animal species but not in cattle, it was considered as a new
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bovine miRNA. If a small RNA is 19-24 nt long but does not match any registered miRNAs in the
miRBase database, it was considered as a potentially novel bovine miRNA. Each identified
miRNA was located in the bovine genome using the BLAT function in the UCSC genome
browser (http://genome.ucsc.edu/) (Karolchik et al., 2008). The genomic sequence containing
the miRNA with 100 nt flanking sequences was analyzed for hairpin structure using the Mfold
program (version 3.2) at (http://mfold.bioinfo.rpi.edu/cgi-bin/rna-form1.cgi) (Zuker, 2003).
Prediction of target genes was performed using TargetScan (http://www.targetscan.org/).

MicroRNA expression analysis
The relative amount of miRNAs was determined by quantitative real-time PCR using the
miScript PCR system (Qiagen, Valencia, CA) according to the manufacturer’s protocol. Total
RNA (1 µg from somatic tissues or fetal ovaries, n = 3) was converted to cDNA using miScript
reverse transcriptase mix (Qiagen, Valencia, CA). The cDNA was then used for real time PCR
quantification of miRNA using a miRNA specific primer and the miScript universal primer
(Qiagen, Valencia, CA). Ribosomal protein S18 (RPS18) gene was used as an endogenous
control. The primers for miRNAs and the control gene are listed in Table 1. The Bio-Rad iCycler
iQ Real Time Detection System was used to perform the quantitative analysis using miScript
QuantiTect SYBR Green PCR master mix (Qiagen, Valencia, CA) in 25-µl reaction volumes
containing 300 nM of each primer and cDNA derived from 0.1 µg of total RNA. Cycling
parameters were 95 C for 15 min, and then 40 cycles of 95 C for 15 sec, 55 C for 30 sec and 70
C for 30 sec. Standard curves for all miRNAs and the endogenous control were constructed
using the 10-fold serial dilution of a cDNA from a pool of somatic tissues. For each sample, the
quantity of miRNA and the reference gene mRNA (RPS18) was determined from the
appropriate standard curves. The quantity of the miRNA was then divided by the quantity of the
reference gene to obtain a normalized value. The expression of the miRNA was expressed as
relative fold change. When comparing miRNA expression between fetal ovaries and pools of
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somatic tissues, the somatic tissue pools were used as a calibrator. When comparing the
expression of the novel miRNA in multiple tissues, the tissue with the lowest expression was
used as a calibrator. The heatmap showing relative miRNA expression between fetal ovaries
and pools of somatic tissues was constructed using Multiexperiment Viewer (MeV) software.
GV oocytes and early stage embryos used for quantitative measurement of miRNA
expression were purchased from Bomed, Inc (Madison, WI). cDNA from oocyte and embryo
samples (n = 3 pools of 5 each) was prepared by lysing the samples in 1X miScript RT buffer
containing 0.5% NP-40 at 95 C for 5 min followed by addition of miScript reverse transcriptase
mix (Qiagen, Valencia, CA) and incubation at 37 C for 60 min. The cDNA was then used for
determination of miRNA expression by quantitative real time PCR as described above. mir-125b
was used as an endogenous control to normalize the target miRNA expression in oocytes and
early embryos as this miRNA has been shown to be expressed consistently in preimplantation
mouse embryos (Byrne and Warner, 2008).

RESULTS AND DISCUSSION

Cloning and identification of miRNAs from bovine fetal ovary
A miRNA library was constructed using small RNA isolated from bovine fetal ovaries.
Sequencing of 1536 randomly selected clones from the library generated a total of 684 good
quality sequences of typical mature miRNA size (19-24 nt). Public database search revealed
that the majority of these small RNA sequences are miRNAs (679 out of 684) and only a small
fraction represents degraded mRNA or tRNA (Table 2). The majority of the miRNAs are 20-23
nt in size, which is the typical size range for DICER-derived products and the 21-22 nt size class
is predominant (Fig. 1). Furthermore, the majority of the bovine miRNAs begin with a 5’ uridine,
a characteristic of miRNAs (Bartel, 2004).
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Among the 679 miRNA sequences, 635 of them represent 42 distinct bovine miRNAs
already annotated in the miRbase database (Table 3). The remaining 44 miRNAs include 43
representing 15 distinct miRNAs that are conserved among other animal species but not yet
identified in cattle, and one miRNA that does not match any known miRNAs registered in the
miRbase database (Table 4). A search of the bovine genome database revealed chromosomal
locations and potential precursors for all newly identified miRNAs except for bta-mir-652. The
new

bovine

miRNAs

will

be

submitted

to

the

miRNA

registry

website

at

http://microRNA.sanger.ac.uk/registry for official annotation. Overall, nearly all cloned bovine
miRNAs from fetal ovaries are homologous to known miRNAs in animal species, supporting the
notion that miRNAs are evolutionarily conserved (Bartel, 2004).
The miRNAs cloned from bovine fetal ovaries vary greatly in their representation in the
cloned population, with 50% of them being represented by at least two clones (Table 3 and
Table 4). bta-mir-99a and bta-mir-125b are the most abundant miRNAs in the cloned miRNA
population, accounting for 33% and 31% of all cloned miRNAs. This observation is consistent
with the data from a mouse study where there was great abundance of these two miRNAs in
ovaries (Mishima et al., 2008). In addition, there are 80 clones representing miRNAs of the btalet-7 family that consists of 10 isoforms (a, b, c, d, e, f, g, a*, b*, e*). let-7, the founding member
of the family is required for timing of cell fate determination (Pasquinelli et al., 2000; Reinhart et
al., 2000). The relative abundance of these miRNAs in ovaries may suggest their housekeeping
cellular roles during ovarian development.
One of the important criteria that distinguish miRNAs from other endogenous small
RNAs is the ability of the miRNA-surrounding sequence to adopt a hairpin structure with the
miRNA positioned within one stand of the hairpin in order to be excised during the Dicer
processing (Ambros et al., 2003). To confidently annotate the newly identified bovine miRNAs,
they were aligned to the bovine genomic sequences in the UCSC genome browser to identify
the miRNA precursor sequences. Precursor sequences for 14 of the 15 new bovine miRNAs
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were identified in the current bovine genome database. A total of 17 genomic loci were found
including 12 single-copy loci corresponding to 12 miRNAs, two loci encoding bta-miR-299-5p
and three loci for bta-miR-339-5p (Fig. 2). The genomic locus for bta-miR-652 was not
identified, presumably due to incompleteness of the bovine genome sequence. All precursor
sequences identified for the new bovine miRNAs are in the typical size range (70-100 nt) for
animal miRNA precursors (Bartel, 2004) and can form thermodynamically stable hairpin
structures that fulfill the miRNA biogenesis criteria (Fig. 2).

Analysis of cloned bovine miRNAs
To identify miRNAs specifically or predominantly expressed in fetal ovaries, the relative
abundance of all cloned bovine miRNAs in fetal ovaries and pools of somatic tissues (brain,
hypothalamus, liver, spleen, heart, lung, kidney, small intestine and muscle) was assessed by
quantitative real time PCR. The data are shown as a heatmap in Fig. 3. Of the 58 miRNAs
tested, eight miRNAs including bta-miR-99a, bta-miR-10b, bta-miR-199a-3p, bta-miR-199a-5p,
bta-miR-424, bta-miR-100, bta-miR-455 and bta-miR-214* showed over 10-fold greater in
relative abundance in fetal ovaries compared to the somatic tissue pools. Some of these
miRNAs (e.g. bta-miR-99a, bta-miR-10b, bta-miR-100 and bta-miR-424) are also abundantly
present in human ovaries (Liang et al., 2007). Sequencing-based miRNA expression profiling
has often been used as a tool to measure the relative abundance of miRNAs (Landgraf et al.,
2007). The expression data for many of these miRNAs (e.g. bta-miR-99a) appear to match the
cloning frequency data; however, some of them (e.g. bta-miR-199a-3p, bta-miR-199a-5p) are
represented by only a few copies from the sequencing data (Table 3 and Table 4). Such
discrepancies between cloning frequency and expression results have been reported previously
for miRNAs in cattle as well as in other species (Sempere et al., 2004; Gu et al., 2007; Reddy et
al., 2009).
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The ovary contains multiple somatic cell types such as granulose cells, theca cells and
cumulus cells in addition to oocytes. Therefore, the miRNAs cloned from the fetal ovaries may
be derived from either oocytes or somatic cell types. To determine the cellular origin, we
examined the expression of the eight miRNAs predominantly expressed in fetal ovaries in
germinal vesicle (GV) stage oocytes. As shown in Fig. 4, two miRNAs, bta-mir-424 and bta-mir10b, were in greater relative abundance in GV oocytes relative to the remaining six miRNAs
abundantly present in fetal ovaries, suggesting that these six miRNAs are expressed primarily in
the ovarian somatic cells. To further investigate the role of bta-mir-424 and bta-mir-10b in
oocyte maturation and early embryogenesis, relative amounts of these two miRNAs in GV and
MII stage oocytes, and two-cell, four-cell, eight-cell, 16-cell, morula and blastocyst stage
embryos were assessed. The expression patterns of the two miRNAs are very similar, being
highly abundant in GV and MII stage oocytes as well as in early stage embryos (until 16-cell)
with a tendency of decreasing in morula and blastocyst stage embryos (Fig. 5). Such expression
patterns indicate that these miRNAs are maternally inherited and may potentially be involved in
the maternal transcript turnover during zygotic gene activation (Giraldez et al., 2006).

Characterization of the novel bovine miRNA
Many oocyte-specific genes are important for folliculogenesis, fertilization and early
development (Zheng and Dean, 2007). Such genes are likely regulated by miRNAs specifically
or predominantly present in oocytes. Fetal ovary is a rich source of oocytes and cloning of
miRNAs from this tissue could lead to the discovery of novel oocyte-specific miRNAs. However,
the novel miRNA cloned in this study does not appear to be oocyte-specific as it is expressed in
pools of somatic tissues (Fig. 3). To further analyze the profile of this novel miRNA, the relative
amount of this miRNA in 12 different bovine tissues was evaluated. Fig. 6A shows that the novel
miRNA is ubiquitous. Interestingly, the novel miRNA appears to be in greater relative amounts
in the brain and hypothalamus than in either adult or fetal ovaries. To investigate the role of this
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novel miRNA in oocyte maturation and early embryonic development, the relative amount of this
novel miRNA in GV and MII stage oocytes as well as in preimplantation stage embryos was
eveluated. As shown in Fig. 6B, the relative amount of this novel miRNA is small in oocytes and
remains so in early embryos until morula stage when amounts increase, peaking in the
blastocyst stage. Such expression profile may suggest a role of this miRNA in blastocyst cell
differentiation.
By searching the bovine genome database, a genomic locus for the novel miRNA was
identified on chromosome 10. The precursor sequence was predicted to form a hairpin structure
that meets the miRNA biogenesis criteria (Fig. 6C). A search of the mouse and human genome
database for the novel miRNA failed to identify homologous sequences, indicating that the novel
miRNA could be cattle-specific. Although miRNAs are evolutionary conserved, species-specific
miRNAs have been reported previously (Bentwich et al., 2005).
To identify potential target genes of the novel miRNA, a target prediction was performed
in the present study by searching for the presence of conserved 7-mer sites in the 3’ UTR of
mRNAs that match exactly the seed region (positions 2-8) of the mature miRNA using
TargetScan software. A total of 15 target genes were identified that might be regulated by this
novel miRNA (Table 5). Interestingly, most of these genes are involved in signaling pathways
and cell differentiation.

CONCLUSION
Cloning of miRNAs is the starting point to understand the diversity and possible roles of
miRNAs in regulation of gene expression in an organism. This study led to the identification of
58 distinct fetal ovary-expressed miRNAs including 15 new bovine miRNAs that are cloned from
cattle for the first time and a completely novel miRNA that has never been cloned in other
mammalian species. Further analyses of the targets of these ovary-expressed miRNAs will help
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us understand their roles in regulation of gene expression during folliculogenesis and early
embryogenesis in cattle.
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Table 1. List of primers used in the study

	
  

Primer name

Primer sequence (5’ to 3’)

bta-miR-99a
bta-miR-125b
bta-miR-125a
bta-miR-125b-1
bta-miR-26a
bta-let-7a
bta-let-7b
bta-let-7c
bta-let-7d
bta-let-7e
bta-let-7f
bta-let-7g
bta-let-7a*
bta-miR-10a
bta-miR-10b
bta-miR-126*
bta-miR-199a-3p
bta-miR-199a-5p
bta-miR-181a
bta-miR-23b
bta-miR-92
bta-miR-30d
bta-miR-127
bta-miR-99b
bta-miR-19b
bta-miR-145
bta-miR-186
bta-miR-18a
bta-miR-151*
bta-miR-374a
bta-miR-20a
bta-miR-15a
bta-miR-455
bta-miR-127
bta-miR-25
bta-miR-320
bta-miR-145
bta-miR-30e-5p
bta-miR-365
bta-miR-455
bta-miR-369-3p
bta-miR-30b
bta-miR-150
bta-miR-455*
bta-miR-126
bta-miR-424
bta-miR-100
bta-miR-30e*
bta-miR-214*
bta-miR-532-3p
bta-miR-299-5p
bta-let-7b*

AACCCGTAGATCCGATCTTGT
TCCCTGAGACCCTAACTTGTGA
TCCCTGAGACCCTTTAACCTGTG
TCCCTGAGACCCTAACTTGTGA
TTCAAGTAATCCAGGATAGGCT
TGAGGTAGTAGGTTGTATAGTT
TGAGGTAGTAGGTTGTGTGGTT
TGAGGTAGTAGGTTGTATGGTT
AGAGGTAGTAGGTTGCATAGTT
TGAGGTAGGAGGTTGTATAGT
TGAGGTAGTAGATTGTATAGTT
TGAGGTAGTAGTTTGTACAGTT
CTATACAATCTACTGTCTTTCT
TACCCTGTAGATCCGAATTTGTG
TACCCTGTAGAACCGAATTTGTG
CATTATTACTTTTGGTACGCG
ACAGTAGTCTGCACATTGGTTA
CCCAGTGTTCAGACTACCTGTT
AACATTCAACGCTGTCGGTGAGTT
ATCACATTGCCAGGGATTACCAC
TATTGCACTTGTCCCGGCCTGT
TGTAAACATCCCCGACTGGAAGCT
TCGGATCCGTCTGAGCTTGGCT
CACCCGTAGAACCGACCTTGCG
TGTGCAAATCCATGCAAAACTGA
GTCCAGTTTTCCCAGGAATCCCT
CAAAGAATTCTCCTTTTGGGCT
TAAGGTGCATCTAGTGCAGATA
TCGAGGAGCTCACAGTCTAGT
TTATAATACAACCTGATAAGTG
TAAAGTGCTTATAGTGCAGGTAG
TAGCAGCACATAATGGTTTGT
TATGTGCCTTTGGACTACATC
TCGGATCCGTCTGAGCTTGGCT
CATTGCACTTGTCTCGGTCTGA
AAAAGCTGGGTTGAGAGGGCGA
GTCCAGTTTTCCCAGGAATCCCT
TGTAAACATCCTTGACTGGAAGCT
TAATGCCCCTAAAAATCCTTAT
TATGTGCCTTTGGACTACATC
AATAATACATGGTTGATCTTT
TGTAAACATCCTACACTCAGCT
TCTCCCAACCCTTGTACCAGTGT
GCAGTCCATGGGCATATACACT
CGTACCGTGAGTAATAATGCG
CAGCAGCAATTCATGTTTTGA
AACCCGTAGATCCGAACTTGTG
CTTTCAGTCGGATGTTTACAGC
GCCTGTCTACACTTGCTGTGC
CCTCCCACACCCAAGGCTTGCA
GGTTTACCGTCCCACATACAT
TATACAACCTACTGCCTTCCC
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bta-let-7e*
bta-miR-339-5p
bta-miR-504
bta-miR-451
bta-miR-423-5p
bta-miR-652
rno-miR-125b*
bta-miR-143
novel miRNA
RPS18-F
RPS18-R

	
  

CTATACGGCCTCCTAGCTTTCC
TCCCTGTCCTCCAGGAGCTCAC
AGACCCTGGTCTGCACTCTGTC
AAACCGTTACCATTACTGAGTT
TGAGGGGCAGAGAGCGAGACTT
AATGGCGCCACTAGGGTTGTG
ACAAGTCAGGCTCTTGGGACCT
TGAGATGAAGCACTGTAGCTC
AAAACCCGAATGAACTTTTTGGA
GTGGTGTTGAGGAAAGCAGACA
TGATCACACGTT CCACCTCATC
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Table 2. Identities of the cloned miRNA sequences from bovine fetal ovary
RNA species

Total sequences

Total RNA sequences

684

Annotated bovine miRNAs

635

Newly identified bovine miRNAsa

43

Novel miRNAsb

1

mRNA

4

tRNA

1

a

Sequences homologous to known mammalian miRNAs in the miRbase database

b

Sequences do not match any known miRNAs in the miRase database
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Table 3. Known miRNAs cloned from bovine fetal ovary
miRNA

Sequence (5’ to 3’)

Size

bta-miR-99a

AACCCGUAGAUCCGAUCUUGU

21

Number
of clones
223

bta-miR-125b

UCCCUGAGACCCUAACUUGUGA

22

bta-let-7c

UGAGGUAGUAGGUUGUAUGGUU

bta-miR-125a

Chromosome

Strand

Start

End

1

-

213

15,1*

-

22

32

1,8*, 5^

-, +*, +^

UCCCUGAGACCCUUUAACCUGUG

22

26

18

+

bta-miR-26a

UUCAAGUAAUCCAGGAUAGGCU

22

25

5,22*

+

bta-let-7b
bta-miR-10b

UGAGGUAGUAGGUUGUGUGGUU
UACCCUGUAGAACCGAAUUUGUG

22
22

19
14

5
2

+
-

bta-let-7a

UGAGGUAGUAGGUUGUAUAGUU

21

9

15,8*, 5^

-, +*, +^

bta-miR-145
bta-miR-126*

GUCCAGUUUUCCCAGGAAUCCCU
CAUUAUUACUUUUGGUACGCG

23
21

8
7

7
11

+
+

bta-let-7a*

CUAUACAAUCUACUGUCUUUCU

21

6

8,5*

+, +*

bta-let-7e

UGAGGUAGGAGGUUGUAUAGU

22

5

18

+

bta-let-7f

UGAGGUAGUAGAUUGUAUAGUU

22

4

X, 8*

-, +*

bta-miR-181a

AACAUUCAACGCUGUCGGUGAGU

23

4

16,11*

-, +*

bta-miR-10a

UACCCUGUAGAUCCGAAUUUGUG

22

3

19

+

bta-miR199a-3p

ACAGUAGUCUGCACAUUGGUUA

21

3

7,16*, 11^

-, -*, -^

bta-let-7d
bta-miR-23b

AGAGGUAGUAGGUUGCAUAGUU
AUCACAUUGCCAGGGAUUACCAC

21
23

2
2

8
8

+
+

bta-miR-92

UAUUGCACUUGUCCCGGCCUGU

22

2

Un.004.53, 12

-, +

bta-miR-30d
bta-miR-127

UGUAAACAUCCCCGACUGGAAGU
UCGGAUCCGUCUGAGCUUGGCU

24
21

2
2

14
21

+
+

20137011
31406392
20087164*
20136289
89743304*
123307215^
57588678
60085865
11464112*
123308017
21426250
31455172
89743304*
123307215^
60270246
108009400
89743355
123307263*
57588172
58738580
89743658*
76125661
99136799*
39116904
13733563
36247801*
102419025^
89745865
85962081
180994
64665850
6473527
65868487

20137031
31406413
20087185*
20136310
89743325*
123307236^
57588700
60085886
11464133*
123308038
21426272
31455193
89743325*
123307236^
60270268
108009420
89743375
123307283*
57588192
58738601
89743679*
76125684
99136822*
39116926
13733584
36247822*
102419046^
89745886
85962103
181015
64665871
6473550
65868508

CACCCGUAGAACCGACCUUGCG

22

2

18

+

57588003

57588024

UGUGCAAAUCCAUGCAAAACUGA

22

2

Un.004.53
12*, 1^

-, +*, +^

181144
64665734
6894622
31406392
20087164*
49631992
13733604
36247840*
79661874
362122*
64665250
181545*
2275092
3052129
93458*
64665560^
79200656^^
18887792
108764304
65868487
38456026

181166
64665756
6894642
31406413
20087185*
49632013
13733625
36247861*
79661895
362142*
64665271
181566*
2275112
3052151
93480*
64665582^
79200676^^
18887812
108764324
65868508
38456047

bta-miR-99b
bta-miR-19b
bta-miR125b-1
bta-let-7g
bta-miR199a-5p

UCCCUGAGACCCUAACUUGUGA

22

2

15,1*

-

UGAGGUAGUAGUUUGUACAGUU

21

1

22

+

CCCAGUGUUCAGACUACCUGUU

22

1

7,16*

-, -*

bta-miR-186

CAAAGAAUUCUCCUUUUGGGCU

22

1

3,Un.004.158*

+, -*

bta-miR-18a

UAAGGUGCAUCUAGUGCAGAUA

22

1

12, Un.004.53*

+, -*

bta-miR-151*

UCGAGGAGCUCACAGUCUAGU

21

1

14

+

bta-miR-20a

UAAAGUGCUUAUAGUGCAGGUAG

23

1

11, Un.004.8*,
12^, 4^^

-, +*, +^,
-^^

bta-miR-15a
bta-miR-455
bta-miR-127
bta-miR-25

UAGCAGCACAUAAUGGUUUGU
UAUGUGCCUUUGGACUACAUC
UCGGAUCCGUCUGAGCUUGGCU
CAUUGCACUUGUCUCGGUCUGA

21
21
21
21

1
1
1
1

12
8
21
25

+
+
+
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+

72629915
16455541
60270246

72629936
16455562
60270268

3

-

112440616

112440639

1

19,25*

-, +*

1
1
1
1

14
18
8
11

+
+
+

18298087
14332892
6477882
55905355
108764342
108009438

18298108
14332913
6477903
55905377
108764363
108009458

bta-miR-320

AAAAGCUGGGUUGAGAGGGCGA

21

1

8,20*

-, +*

bta-miR-145
bta-miR-30e5p

GUCCAGUUUUCCCAGGAAUCCCU

23

1

7

UGUAAACAUCCUUGACUGGAAGU

24

1

bta-miR-365

UAAUGCCCCUAAAAAUCCUUAU

22

bta-miR-30b
bta-miR-150
bta-miR-455*
bta-miR-126

UGUAAACAUCCUACACUCAGCU
UCUCCCAACCCUUGUACCAGUGU
GCAGUCCAUGGGCAUAUACACU
GUACCGUGAGUAAUAAUGCG

22
23
21
21
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Table 4. Newly identified and novel miRNAs cloned from bovine fetal ovary
miRNA

Sequence (5’ to 3’)

Size

Number
of
clones

Chromosome

Strand

Start

End

Homology

bta-miR-100

AACCCGUAGAUCCGAACUUGUG

22

14

15

-

31460993

31461014

hsa,mml,ptr,rno

bta-miR-424

CAGCAGCAAUUCAUGUUUUGA

21

12

Un.004.53

-

446910

446931

bta-miR-143
bta-miR-30e*
bta-miR125b*
bta-miR-214*
bta-miR-5323p
bta-miR-2995p
bta-let-7b*
bta-let-7e*

UGAGAUGAAGCACUGUAGCUC
CUUUCAGUCGGAUGUUUACAGC

21
22

3
2

7
3

+
-

60268857
112440576

60268877
112440597

ACAAGUCAGGCUCUUGGGACCU

21

2

1

-

20087125

20087146

hsa,rno,mmu

GCCUGUCUACACUUGCUGUGC

21

1

16

-

36242054

36242075

hsa,mmu,oan

CCUCCCACACCCAAGGCUUGCA

22

1

X

-

54783146

54783167

hsa,mmu,mml

GGUUUACCGUCCCACAUACAU

21

1

21,21*

+, -*

UAUACAACCUACUGCCUUCCC
CUAUACGGCCUCCUAGCUUUCC

21
22

1
1

5
18

+
+

66002464
66002492
123308092
57588238

UCCCUGUCCUCCAGGAGCUCAC

22

1

21,25*, 2^

-, +*, +^

AGACCCUGGUCUGCACUCUGUC
AAACCGUUACCAUUACUGAGUU

22
22

1
1

X
19

-

66002443
66002472
123308072
57588217
34506932
43648269*
125415215
^
12002402
20147907

UGAGGGGCAGAGAGCGAGACUU

22

1

19

+

21234499

bta-miR-652

AAUGGCGCCACUAGGGUUGUG

21

1

Sequence
unavailable

Novel
miRNA

AAAACCCGAAUGAACUUUUUGGA

23

1

20,10*

bta-miR-3395p
bta-miR-504
bta-miR-451
bta-miR-4235p

34506953
43648290*
125415236^
12002423
20147928
21234520

hsa,mml,ptr,rno
hsa,rno,mml,ptr
mmu,hsa,rno

hsa,mmu,rno
hsa,rno,mmu
hsa,rno,mmu
rno,hsa,mmu
hsaa,mmu,mml
hsa,gga,mml
hsa,mmu,mml
hsa,cfa,mmu

-,+*

14022941
103620870*

14022963
103620892*
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Table 5. Potential target genes of the novel bovine miRNA
Gene
symbol
SEMA6C

Gene name
Sema domain, transmembrane domain (TM), and
cytoplasmic domain, (semaphorin) 6C

Cell differentiation/multicellular organismal development

YBX1

Y box binding protein 1

Regulation of transcription/mRNA processing

ZDHHC18

Zinc finger, DHHC-type containing 18

Transferase activity/zinc ion binding

ZZEF1

Zinc finger, ZZ-type with EF-hand domain 1

Regulation of mitotic metaphase/anaphase transition

APLNR

G-protein coupled receptor protein signaling pathway

FRAP1

Apelin receptor
FK506 binding protein 12-rapamycin associated
protein 1

FZD5

Frizzled homolog 5

FZD8

Frizzled homolog 8

TOR signaling pathway/Germ cell development/Cell growth
G-protein coupled receptor protein signaling pathway/Wnt receptor
signaling pathway
G-protein coupled receptor protein signaling pathway/Wnt receptor
signaling pathway

GPR124

G protein-coupled receptor 124

Neuropeptide signaling pathway

MBTD1

MBT domain containing 1

Regulation of transcription

MTMR3

Protein amino acid dephosphorylation

ROCK1

Myotubularin related protein 3
Rho-associated, coiled-coil containing protein
kinase 1

Rho protein signal transduction/actin cytoskeleton organization

TLK2

Tousled-like kinase 2

Cell cycle/chromatin modification/intracellular signaling cascade

UST

Uronyl-2-sulfotransferase

Carbohydrate biosynthetic process/protein amino acid sulfation

Zinc finger and BTB domain containing 7B

Cell differentiation/ectoderm development

ZBTB7B

Function
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Figure 1. Size distribution of 684 miRNAs cloned from bovine fetal ovaries.
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bta-miR-424

Chr Un.004.53:446910-44693

ccu

u
aga ga
c
g
acuc
a C
AA
g cuu
gcagg acccc
gc uccu cuuc uug
cgagggg ug AGCAGC UUCAUGUUUUGAa ug
\
cgucu ugggg
ug agga gaag agc
guucccc au ucgucg gagugcaaaacuu gc
u
au--- ga
u
g
---c a
cg
g aaa
bta-miR-30e*
agau

Chr 3:112440576-112440597

uaa
gc
cg

guu-

.-ugcc

ggccugu
ucgggca
uc-

A
CG
UC
A
- gg
aca ACC UAGA CGA CUUGUG gu u
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Figure 2. Predicted secondary structures for 14 of the 15 newly identified conserved miRNAs.
The mature miRNA sequences are shown in bold and underlined. The predictions were
performed using the Mfold program (version 3.2).
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Figure 3. Heatmap representing expression of 58 bovine miRNAs in fetal ovaries (n = 3) and
somatic tissue pools (n = 3). The relative amounts of the miRNAs were determined by
quantitative real-time PCR. Quantity of each miRNA was normalized to RPS18 mRNA. The
relative amounts of each miRNA were expressed as relative fold change using the somatic
tissue pools as the calibrators).
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Figure 4. Quantitative real time PCR analysis of expression of eight selected miRNAs
(predominant in fetal ovaries) in GV stage oocytes (n = 3 pools of 5 each). Quantity of each
miRNA was normalized to RPS18 mRNA. The relative amount of each miRNA was expressed
as relative fold change using the sample with the lowest expression value as the calibrator (n =
3, mean ±SEM).
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Figure 5. Quantitative real time PCR analysis of bta-mir-424 (A) and bta-mir-10b (B) expression
during oocyte maturation and early embryonic development (n = 3 pools of 5 each). Quantity of
each miRNA was normalized to bta-mir-125b. The relative amount of each miRNA was
expressed as relative fold change using the sample with the lowest expression value as the
calibrator (n = 3, mean ± SEM).
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Figure 6. Characterization of the novel bovine miRNA. (A) Tissue distribution of the novel
miRNA analyzed by real time PCR. Quantity of the miRNA was normalized to RPS18 mRNA
and the relative amount was expressed as relative fold change using the sample with the lowest
expression value as the calibrator (n = 3, mean ± SEM). (B) Quantitative real time PCR analysis
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of the novel miRNA expression during oocyte maturation and early embryonic development (n =
3 pools of 5 each). Quantity of the miRNA was normalized to bta-mir-125b. The relative amount
of each miRNA was expressed as relative fold change using the sample with the lowest
expression value as the calibrator (n = 3, mean ± SEM). (C) Predicted secondary structure of
the novel miRNA. The mature miRNA sequence is shown in bold and underlined. The prediction
was performed using the Mfold program (version3.2).
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ABSTRACT
Factor In the GermLine Alpha (FIGLA), a basic helix-loop-helix transcription factor, is
essential for primordial follicle formation and expression of many oocyte-specific genes that are
required for fertilization and early embryonic survival. Here we report the characterization of
bovine FIGLA gene and its regulation during early embryogenesis. Expression of bovine FIGLA
mRNA is restricted to gonads and can be detected in fetal ovaries harvested as early as 90
days of gestation when primordial follicles start to form. FIGLA mRNA and protein is abundant in
germinal vesicle and metaphase II stage oocytes, as well as in embryos from pronuclear to
eight-cell stage but barely detectable in embryos collected at morula and blastocyst stages,
suggesting that FIGLA might be a maternal effect gene. Recent studies in zebrafish and mice
have highlighted the importance of non-coding small RNAs (microRNAs) as key regulatory
molecules targeting maternal mRNAs for degradation during embryonic development. We
hypothesized that FIGLA, as a maternal transcript, is regulated by microRNAs during early
embryogenesis. Computational predictions identified a potential microRNA recognition element
(MRE) for miR-212 in the 3’ UTR of the bovine FIGLA mRNA. Bovine miR-212 is expressed in
oocytes and tends to increase at four-cell and eight-cell stage embryos followed by a decline at
morula and blastocyst stages. Transient transfection and reporter assays revealed that miR-212
repressed the expression of FIGLA in a MRE dependent manner. Furthermore, ectopic
expression of miR-212 mimic in bovine early embryos dramatically reduced the expression of
FIGLA mRNA and protein. Collectively, our results demonstrate that FIGLA is spatio-temporally
regulated during bovine early embryogenesis and miR-212 is an important negative regulator of
FIGLA during the maternal-to-embryonic transition in bovine embryos.
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INTRODUCTION
During oocyte growth and follicular development oocytes accumulate maternal effect
factors necessary for early embryogenesis (Gosden, 2002). Identification and characterization
of maternal (oocyte-derived) genes would be extremely useful in unraveling their specific
functions in fertilization, early embryogenesis and preimplantation development. However the
identities and functions of key oocyte-specific genes involved in the above processes are
relatively unknown, especially in farm animal species. One such oocyte-specific gene is factor in
the germline alpha (FIGLA), a critical transcription factor required for primordial follicle formation
(Soyal et al., 2000). Lack of FIGLA in mice causes infertility and alters expression of many
oocyte specific genes that are required for fertilization and early embryonic survival (Joshi et al.,
2007). However, the temporal and cell specific expression of FIGLA in bovine oocytes and early
embryos have not been described previously. Furthermore, recent studies in zebrafish have
highlighted the importance of non-coding small RNAs (microRNAs) as key regulatory molecules
targeting maternal mRNAs for degradation during embryonic development (Giraldez et al.,
2006) (3). Therefore, we attempted to study the expression and microRNA-mediated regulation
of FIGLA during early embryogenesis in cattle. The objectives of the present study are to 1)
Clone bovine FIGLA and determine its expression during bovine early embryogeneis.2) Identify
microRNA (miRNA) targeting bovine FIGLA and characterize its expression during early
embryogenesis. 3) Determine the effect and specificity of miRNA-212 in regulating bovine
FIGLA expression both exogenously (HeLa cells) and endogenously (early embryos).

MATERIALS AND METHODS

Cloning of Bovine FIGLA cDNA
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Cloning of bovine FIGLA was performed as described in (Tejomurtula et al., 2009) with minor
modifications.

RNA preparation and RT-PCR analysis
RNA isolation from different tissues and RT-PCR analysis were performed as described
previously (Tripurani et al., 2011) (Table 1 list of primer sequences).

Northern blot analysis
To determine the size of bovine FIGLA transcript, a northern blot was performed as
described previously (Tejomurtula et al., 2009) with mRNA from an adult ovary sample.

Quantification of FIGLA mRNA and protein in oocytes and early embryos
Quantitative measurement of FIGLA mRNA and protein expression in oocytes and early
mebyros was performed as described previously (Tejomurtula et al., 2009; Tripurani et al.,
2011) (Table 1 list of primer sequences).

MicroRNA expression analysis
Bovine tissue sample collection, total RNA isolation and miRNA expression analysis in
multiple tissues, oocytes and early embryos were performed as described previously (Tripurani
et al., 2010) (Table 1 list of primer sequences).

Cell transfection and luciferase reporter assays
HeLa cells were cultured in DMEM containing 10% FBS and 1% penicillin/streptomycin.
For transient transfection FuGENE6 was used according to the manufacturer’s instructions.
Luciferase reporter assay was performed using the Dual-Glo luciferase assay system.
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Microinjection experiments
Presumptive bovine zygotes were microinjected with 20 µM of miRNA-212 mimic and cultured
for 72 h in KSOM medium. The efficacy of FIGLA mRNA and protein knockdown was
determined by real-time and immunocytochemistry in eight- to 16-cell embryos as described
previously (Tripurani et al., 2011).

RESULTS & DISCUSSION

cDNA cloning and genome organization of bovine FIGLA
Using the primers designed based on the predicted bovine FIGLA cDNA sequence; we
successfully amplified a cDNA fragment (455 bp) representing the coding region of bovine
FIGLA from bovine fetal ovary cDNA. Northern blot analysis detected a single transcript of
approximately 0.7 kb in bovine adult ovary sample (Fig. 2A). Thus additional 5’ (42 bp) and 3’
(133 bp) sequences were obtained using RACE procedures. The assembled full length FIGLA
cDNA is 630 bp containing an open reading frame encoding a protein of 172 amino acids with a
conserved basic helix-loop-helix domain (Fig. 1). A blast search of the bovine genome database
at NCBI revealed that the bovine FIGLA gene is located on chromosome 11 and spans
approximately 14.7 kb. Exon and intron boundaries of the genes were determined using the
Spidey program (http://www.ncbi.nlm.nih.gov/IEB/Research/Ostell/Spidey/). The bovine FIGLA
gene has 4 exons and 3 introns as determined by the program (Table 2), and all splice sites are
in agreement with the consensus sequence (GT-AG rule).

Expression of bovine FIGLA
Analysis of tissue distribution by semi-quantitative RT-PCR revealed that FIGLA is
exclusively expressed in the gonads (Fig. 2B). Expression analysis in fetal ovaries of different
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developmental stages revealed that FIGLA is expressed as early as 90 days of gestation period
(when primordial follicles start to form in cows) and is highly abundant in the fetal ovaries of late
gestation (Fig. 2C). Quantitative real-time PCR analysis using RNA isolated from oocytes,
granulosa cells, and cumulus cells indicates that bovine FIGLA is expressed in oocytes but not
in the surrounding follicular somatic cells (Fig. 2D).

Expression of bovine FIGLA mRNA and protein during oocyte maturation and early
embryonic development
To demonstrate the temporal expression of bovine FIGLA during preimplantation embryo
development, real-time PCR analysis was performed. The expression pattern of FIGLA mRNA
and protein during early embryogenesis is similar to several known maternal effect genes
(Pennetier et al., 2004; Pennetier et al., 2006; Bettegowda et al., 2007; Tejomurtula et al., 2009;
Tripurani et al., 2011) (Fig. 3A), dynamically regulated during the window from meiotic
maturation through embryonic genome activation. Western blot analysis demonstrated that the
size of the FIGLA protein is ~ 18kd and that the protein is abundant in GV and MII-stage
oocytes as well as in two-cell stage embryos, but the expression drops by the 16-cell stage
embryos and barely detectable at the blastocyst stage (Fig. 3B). Overall, the expression pattern
of bovine FIGLA i.e non-reactivation at maternal-to-embryonic transition (MET) and degradation
of the protein before implantation, suggests a potential role of FIGLA as a maternal effect factor
during early embryonic development.

Prediction of microRNA binding site in the 3’ UTR of bovine FIGLA
To examine the possibility of FIGLA regulation by miRNAs, we searched for potential
miRNA-binding sites in the 3’ UTR region of FIGLA mRNA by using the “Microinspector”
algorithm (Rusinov et al., 2005). Computational search identified a total of 17 different miRNAs.
Most of the predicted binding sites (miRNA recognition elements, MREs) of these miRNAs in

	
  

175	
  

the 3’ UTR of FIGLA are poorly conserved. Only one specific miRNA, miR-212, targeting the 3’
UTR of FIGLA mRNA shows complete conservation of the “seed” region across species (Fig.
4A). The seed region is the most important region of miRNA: mRNA interaction and has been
has been repeatedly demonstrated to be a key determinant of miRNA-induced repression of
gene expression (Lewis et al., 2003; Brennecke et al., 2005). Furthermore, secondary structure
analysis revealed that the MRE in the bovine FIGLA 3’ UTR has a low free energy of
hybridization with the cognate miRNA (-20.86 kcal/mol) and the apparent miR-212 binding site
was positioned on a hairpin-loop structure in an exposed position (Fig. 4B). These results
suggest that miR-212 is likely to be an important regulator of FIGLA and the microRNA: mRNA
interaction is evolutionary conserved.

Expression analysis of miR-212
Quantitative real-time PCR analysis was performed to determine the expression pattern
of miR-212. miR-212 was predominantly expressed in hypothalamus and brain; it was also
expressed significantly in fetal and adult ovary (Fig. 5A). Expression analysis during oocyte
maturation and early embryonic development showed that miR-212 is expressed in germinal
vesicle oocytes and tends to increase at the four-cell and eight-cell stage embryos followed by a
decline at morula and blastocyst stages (Fig. 5B), suggesting that miR-212 is presumably of
maternal origin and potentially involved in maternal transcript degradation during MET. Similar
expression pattern were observed for miR-430 in zebrafish (Giraldez et al., 2006), miR-427 in
Xenopus (Lund et al., 2009) and miR-290 in mouse (Tang et al., 2007), which are known to play
a key role in promoting maternal transcript turnover during maternal-zygotic transition.
Furthermore, the expression pattern of miRNA-212 during the early embryogenesis is inversely
correlated FIGLA expression during early embryogenesis, such that miR-212 expression
increases steadily from two-cell to eight-cell stage of embryogenesis, while FIGLA expression
decreases gradually during the same period. The inverse correlation between miR-212 and
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FIGLA expression supports that miR-212 might be a post-transcriptional regulator of FIGLA
during maternal-to-embryonic transition.

Effect and specificity of miRNA-212 action on FIGLA expression
To validate the binding of miR-212 to bovine FIGLA, we ectopically expressed FLAG
tagged-FIGLA transcript in HeLa cells. Western blot analysis with an antibody against FLAG
shows a significant inhibition of FLAG protein expression in cells expressing bta-miR-212
compared to the control cells without bta-miR-212 (Fig. 6A), indicating that translation of FIGLA
is repressed by miR-212. Densitometeric analysis of western blot data showed a significant
repression of FIGLA expression in the miR-212 transfected cells (Fig. 6B). In addition, we
validated the specificity and the efficacy of miR-212 action; we inserted FIGLA 3’ UTR sequence
downstream of the firefly luciferase-coding region. A four-base pair mismatch mutation was
introduced in the predicted MRE in the 3’ UTR of the FIGLA for miR-212 such that interaction
between miR-212 and FIGLA was compromised (Fig. 6C). Ectopic expression of miR-212
suppressed the activity of chimeric luciferase construct containing the miR-212 MRE of FIGLA
at its 3’ end. Suppression of luciferase activity was abolished when a mutation was introduced
into the seed region of the miRNA-212 recognition sequence in the FIGLA 3’ UTR. These data
indicate that the predicted MRE in FIGLA 3’ UTR is critical for the direct and specific binding of
miR-212 (Fig. 6D).

Effect of miR-212 on FIGLA expression in early embryos
To further confirm and extend our hypothesis, we investigated whether miR-212 can
regulated FIGLA in early embryos. Ectopic expression of miRNA-212 mimic in early embryos
significantly repressed the expression of FIGLA mRNA and protein in the eight-cell stage
embryos compared to the controls (Fig. 7A, B), indicating that miRNA-212 is a bona fide
negative regulator of FIGLA.
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CONCLUSION
Collectively, our study supports potential a role for maternal FIGLA in early
embryogenesis and miRNA-212 in regulating FIGLA expression during MET. Future studies of
interest will be to investigate the functional role of FIGLA and miR-212 during bovine early
embryogenesis by performing loss-of-function studies.
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Table 1. List of primers used in this study
Gene
Name
FIGLA

RPS18
RPL19
GFP
miR-212

Primer Name

Primer sequence (5’ to 3’)

Application

FIGLA-ATG-F
FIGLA-R575
FIGLA -RACE3SP1
FIGLA -RACE3SP2
FIGLA -RACE3SP3
FIGLA -RACE5SP1
FIGLA -RACE5SP2
FIGLA -RTPCR-F
FIGLA -RTPCRR
FIGLA -Real
time-F
FIGLA -Real
time-R

ATGGACGCCGCGCCGGAGCT
CTCACCACTGCCACCATCTGCCC

cDNA cloning
cDNA cloning

GGCTGTGCTATGGGCTTGAAGAA

3`RACE

GAATGAGAAGGAAGGGTCCTG

3`RACE

CCTGGGCAGATGGTGGCAGTG

3`RACE

GAGCCGGCAGATGGTGGCCTG

5`RACE

GCAGCACGTCGTCCAGGAGCT
CCGCCTGCCGAGCTCCTGGACGA

5`RACE
RT-PCR analysis

CTCACCACTGCCACCATCTGCCC

RT-PCR analysis

GACCCCGATCATCAGAGCTAT

Real Time PCR

CTCACCACTGCCACCATCTGCCC

Real Time PCR
Cloning of FIGLA mRNA
into pcDNA3.1
Cloning of FIGLA mRNA
into pcDNA3.1
Cloning of FIGLA 3`UTR
into pmirGLO vector
Cloning of FIGLA 3`UTR
into pmirGLO vector
Generating mutant FIGLA
3`UTR for luciferase
reporter assay
Generating mutant FIGLA
3`UTR for luciferase
reporter assay
Cloning of FLAG tagged
FIGLA mRNA into
pcDNA3.1
Real Time PCR
(endogenous control)
Real Time PCR
(endogenous control)
RT-PCR control
RT-PCR control
Real Time PCR
(exogenous control)
Real Time PCR
(exogenous control)
Real Time PCR
Cloning of miR-212 into
pcDNA3.1
Cloning of miR-212 into
pcDNA3.1
Real Time PCR
(endogenous control)

FIGLA -BamHI-F

TATGGATCCAGCCATGGACGCCGCGCCCGAGCTCCT

FIGLA -XhoI-R
FIGLA -3`UTRSacI-F
FIGLA -3`UTRXbaI-R

ATACTCGAGACGACTGCATTTATTTGTCTGTAG

FIGLA 3UTRmut-F

TACGAAAAGTGAAAAGGCTGGCCGTCCGCTACCTTCTACAGACAAATAAA

FIGLA 3UTRmut-R

TTTATTTGTCTGTAGAAGGTAGCGGACGGCCAGCCTTTTCACTTTTCGTA

FIGLA -FLAGBamHI-F
RPS18RealTime-F
RPS18RealTime-R
RPL19-RTPCR-F
RPL19-RTPCR-R

TATGAGCTCATTCCCCATAGAACTGAGTCACA
ATATCTAGAAAACTTTTACGACGCATTTA

TATGGATCCATGGATTACAAGGATGACGATGACAAGATGGACGCCGCGCCCGAGCTCCT
GTGGTGTTGAGGAAAGCAGACA
TGATCACACGTTCCACCTCATC
GAAATCGCCAATGCCAACTC
GAGCCTTGTCTGCCTTCA

GFP-Realtime-F

CAACAGCCACAACGTCTATATCATG

GFP-Realtime-R
miR-212 - RT
miR-212-BamHIF

ATGTTGTGGCGGATCTTGAAG
ACCUUGGCUCUAGACUGCUUACU
TATGGATCCAAGCGCCGGGGCCGAGAAGGGTTGGA

miR-212-XhoI-R

ATACTCGAGGAGGGGCCGGGGGCGCGGCAGGT

miR-125b-RT

TCCCTGAGACCCTAACTTGTGA

miR-125b
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Table 2. Genome organization of bovine FIGLA

	
  
Exon no.

Size (bp)

Sequence

Intron no.

Size (bp)

Sequence

1

231

CGCGAGCGGgtgagttca

1

4011

cctttccagATAAAAAAT

2

153

GACTCCGAGgtaaaggtt

2

1591

ggtttctagAAACGAGAC

3

151

GTGGCAGTGgtgagttgg

3

8531

ctgtttcagGTTCTCTCA

4

77

	
  
a

Exon and intron sizes are given in base pairs. Intronic and exonic sequences are shown in lower-case and upper

case characters, respectively. The first and last two bases of the introns (gt and ag for donors and acceptor splice
sites, respectively) are shown in bold and underlined.
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1 CCCCGGGGAAGGTCCAGCTGCCCGCCGCCCCCGCGCGCAGCCATGGACGCCGCGCCCGAGCTCCTGAGGGTACCGCCTGCCGAGCTCCTG
1
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541 CTCAAGTACGAAAAGTGAAAAGGCTGGCCCAGGGCTACCTTCTACAGACAAATAAATGCAGTCGTAAAAGTTTAAAAAAAAAAAAA
137 L K Y E K *

Figure 1. Nucleotide sequence of the bovine FIGLA cDNA with deduced amino acid sequence.
The initaitaor “AUG” and the stop “TAG” codons are boxed and the polyadenylation signal is
bold and underlined. The basic region is underlined; the two helices are highlighted; and the
loop region is bold.
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Figure 2. Expression analysis of bovine FIGLA A) Northern blot analysis of FIGLA transcript in
adult ovary. B) Expression of FIGLA mRNA in various bovine tissues. C) Expression of FIGLA
mRNA in bovine fetal ovaries of different developmental stages. D) Quantitative expression of
FIGLA mRNAs in granulose cells, cumulus cells and GV oocytes.
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Figure 3. Spatiotemporal expression of FIGLA mRNA and protein during oocyte maturation and
early embryonic development. A) Analysis of steady-state levels of FIGLA mRNA in in vitro
produced bovine pre-implantation stage embryos. The oocytes and embryo samples used in
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this experiment included GV- and MII-stage oocytes, pronuclear (PN), 2-cell (2C), 4-cell (4C), 8cell (8C), 16-cell (16C), morula (MO)-stage and blastocyst (BL)-stage embryos. Data were
normalized relative to abundance to exogenous control (GFP) RNA and as shown as mean +
SEM (n = 4 pools of 10 embryos per stage). Different letters indicate statistical difference (P<
0.05). B) Analysis of FIGLA protein in bovine oocytes and early embryos by Western blot
analysis using antibodies specifically against FIGLA (25 oocytes or embryos per lane).
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Figure 4. miR-212 binding site in FIGLA 3`UTR. A) 3`UTR alignment of bovine, mouse and
human FIGLA cDNA sequences. The outlined box indicates the conserved “seed” region
complimentary to miR-212. B) Predicted miR-212 binding site in bovine FIGLA 3`UTR.
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Figure 5. Expression analysis of miR-212. (A) Tissue distribution of miR-212 analyzed by
quantitative real-time PCR. Data were normalized to abundance of RPS18 mRNA and
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abundance expressed as relative fold change using the sample with the lowest value as the
calibrator (n = 4 per tissue; mean ± SEM depicted). (B) Realtive abundance of miR-212 in
bovine oocytes and in vitro produced bovine embryos. Data were normalized to abundance of
miR-125b mRNA and expressed as relative fold change using the sample with the lowest value
as the calibrator (n = 4 pools of five oocytes/embryos each; mean ± SEM depicted). Different
letters indicate statistical difference (P< 0.05).
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Figure 6. Specific regulation of FIGLA by miR-212 in vitro in HeLa cells. (A) Western blot
showing significant downregulation of bovine FIGLA protein by ectopic expression of miR-212 in
HeLa cells. β- Actin was used as a loading control. (B) The protein levels were quantified from
the western blots by densitometry, normalized to the β- Actin level and presented as fold
change + SEM (n = 4) relative to the FIGLA level of mock transfected cells. (C) Diagram of
luciferase reporter construct with putative miR-212 binding site and mutations in the 3`UTR of
FIGLA. (D) Repression of luciferase activity due to specific interaction between miR-212 and the
predicted MRE in the luciferase–FIGLA–3` UTR constructs. Repression was abolished when the
MRE was mutated. Relative firefly luciferase values were determined by a ratio of firefly to
renilla luciferase with the negative control (cells transfected with native FIGLA-3`UTR construct
alone) set at 1. Each group represents the mean ± SEM of four wells for an experiment
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repeated six times with similar results.
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Figure 7. miR-212 represses endogenous FIGLA expression in early embryos. (A) Effect of
miR-212 mimic (20 µM) microinjection on abundance of FIGLA mRNA in eight-cell embryos as
determined by quantitative real-time PCR. Data were normalized relative to abundance of
endogenous control ribosomal protein S18 (RSP18) and are shown as mean ± SEM (n = 4
pools of 10 embryos per treatment). Different letters indicate statistical difference (P < 0.05). (B)
Effect of miR-212 mimic (20 µM) microinjection on abundance of FIGLA protein in eight-cell
embryos as determined by immuofluorescent staining with anti-FIGLA antibody (n = 4 pools of
5-10 embryos per treatment). Uninjected embryos and embryos injected with a nonspecific
miRNA (Neg miRNA) were used as controls. Nuclear DNA was stained with DAPI.
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ABSTRACT
Sumoylation is a posttranslational modification in which a SUMO (small-ubiquitin-related
modifier) moiety is conjugated to specific proteins involved in transcriptional regulation, protein
transport, chromosome segregation and signal transduction via an enzymatic cascade. A
central component of this cascade is the SUMO-conjugating enzyme Ubc9, which is highly
conserved across species and is essential for several developmental processes such as cell
cycle regulation, chromosome segregation, cell viability and maintenance of nuclear integrity.
However the connection between these developmental roles of Ubc9 and its function during
oocyte and early embryonic development remains largely unknown. As the first step towards
understanding the physiological role of bovine Ubc9, we analyzed the expression of Ubc9
mRNA in bovine tissues including fetal ovaries of different developmental stages, and
characterized the temporal expression patterns of Ubc9 mRNA and protein during oocyte
maturation and early embryogenesis. Bovine Ubc9 is ubiquitously expressed in all tissues and
can be detected in fetal ovaries as early as 90 days of gestation, and is highly abundant in fetal
ovaries of late gestation. Real time PCR analysis and immunocytochemical analysis
demonstrated that expression of Ubc9 mRNA and protein is abundant in germinal vesicle (GV)
and metaphase II (MII) stage oocytes, as well as in early embryos, but decreases between 8cell and blastocyst stage, suggesting that Ubc9 might be a maternal effect gene. In order to
define the molecular mechanisms of Ubc9-dependent biological processes during oogenesis in
cattle, we performed yeast two-hybrid assay to identify putative SUMO substrates from a bovine
fetal ovary library using Ubc9 as bait. A total of 19 interacting clones were identified including 3
clones encoding activating transcription factor 7 interacting protein 2 (ATF7IP2). Inspection of
the ATF7IP2 sequence using SUMOsp 2.0 software program predicted two high probability
putative SUMO attachment sites, indicating that ATF7IP2 is a potential SUMO substrate. Real
time PCR analysis revealed that ATFIP2 is gonad specific and expression of ATFIP2 mRNA can
be detected in fetal ovaries harvested as early as 90 days of gestation and tends to increase
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with increased gestational age. Further analysis using RNA isolated from oocytes, granulosa
and cumulus cells of antral follicles indicates that bovine ATF7IP2 mRNA is expressed in
oocytes and in surrounding follicular cells. ATF7IP2 is stage-specifically expressed during
oocyte maturation and early embryonic development. Collectively, our results suggest that Ubc9
is developmentally regulated in cattle and it interacts with ATF7IP2, a gonad-specific protein,
which might play an important role in oocyte development and early embryonic development.
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INTRODUCTION
Post-translation modification of proteins is an important regulatory mechanism of protein
function. In addition to ubiquitin, recently the small ubiquitin-like modifier (SUMO) has been
shown to reversibly modify many proteins important for a wide range of cellular processes,
including gene transcription, cell cycle, protein stability, nuclear localization, signal transduction,
protein-protein interactions and chromatin dynamics (Geiss-Friedlander and Melchior, 2007).
SUMO constitutes a highly conserved protein family and are ubiquitously expressed throughout
the eukaryotic kingdom. Simple eukaryotes such as yeast, worms and flies have a single SUMO
gene, whereas plants and vertebrates express several SUMO proteins. Till date, four SUMO
family members, SUMO-1 to SUMO-4 have been found in mammals. SUMO proteins are ~
10kD in size and share only ~ 18 % sequence identity with ubiquitin, but the three-dimensional
structure of SUMO is similar to ubiquitin (Melchior, 2000). SUMO-2 and SUMO-3 are 97%
similar to each other and are 50% identical to SUMO-1 protein that is the most studied
(Melchior, 2000). SUMO 1, 2 and 3 are ubiquitously expressed in all tissues and at all
developmental stages, whereas SUMO-4 expression is restricted to kidneys and spleen (GeissFriedlander and Melchior, 2007). SUMOylation, the conjugation of SUMO peptide to the target
protein, results in the formation of an isopeptide bond between the C-terminal glycine residue of
the modifier protein and the ε-amino group of a lysine residue in the acceptor protein by a series
of enzymatic reactions similar to those involved in the ubiquitination (Johnson, 2004).
SUMOylation is a highly conserved pathway from yeast to humans and mostly targets proteins
that contains a consensus motif ψKXE, where ψ represents a large hydrophobic amino acid, K
is the SUMO attachment site, X is any residue and E is a glutamic acid (Johnson, 2004). Unlike
ubiquitination, which targets proteins for degradation, SUMOylation affects the target proteins
intercellular localization, interactions, stability and activity (Hay, 2005).
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A number of studies indicate that SUMO proteins are essential for diverse reproductive
functions, including gametogenesis, ovulation and steroid receptor activity (Broday et al., 2004;
Jones, 2006; Abdel-Hafiz et al., 2009; Wang et al., 2010). SUMO-conjugating enzyme, Ubc9 a
central component of the SUMOylation pathway has been reported to affect various cellular
processes during embryonic development in various organisms. Early studies in drosophila
found that loss of Ubc9 have multiple defects in anterior segmentation due to misregulation of
the segmentation genes during the drosophila embryogenesis (Epps and Tanda, 1998). RNAimediated knockdown of Ubc9 in C.elegans resulted in the embryonic arrest after gastrulation
and pleiotrophic defects in larval development such as vulval eversion at the fourth larval stage
and abnormal tail morphology (Jones et al., 2002). Expression of dominant-negative version of
Ubc9 in zebrafish embryos leads to early embryonic apoptosis and inactivation of zygotic Ubc9
function causes more specific developmental defects in brain, eyes and pharyngeal arches due
to defects in cell cycle (Nowak and Hammerschmidt, 2006). Furthermore, Ubc9-deficient mouse
embryos die at the early postimplantation stage due to severe defects in the nuclear
organization and chromosome segregation (Nacerddine et al., 2005). Together, these studies
indicate that Ubc9 is essential for the normal development of both vertebrate and invertebrate
metazoans. However the connection between these developmental roles of Ubc9 and its
function during mammalian oogenesis remains largely unknown.
In recent years, cattle has been recognized as a potential model system for comparative
genomics and biomedical research, because cattle and humans have similarities in many
aspects of their biochemistry, physiology, reproduction and pathology (Malhi et al., 2005; Gibs
et al., 2006). Despite the recognized importance of Ubc9 in regulating gene expression during
development and other biological processes, there has been little information about the impact
of Ubc9 on developmental programs in cattle. In this study, as the first step towards
understanding the physiological role of Ubc9, we analyzed the expression of Ubc9 mRNA in
bovine tissues including fetal ovaries of different developmental stages, and characterized the
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temporal expression patterns of Ubc9 mRNA and protein during oocyte maturation and early
embryogenesis. Furthermore, to define the molecular mechanisms of Ubc9-dependent
biological processes during oogenesis in cattle, we performed yeast two-hybrid assay to identify
putative SUMO substrates from a bovine fetal ovary library using Ubc9 as bait.

MATERIALS AND METHODS

Tissue collection, RNA preparation and cDNA synthesis
Bovine tissue samples including fetal ovary, adult ovary, adult testis, liver, lung, kidney,
small intestine and spleen were obtained at a local slaughterhouse. Fetal age was estimated
based on crown-rump length (Richardson et al., 1990). Granulosa and cumulus cells were
isolated from antral follicles according to a previously established method (Murdoch et al., 1981;
Bettegowda et al., 2008). All samples were frozen in liquid nitrogen and stored at -800 C until
use. Total RNA was isolated using the TRIzol reagent (Invitrogen, Carlsbad, CA) according to
the manufacturer’s instruction. Concentrations of isolated RNA were determined by measuring
absorbance at 260 nm using a Nanodrop spectrophotometer (Thermo Scientific, Wilmington,
DE). Purity of RNA was determined by calculating the ratio of absorbance at 260 nm and 280
nm, and integrity of RNA was determined by agarose gel electrophoresis. After treatment with
TURBOTM DNaseI (Ambion, Inc., Austin, TX), reverse transcription was performed on
approximately two micrograms of isolated RNA in 20 µl of reaction solution using oligo d(T) 18
primer and Superscript III reverse transcriptase (Invitrogen).

Quantitative Real-Time PCR Assay
The quantification of Ubc9 and ATF7IP2 transcripts was done by real-time quantitative
RT-PCR using iQ SYBR Green Supermix (Bio-Rad). Ribosomal protein S18 (RPS18) gene was
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used as an endogenous control. Primers are listed in the supplemental table 1 and were
designed using primer 3 input software. Each reaction mixture consisted of 2µl of cDNA, 1.5 µl
of forward primer (10µM) and reverse primer (10µM), 7.5 µl of nuclease free water and 12.5µl of
iQ SYBR Green Supermix in a total reaction volume of 25 µl. Reactions were performed in
triplicates for each sample on a Bio-Rad CFX 96TM Real-Time PCR Detection System (BioRad). Cycling parameters were 950C for 10 min, and then 40 cycles of 95◦C for 15s, 60◦C for
30s. Standard curves for each gene and controls were constructed using tenfold serial dilutions
of corresponding plasmids containing cDNA inserts for Ubc9, ATF7IP2 and RPS18 [vector
pGEM-T Easy (Promega)] and run on same plate as samples. For each sample, the quantity of
the mRNA for Ubc9 and ATF7IP2 and the reference gene mRNA (RPS18) was determined from
the appropriate standard curves. The quantity of the Ubc9 and ATF7IP2 mRNA was then
divided by the quantity of the reference gene to obtain a normalized value. The expression of
Ubc9 and ATF7IP2 mRNA was then expressed as relative fold change.

Quantification of Ubc9 and ATF7IP2 mRNA in oocytes and early embryos
For quantitative measurement of Ubc9 and ATF7IP2 mRNA expression during oocyte
maturation and early embryonic development, real-time PCR was performed. The oocytes and
embryo samples used in the experiment included GV- and MII-stage oocytes and pronuclear,
two-cell, four-cell, eight-cell, 16-cell, and morula- and blastocyst-stage embryos were generated
by in vitro maturation, in vitro fertilization and embryo culture of abattoir-derived oocytes as
described previously (Bettegowda et al., 2006). Procedures used for RNA isolation, cDNA
synthesis, and quantitative real-time PCR analysis of mRNA abundance during oocyte
maturation and early embryonic development were conducted as described previously
(Bettegowda et al., 2006; Tejomurtula et al., 2009).

Immunocytochemistry
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Localization of Ubc9 protein in oocytes and early embryos was performed according to
previously published procedure (Tripurani et al., 2011) using a rabbit monoclonal anti-Ubc9
antibody (1:50 dilution; ab75854; Abcam, Cambridge, MA). At least 10 oocytes/embryo were
processed for each stage per treatment, and experiments were replicated at least three times.
For negative control, the oocytes and embryos were incubated in the absence of anti-Ubc9
antibody.

Yeast two-hybrid assay
Yeast two-hybrid screening of a cDNA library from bovine fetal ovary using bovine Ubc9
as the bait was carried out using a MatchmakerTM Gold Yeast Two-Hybrid System (Clontech
Laboratories, Inc., Mountain View, CA, USA) according to the manufacturer’s instructions. The
bait construct pGBKT7-53-Ubc9 encoding the entire open reading frame of Ubc9 (477bp) fused
in frame to the GAL4 DNA binding domain was constructed by inserting the PCR-generated
fragment into the NdeI and the BamHI sites of the pGBKT7-53. The bovine fetal ovary cDNA
library was constructed using Make Your Own Mate & PlateTM Library System (Clontech)
according to the manufacturer’s instructions. Yeast strain Y2H Gold strain was co transformed
with pGBKT7-53-Ubc9 and pGADT7-Rec plasmid bovine fetal ovary cDNA library using
YeastmakerTM Yeast Transformation System 2 (Clontech). The binding specificities of the
isolated prey clones were checked after cotransformations by growth on high-stringency
selective yeast media. Plasmid DNA from prey yeast clones was extracted using Easy Yeast
Plasmid Isolation Kit (Clontech) and sequenced. β-Galactosidase Liquid Assay was performed
to test the specificity of the interaction according to the method described in the manual of the
MatchmakerTM Gold Yeast Two-Hybrid System (Clontech).

Statistical analysis
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Differences in the Ubc9 and ATF7IP2 mRNA abundance were analyzed by one-way
ANOVA using the general linear models (GLM) procedure of SAS.

RESULTS AND DISCUSSION
Expression analysis of Ubc9
The bovine Ubc9 mRNA sequence was used as a template to design gene-specific
primers (Table 1) for expression analysis. To determine the tissue distribution of UBC9,
quantitative real-time PCR was performed in cDNA derived from multiple bovine tissues. As
shown in Fig. 1A, UBC9 transcripts were expressed ubiquitously expressed in bovine tissues
including fetal and adult ovaries, consistent with the expression pattern observed in mouse
(Azuma et al., 2001), rat (Golebiowski et al., 2003) and human (Yasugi and Howley, 1996),
indicating that SUMOylation pathway is evolutionary conserved and functional in most organs.
Among developing ovaries, bovine Ubc9 expression is observed as early as 90 days of
gestation (when primordial follicles first observed), and is highly abundant in the fetal ovaries of
late gestation (Fig. 1B). Recently Marongiu et al (Marongiu et al., 2010) reported that Ubc9 is
co-expressed with FOXL2, a forkhead transcription factor essential factor in the ovarian function
in the mouse ovarian follicles at different development stages of development, suggesting that
Ubc9 may function during follicular development. Further, Ubc9 was expressed in GV oocytes
and surrounding follicular cells (granulosa and cumulus cells (Fig. 1C).
The mRNA and protein expression of the bovine Ubc9 during oocyte maturation and
early

embryonic

development

was

determined

by

quantitative

real-time

PCR

and

immunocytochemistry. Ubc9 mRNA and protein was found to be highly abundant in the GV and
MII-stage oocytes, as well as at early developmental stages (between pronuclear and eight-cell
stages) and further downregulated at 16-cell, morula and blastocyst stages (Fig. 1D, E). The
expression pattern of Ubc9 mRNA and protein is similar to a number of known maternal effect
genes (Tong et al., 2000; Burns et al., 2003; Pennetier et al., 2004; Vigneault et al., 2004;
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Bettegowda et al., 2007; Tejomurtula et al., 2009), dynamically regulated during the window
from meiotic maturation through embryonic genome activation. Moreover, results from embryo
culture experiments in the presence of the transcription inhibitor α-amanitin suggest that the
Ubc9 gene is maternal/oocyte derived (data not shown). Overall, the expression pattern of
bovine Ubc9 i.e. non-reactivation at maternal-to-embryonic transition (MET) and degradation of
the protein before implantation, suggests the role of Ubc9 as a maternal effect factor during
early embryonic development.
Recent studies in mouse have shown that Ubc9 mRNA is temporally regulated during
oocyte growth and preimplantation development (Ihara et al., 2008) and loss of Ubc9 leads to
embryonic lethality (Nacerddine et al., 2005). Embryos from Ubc9 deficient mice were able to
develop up to blastocyst stage and undergo implantation, likely due to persistence of maternal
protein during preimplantation cleavage stages, but they fail to expand and show apoptosis of
inner cell mass (Nacerddine et al., 2005). Furthermore, Ubc9 mutant embryos show major
chromosome defects and severe alterations in nuclear organization such as disassembled
nucleoli and PML nuclear bodies, misshapen nuclei, as well as mislocalized RanGAP1 and Ran
(Nacerddine et al., 2005). Together, these studies reveal a major role for Ubc9 and, by
implication, the SUMO pathway in embryonic viability, chromosome segregation and nuclear
integrity. However, the role of Ubc9 (maternally-derived) during the early cleavage stages,
specifically during the maternal-embryonic transition is still unknown and warrants further
investigation due to the dynamic nature of UBC9 during development.

Identification of Ubc9 interacting proteins
The identification of target proteins for small ubiquitin-like modifiers (SUMOs) is the first
step towards a detailed understanding of the cellular functions of SUMOs. Recently, numerous
proteins have been identified as SUMO target proteins in several model systems such as yeast,
C.elegans, D.melanogaster, A.thaliana including mammals (Müller et al., 2001; Li et al., 2004;
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Panse et al., 2004; Vertegaal et al., 2004; Wohlschlegel et al., 2004; Zhang et al., 2004; Zhao et
al., 2004; Talamillo et al., 2008; Elrouby and Coupland, 2010). However, the identity, function
and regulation of SUMO target proteins during mammalian oogenesis have not been
investigated in depth. In order to elucidate the molecular mechanisms of Ubc9-dependent
biological processes during oogenesis in cattle, we performed yeast two-hybrid assay to identify
putative SUMO substrates from a bovine fetal ovary library using Ubc9 as bait. Yeast-two hybrid
method have been used previously to identify and characterize SUMO substrates in various
organisms and cell culture systems Müller, 1998, p01733; Giorgino, 2000, p00336; Melchior,
2000, p00351; Bhaskar, 2000, p01732}. One of the great advantages of this technique is that it
not only identifies SUMO-interacting proteins, but also can be adapted so that covalent and
noncovalent interactions with SUMO can be distinguished (Hannich et al., 2005). Because Ubc9
is the only known SUMO-conjugating enzyme and can directly conjugate SUMO proteins to the
target protein by recognizing and binding to the consensus SUMOylation motif (ψKXE) in target
protein (Sampson et al., 2001), we performed yeast two-hybrid screening using Ubc9 as bait.
A total of 9 yeast clones were identified as a result of their growth in high-stringency
medium (SD/-ade/-his/-leu/-trp). Plasmids were rescued from the respective yeast clones and
were subjected to DNA sequence analysis. The sequence data revealed that these clones
contain inserts with strong homology to five proteins (Table 2). Of the five proteins, RAN binding
protein 2 (RANBP2) and E3 SUMO-protein ligase (PIAS1) were previously identified as Ubc9
interacting proteins using different approaches (Mahajan et al., 1997; Schmidt and Müller, 2002;
Tatham et al., 2005), whereas the three remaining proteins have not been previously shown to
interact with Ubc9. These proteins include activating transcription factor 7 interacting protein 2
(ATF7IP2), lymphocyte cytosolic protein 1 (LCP1) and exosome complex exonuclease RRP45.
Further, analysis of protein sequences using SUMOsp 2.0 software program predicted high
probability putative SUMO attachment sites in all the five proteins (Table 2) further supporting
that they are indeed SUMO substrates.
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Expression analysis of ATF7IP2
In addition to several known targets of Ubc9, the screen identified a transcriptional
regulator known as activating transcription factor 7 interacting protein 2 (ATF7IP2). The
complete cDNA sequence (3229 bp) for the novel transcript was obtained by RT-PCR using
fetal ovary mRNA. Sequence analysis revealed that the cDNA has an open reading frame
encoding a protein of 683 amino acids. The ATF7IP2 gene is located on bovine chromosome 25
and spans approximately 52 kb of genomic sequence and contains about 10 exons. Analysis of
tissue distribution of ATF7IP2 by quantitative real-time PCR revealed that ATF7IP2 is
exclusively expressed in both female and male gonads ovarian samples with minor expression
in kidney sample (Fig. 2A). Analysis of mRNA expression for ATF7IP2 in fetal ovaries of
different developmental stages revealed that the transcript is detectable in fetal ovaries
collected at 90 days of gestation (when primordial follicles are first observed in cows) but is
highly abundant in fetal ovaries of late gestation (Fig. 2B). ATF7IP2 mRNA is expressed in
germinal vesicle oocytes and surrounding follicular cells (granulosa and cumulus cells) (Fig.
2C). Furthermore, quantitative real-time PCR analysis demonstrated that expression of
ATF7IP2 mRNA is abundant in germinal vesicle (GV) and metaphase II (MII) stage oocytes, as
well as in early embryos, but decreases between 8-cell and blastocyst stage, suggesting that
ATF7IP2 might be a maternal effect (Fig. 2D).

CONCLUSION
Collectively, our results suggest that Ubc9 is developmentally regulated in cattle and it
interacts with ATF7IP2, a gonad-specific protein, which might play an important role in oocyte
development and early embryonic development.
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Table 1. List of primers used in this study
Gene Name

Primer Name

Primer sequence

Application

Ubc9

Ubc9-RTPCR-For
Ubc9-RTPCR-Rev
Ubc9-Real time-For
Ubc9-Real time-Rev

ACGATTACCCATCCTCACCAC
CCTCGGGACTCATCCAAGTAT
GGAATACGAGAAAAGGGTTCG
CTTCCTTTTACGATGCCACAG

Ubc9-YTH-For-NdeI

TATCATATGATGTCGGGGATCGCCCTCAGC

Ubc9-YTH-Rev-BamHI

ATAGGATCCTTATGAGGGAGCAAACTTCTT

RPS18

RPS18-RealTime-For

GTGGTGTTGAGGAAAGCAGACA

RPL19

RPS18-RealTime-Rev
RPL19-RTPCR-For
RPL19-RTPCR-Rev

TGATCACACGTTCCACCTCATC
GAAATCGCCAATGCCAACTC
GAGCCTTGTCTGCCTTCA

GFP

GFP-Realtime-For

CAACAGCCACAACGTCTATATCATG

GFP-Realtime-Rev
ATF7IP2-ORF-ATG-For
ATF7IP2-ORF-TAA-Rev
ATF7IP2-Real time-For
ATF7IP2-Real time-Rev

ATGTTGTGGCGGATCTTGAAG
ATGGCAAGTCCAGATAGAAGTA
TTAGGTAAGATTTTCAGAAAAC
AATGGCCTGTACTTTATCTAAG
TTAGGTAAGATTTTCAGAAAAC

RT-PCR analysis
RT-PCR analysis
Real Time PCR
Real Time PCR
Cloning of Ubc9 ORF into
pGBKT7-53 DNA-BD vector
for Yeast two hybrid
Cloning of Ubc9 ORF into
pGBKT7-53 DNA-BD vector
for Yeast two hybrid
Real Time PCR
(endogenous control)
Real Time PCR
(endogenous control)
RT-PCR control
RT-PCR control
Real Time PCR (exogenous
control)
Real Time PCR (exogenous
control)
cDNA cloning
cDNA cloning
Real Time PCR
Real Time PCR

ATF7IP2
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Table 2. Ubc9 interacting proteins (UIP) identified by yeast two-hybrid screening. The SUMOsp 2.0
software program was used to predict and score sumoylation sites within the interacting proteins. The
consensus sumoylation site ψKXE is underlined in each interacting protein
CLONE

Gene Name

Accession
Number

No of
Clones

SUMO SITE (ΨKXE)

UIP-1

Activating transcription factor 7 interacting
protein 2 (ATF7IP2)

XP_002698006.1

3

DILKSEE, ETVKSET

UIP-2

RAN binding protein 2 (RANBP2)

DAA24795.1

1

EAIKKEM, VTLKNEG,
SSVKCEA

UIP-3

Lymphocyte cytosolic protein 1 (LCP1)

DAA23956.1

1

DLLKTEN

UIP-4

E3 SUMO-protein ligase (PIAS1)

NP_001068864.1

3

LGPKHEL

UIP-5

Exosome complex exonuclease RRP45

NP_001030225.1

1

TAFKMEK
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Figure 1. Spatio-temporal expression patterns of bovine Ubc9. A) Ubc9 mRNA expression in
various bovine tissues (mean ± SEM, n=3) determined by quantitative real-time PCR. B)
Quantitative real-time PCR analysis of Ubc9 mRNA expression in bovine fetal ovaries of
different developmental stages (mean ± SEM, n=3). C) Expression of bovine Ubc9 mRNA in
granulosa cells, cumulus cells and germinal vesicle oocytes (mean ± SEM, n=3). Bovine RPS18
was used as an endogenous control. D) Relative abundance of Ubc9 expression in bovine
oocytes and in vitro produced bovine early embryos. The oocytes and embryo samples used in
the experiment included GV- and MII-stage oocytes, pronuclear (PN), two-cell (2C), four-cell
(4C), eight-cell (8C), 16-cell (16C), morula (MO)-stage, and blastocyst (BL)-stage embryos.
Ubc9 transcript levels were normalized relative to abundance of exogenous control (GFP) RNA
and as shown as mean ± SEM (n=4 pools of 10 embryos per treatment). Different letters
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indicate statistical difference (P < 0.05). E) Immunoflorescent localization of Ubc9 protein during
oocyte maturation and preimplantation bovine embryos. Nuclear DNA was stained with 4, 6diamidino-2-phenylindole. No staining signal was observed in the embryos incubated in the
absence of Ubc9 antibody (panel J).
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Figure 2. Expression analysis of bovine ATF7IP2. A) Quantitative real-time PCR analysis of
ATF7IP2 mRNA expression in various bovine tissues (mean ± SEM, n=3). B) ATF7IP2 mRNA
expression in bovine fetal ovaries of different developmental stages (mean ± SEM, n=3). C)
Expression of bovine ATF7IP2 mRNA in granulosa cells, cumulus cells and germinal vesicle
oocytes (mean ± SEM, n=3). D) Relative abundance of ATF7IP2 expression in bovine oocytes
and in vitro produced bovine early embryos. The oocytes and embryo samples used in the
experiment included GV- and MII-stage oocytes, pronuclear (PN), two-cell (2C), four-cell (4C),
eight-cell (8C), 16-cell (16C), morula (MO)-stage, and blastocyst (BL)-stage embryos (n=3 pools
of 25 embryos per treatment; mean ± SEM). Different letters indicate statistical difference (P <
0.05). Bovine RPS18 was used as an endogenous control.
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SPECIALIZED SKILLS
RT-PCR, PCR, Semi-quantitative PCR, Real-time PCR, plasmid DNA purification/cloning, northern-southernwestern blotting, cDNA/microRNA library construction and screening, microarray, yeast two-hybrid analysis, insitu hybridization, immunohistochemistry, immunocytochemistry, mammalian cell culture, GFP-transient
assays, luciferase reporter assays, site-directed mutagenesis, mammalian embryo culture, confocal
microscopy, recombinant protein production/purification, RNA&DNA/protein and protein-protein interaction
analyses.
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PUBLICATIONS
Swamy K. Tripurani, K B. Lee, L. Wang, G. Wee, G.W. Smith Y.S. Lee, K.E. Latham, and J. Yao. 2011. A
novel functional role for the oocyte-specific transcriptional factor newborn ovary homeobox (NOBOX) during
early embryonic development in cattle. Endocrinology, 152 (3): 1013-1023.	
  

	
  

	
  

B. Lingenfelter, Swamy K. Tripurani, J. Tejomurtula, G.W. Smith, and J. Yao. 2011. Molecular cloning and
expression of bovine nucleoplasmin 2 (NPM2): a maternal effect gene regulated by miR-181a. Reproductive
biology and Endocrinology, (DOI: 10.1186/1477-7827-9-40). 	
  
Swamy K. Tripurani, K. Nakaminami, K B. Thompson, S V. Crowell, C L. Guy and D T. Karlson. 2011 Spatial
and temporal expression of cold-responsive DEAD-box RNA helicases reveals their functional roles during
embryogenesis in Arabidopsis thaliana. Plant molecular biology reporter (DOI: 10.1007/s11105-010-0282-1).

	
  

Swamy K. Tripurani, G. Wee, K B. Lee, G. W. Smith and J. Yao. MicroRNA-196a regulates bovine newborn
ovary homeobox gene (NOBOX) expression during early embryonic development. (Submitted to BMC
Developmental Biology).	
  
Swamy K. Tripurani, Xiao.C, M.Salem, and J. Yao.2010. Cloning and analysis of fetal ovary- microRNAs in
cattle. Animal Reproduction Science, 120: 16-22	
  
J. Tejomurtula, K B. Lee, Swamy K. Tripurani, G. W. Smith, and J. Yao. 2009. Role of importin alpha8, a new
member of the importin alpha family of nuclear transport proteins, in early embryonic development in cattle.
Biology of Reproduction 81 (2): 333-342.
Swamy K. Tripurani, N S. Reddy and K R S. Sambasiva Rao. 2003. Green revolution vaccines, edible
vaccines. African journal of biotechnology 2 (12): 679-683.

------ Manuscripts in preparation ------

	
  

L. Wang, Swamy K. Tripurani, W. Wanna, G.M. Weber, C.E. Rexroad III, and J. Yao. Cloning and
characterization of a novel oocyte-specific gene Fbos and its interactions with proteins important for oocyte
development in rainbow trout (Oncorhynchus mykiss). (Target journal Molecular Reproduction and
Development).	
  
Swamy K. Tripurani, K.B. Lee, G. Wee, G.W. Smith and J. Yao. Cloning and expression of bovine factor in
the germline alpha (FIGLA) in oocytes and early embryos: a potential target of microRNA-212. (Target journal
Biology of Reproduction)	
  

	
  

Swamy K. Tripurani, K.B. Lee, L. Wang, G.W. Smith and J. Yao. The SUMO-conjugating enzyme Ubc9 is
developmentally regulated and interacts with activating transcription factor 7 interacting protein 2 (ATF7IP2) in
cattle. (Target journal Reproductive biology and endocrinology)	
  

	
  

------ Conference proceedings ------
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Swamy K. Tripurani, K.B. Lee, L. Wang, G.W. Smith and J. Yao. The SUMO-conjugating enzyme Ubc9 is
developmentally regulated and interacts with activating transcription factor 7 interacting protein 2 (ATF7IP2) in
cattle. Society for the study of reproduction (SSR) 2011 conference proceedings.	
  
Swamy K. Tripurani, K.B. Lee, G. Wee, G.W. Smith and J. Yao. Cloning and expression of bovine factor in
the germline alpha (FIGLA) in oocytes and early embryos: a potential target of microRNA-212. International
Embryo Transfer Society (IETS) 2011 conference proceedings. Reproduction, fertility and development 23 (1):
109-109.	
  

	
  

	
  

Swamy K. Tripurani, G. Wee, K.B. Lee, G.W. Smith and J. Yao. MicroRNA-196a regulates bovine newborn
ovary homeobox gene (NOBOX) expression during maternal-zygotic transition. Society for the study of
reproduction (SSR) 2010 conference proceedings.	
  
Swamy K. Tripurani, K.B. Lee, L. Wang, G.W. Smith and J. Yao. Cloning and characterization of newborn
ovary homeobox gene (NOBOX) in cattle. International Embryo Transfer Society 2010 conference
proceedings. Reproduction, fertility and development 22 (1): 160-161.	
  
L. Wang, Swamy K. Tripurani, W. Wanna, G.M. Weber, C.E. Rexroad III, and J. Yao. Fbos, a novel oocytespecific protein, interacts with protein important for oocyte development in rainbow trout (Oncorhynchus
mykiss). Society for the study of reproduction (SSR) 2010 conference proceedings.

	
  

	
  

Kyung-Bon Lee, Swamy K. Tripurani, Jianbo Yao, James J. Ireland, and George W. Smith. Involvement of
SMAD signaling in bovine early embryonic development. Society for the study of reproduction 2009 conference
proceedings. Biology of Reproduction 81: 232.	
  
Swamy K. Tripurani, Caide Xiao, Mohamed Salem, and Jianbo Yao. Cloning and expression profiling of fetal
ovary-expressed microRNAs in cattle. Society for the Study of Reproduction 2009 conference proceedings.
Biology of Reproduction 81: 345.	
  
Lei Wang, Swamy K. Tripurani, Warapond Wanna, Gregory M. Weber, Caird E. Rexroad III, and Jianbo Yao.
Cloning and characterization of a novel oocyte-specific gene encoding an F-box protein in rainbow trout
(Oncorhynchus mykiss). Society for the Study of Reproduction 2009 conference proceedings. Biology of
Reproduction 81: 349.	
  

AWARDS & RECOGNITIONS
	
  
	
  

	
  

1st place in student research competition at 2011 International Embryo Transfer Society (IETS)
conference.	
  
Recipient of 2010 USDA NRI CSREES merit Award.	
  
Recipient of 2010 Larry Ewing Memorial Trainee Travel Fund.	
  
2nd place in student research competition at 2010 International Embryo Transfer Society (IETS)
conference.	
  
2nd place in PhD student poster competition at Davis College Research Day, West Virginia University,
2009.	
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